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Two aspects of perinatal amino acid metabolism were studied:-
1. The influence of fetal insulin infusions on the placental transfer of
amino acids, L phenylalanine leucine and lysine was investigated in
sheep of 115 - 127 days gestation.
14
It was confirmed that C labelled ammo acids were transferred readily
from the mother to fetus during a continuous maternal infusion, plasma
water activity reaching a plateau in 1 - 2 hours.
However, most of the plasma activity was contained in the albumin
fraction of the proteins, 89% in the mother and 78% in the fetus.
3 14 • . .
Comparing H and C labelled amino acids, total plasma activity was
lower and plasma water activity higher when 3h labelled phenylalanine
was infused.
Insulin infusions were started after 4 hours continuous labelled amino
acid infusion when steady state transfer conditions had been achieved.
Insulin concentrations increased 8-56 fold but placental amino acid
transfer as judged by changes in amino acid SA was not significantly
changed. Fetal plasma water label remained constant whilst amino acid
concentrations decreased, suggesting that increased net protein synthesis
occurred, probably by decreased fetal protein catabolism.
Fetal phenylalanine flux (prior to insulin infusion) was calculated at
231 and 137 umol/kg/hr, and leucine and lysine flux at 217 umol/kg/hr
and 318 umol/kg/hr respectively.
2. The influence of insulin on plasma amino acid concentrations during intra¬
venous feeding in preterm infants.
During insulin infusions of 0.2 iU/kg/hr, the plasma amino acids decreased
but the rapidity duration and extent of the response varied; such infusions
may, therefore, be of limited value in assisting the tissues to take up
and retain amino acids.
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THE EFFECT OF INSULIN ON FETAL AND NEONATAL AMINO ACID METABOLISM
Optimal fetal growth, resulting in the birth of a well developed
term infant is only possible if the intrauterine environment is
capable of satisfying all fetal requirements. Amongst the most
important of these requirements is the supply of nutrients, of which
amino acids are of obvious importance for protein synthesis. The
availability of amino acids is dependent both on maternal nutrition
and health and the normal development and function of the
placenta. The utilisation of nutrient by the fetus in utero is
determined, to a large extent, by the hormonal and genetic status
of the developing fetus itself, although maternal and placental
metabolism can modify that of the fetus. Postnatally genetic
and hormonal control passes entirely to the infant, who is no
longer subject to either adverse or protective influences of the
intrauterine environment - an example of adverse conditions being
those experienced by an infant of a phenylketonuric or diabetic
mother and an example of in utero protection being that of an
infant with Maple Syrup Urine disease.
In this study unanaesthetised, unstressed sheep in the last
trimester of pregnancy have been used to study placental transfer
of the L-amino acids phenylalanine, leucine and lysine, and their
subsequent utilisation by the fetus.
The influence of fetal insulin concentration on placental
transfer and fetal amino acid metabolism in the sheep is
reported, together with some observations on the effects of insulin
on the post natal metabolism of intravenously fed preterm human
infants.
Preterm, but appropriate weight for gestation infants have
grown and developed normally _in utero until delivery. After
birth the paediatric objective for these infants is to promote
growth and development at a rate similar to that which would
have been subsequently achieved in utero. However, immaturity
of organ function and lack of nutritional reserves handicap the
preterm infant whose nutritional requirements per Kg body
weight exceed those of the term infant. In order to achieve
optimal nutrition in the preterm infant the normal nutritional
supply and demand in utero must be known and the changed and
possibly increased demands of extra-uterine life studied. In
this thesis, placental transfer and fetal metabolism of amino
acids are investigated in an attempt to improve understanding
of fetal nutrition. Particular attention has been given to the
role of insulin in fetal growth and its possible use in reversing
catabolism and promoting anabolism in the sick preterm infant.
Pother and fetus are both ultimately dependent for amino
acids on maternal dietary protein and its efficient absorption and
utilisation. The fetus is additionally dependent on the transport
of available nutrients across the placenta and any impairment to
the nutrient supply due to either maternal dietary deprivation or
placental insufficiency, can reduce fetal growth.
Growth depends not only on a supply of amino acids but also on fetal
utilisation of these in peptide and protein synthesis, the two phenomena
being inseparably linked. In the steady state rates of protein synthesis
and catabolism are equal but in the developing fetus rapid growth must
result in net synthesis exceeding net catabolism. These rates may be
measured using radioactive (and more recently with 1 C and labelled''")
amino acids but this
method of approach is obviously only possible in animal species,
and the majority of studies have been "acute" experiments in
anaesthetised animals.
Only recently have "chronic" animal studies been used in which
catheterisation of fetal vessels permitted physiological and
biochemical observations in the conscious animal.
Even so, the influence on these observations of relatively
minor stresses to which the mother may be subjected and the
length of time required to regain a steady physiological state
following catheterisation procedures has not been recognised .
Care was therefore taken to ensure that animals used in the experiments
were in a near normal physiological condition.
ISaternal placental
and fetal hormones have been shown to influence fetal growth in
a variety of animals ' .
In man, fetal pancreatic insulin has a major influence on fetal
growth . In this study the action of insulin on fetal metabolism
was examined by infusing 5 sheep fetuses under stead}' state
conditions. Changes in transfer and plasma clearance rates of
labelled amino acid
were measured to assess the response to insulin.
The rate of growth in the newborn as in the fetus must correlate
with the rate of protein synthesis. In order to achieve anabolism
and growth the dietary protein intake must exceed basal metabolic
requirements. In the normal term infant receiving an adequate milk
intake dietary protein is available for protein synthesis.
Howeverinthe preterm or light for date (LFD) infant not only may
dietary intake and intestinal absorption be diminished relative
Ur
to size, but obligatory energy expenditure may be increased,
e.g. through increased heat and water losses. In addition, energy
reserves of glycogen and fat are small. The preterm and LFD infant
are, therefore, more likely to utilize dietary protein and body
tissue (primarily muscle) protein in order to meet these energy
requirements. When requirements cannot be met by enteral feeding,
parenteral infusions of amino acids, fat, carbohydrate mineral
solution and vitamins can reverse catabolism and promote protein
synthesis and growth. Under very carefully controlled conditions
it may be possible to further increase the protein synthetic rate
by supplying exogenous insulin. Changes in neonatal plasma
concentrations of amino acids, fat and glucose were monitored in
infants receiving total parenteral nutrition to assess whether
the infusion of insulin could promote anabolism.
5
LITERATURE BACKGROUND
i MATERNAL, FETAL AND NEONATAL AMINO ACID ENVIRONMENT
Amino acid concentrations of maternal and fetal fluids have been
measured, and changes in these examined in relation to gestational age,
pregnancy complications and maternal nutrition. Abnormal concentration
relationships between mother and fetus could indicate either altered
transfer rates across the placenta or altered fetal utilisation.
a. Maternal Amino Acid Environment
Both essential and non essential free amino acid concentrations
decrease in maternal plasma during the first trimester of pregnancy
and are maintained at this new lower concentration until pregnancy
10,11,12,13,14,15,16
terminates, when non-pregnant values are rapidly regained.
There is little doubt that endocrine changes, in addition to
17,18,19,20
fetal demands, are responsible for this general reduction, probably
through increasing cellular uptake into the uterus and its contents,
12,18,21
and increasing amino acid, urinary excretion.
ii 22 ii
Additionally, Bjornesjo observed that although amino acid
concentrations were decreased in plasma during pregnancy, red
blood cell concentrations were increased. This he felt might also
have been mediated through endocrine influences, (oestrogen, insulin)
there being an increased uptake of amino acids from plasma.
b. Fetal and Neonatal Plasma Amino Acid Environment
That amino acids are at a greater concentration in fetal than
13,14,15,16,23,24,25
in maternal plasma water has been observed by many investigators.
The ratio of umbilical venous (uv)rmaternal venous (mv)
free amino acid concentrations in man is between 1:1 and 2:1 for
lo
most amino acids, although changes in the ratio of individual amino
acids occur as pregnancy progresses. Highest uv concentrations of
plasma free amino acids have been observed during the second
13,25
trimester of pregnancy. The ratio in the sheep is higher than in
26
man, while that of the guinea pig falls between the two.
Small, but characteristic, changes in plasma composition
occur during the first three days of neonatal life, most amino
27,28
acids decreasing.
c. Amniotic Fluid, Fetal and Neonatal Urine Composition
Like fetal plasma, free amino acid concentrations in amniotic
25
and fetal urine decrease during the third trimester. Fetal urinary
amino acid concentrations are generally below those of fetal plasma.
In mid pregnancy there is a linear correlation for ten amino acids
between concentrations in amniotic fluid and fetal urine in man,
but at term, when large volumes of amniotic fluid (total volume
31 32
1000 ml) are swallowed by the fetus (approximately 450 ml/day)
25
no correlation exists. Correlations between mv (8) and umbilical
arterial (7) concentrations however, are found.
At birth, there is a rapid increase in urinary amino acid
concentration so that urine amino acid concentrations are higher
25
than that of neonatal plasma.
d. Disorders of the Amino Acid Environment
Deviation from the normal free plasma amino acid concentrations
e.g. in phenylketonuria and pre-eclampsia may be associated with
abnormal fetal growth, reflecting changes in either fetal metabolism
or placental transfer.
7
Free amino acid concentrations in plasma of both maternal
and fetal blood have been found to be increased in pregnancies
23,28,30
of pre-eclamptic mothers with LFD (light for date) infants.
However, the uv:mv ratios were decreased, particularly those of
branched-chain amino acids (BCAA) and urea. It is suggested that
alterations in hormonal balance and maternal blood flow in these
mothers reduces the placental uptake, and thereby transfer to the
23
fetus of both amino acids and glucose. This results in utilization
of amino acids for gluconeogenesis. Thus the high fetal uv
concentration of plasma free amino acids represents fetal starvation
rather than protection of the fetus from adverse placental conditions.
33
This is supported by the finding that although in plasma of phenylketo¬
nuria mothers the phenylalanine concentration was increased, the
uv:mv ratio was relatively normal. The fetal plasma free phenylalanine:
tyrosine ratio however was 8.16:1 compared with 2.47:1 in normal
pregnancies (see page 2b) .
Abnormal hormonal status in maternal diabetes has little
13,23
effect on plasma amino acid concentrations, but significantly
34
increases fetal growth rate, including that of the B islets of
the fetal pancreas, resulting in an increased fetal insulin
35
concentration (8.2 jul/ml compared with 53.5 js1/ml) .
Despite similar post natal diets, the plasma amino acids and
protein of LFD and large infants may still show variations from
23,28
those of normal infants seven days after birth. Additionally,
in the preterm infant, a limited dietary intake coupled with
limited digestive ability, immature enzyme function and, often,
$
clinical illness (ideopathic respiratory distress syndrome,
infection, biochemical and coagulation problems) may significantly
alter the plasma amino acid profile from that of normal human
milk fed term infants.
Significant alterations can also occur when parentral feeding
is employed in preterm infants to increase nutrient intake.
Many of the changes induced by parenteral feeding are governed by
external factors e.g. amino acid solution used, rate of infusion
36,37
and balance with other calorie sources, but alterations can also
be related to immaturity, and these changes must be considered
when assessing the requirements for any form of nutrition.
Small carbohydrate and fat reserves, in addition to a low
caloric intake may force the preterm infant to use amino acids
for gluconeogenesis. Thus, the plasma amino acid profile might
resemble that observed in the plasma of starved children and adults -
with alanine, glutamine, glycine, histidine, serine, methionine,
isoleucine and ornithine all being reduced.
Impaired gluconeogenesis resulting from enzyme immaturity
might, however, produce the opposite effect and plasma alanine,
aspartic acid, serine, glycine and methionine concentrations could
increase. Immature enzyme function might also influence methionine
and cystine, phenylalanine and tyrosine concentrations (see page 22) ,
cystine, tyrosine, histidine and arginine being essential not only
36,38,39
for preterm but also term infants.
The use of insulin in these small preterm parenterally fed
infants to promote protein synthesis would probably only be effective
if there was a balanced supply of amino acids, dietary amino acid
40-53
imbalance having been shown to reduce growth rate.
54,55 56,57,58
Both acute and chronic maternal under and/or malnutrition
has been found to be associated with an increased incidence of
intrauterine growth retardation, with the infant being further
disadvantaged by poor maternal lactation. However, diet may
not be the only factor responsible, hard manual work of the
women in many of the studies causing an alteration in blood flow
57
patterns and a decreased flow to the uterus and placenta. Uv:mv
59,60,61
ratios and concentrations of plasma free amino acids resembled
those of LFD infants of pre-eclamptic mothers. Hence, although
different factors may be responsible for decreased placental transfer
the fetus responds in a similar manner.
The ratio of plasma free glycine + serine + glutamine +
taurine : leucine + isoleucine + valine + methionine concentrations
62,63
has been used to assess dietary deficiency. This showed that
metabolism in the perinatal period was different in LFD infants,
the ratio being increased on day one, irrespective of gestation, in
contrast to that or normal infants which decreased. The increase
was caused by depressed essential amino acid concentrations.
In man, anaesthesia during labour has little effect on maternal
15
amino acid concentrations, alanine and cystine falling slightly.
However, these two amino acids have been found to be increased in
23
Caesarean sections together with lysine and glutamic acids.
Surgery to implant fetal catheters, however, has a profound effect
64
on amino acid concentrations. These changes are discussed on page
to
e. Abnormalities of Placental Structure
As the supply of fetal nutrients depends on the efficient
functioning of the placenta, it might be thought that the
placental lesions would result in a growth retarded infant. However,
65
although Gruenwald (1963) found lesions in placentae of 36-41 week
gestational infants, the infants showed no detectable growth
retardation. Only occasionally could fetal growth retardation be
ascribed to either smaller placentae or gross lesions. The study
did not preclude the possibility of retardation through minute
occlusions of the placental villi.
Later, Aherne and Dunnill reported that the placental volume
and chorionic villous surface area were reduced in hypertension and
that the ratio of parenchyma:non parenchymal tissue was reduced in
66
small for dates infants.
67
Pearse and Sornson examining free amino acid contents of normal
and abnormal placentae found an increase in concentration as
pregnancy progressed. Infarcted placentae had low concentrations
and placenta of pre-eclamptic mothers high amino acid concentrations.
The reduced blood flow and therefore amino acid supply in the former
and increased maternal plasma amino acid values in the second could
well produce these effects.
The importance of good maternal and placental circulation for
68
satisfactory fetal growth was studied in pigs by Wootton et a_l (1977).
Significant positive correlations between placental blood flow and
both placental and fetal weight, compared with correlations between
placental and fetal weights highlighted the problems a reduction in
blood circulation through vascular disease or circumstance such as
u
"TA*>l_E I
MEAN PLASMA AMINO ACID CONCENTRATIONS IN PREGNANT SHEEP*
Maternal Fetal
+
Mean - SD Mean - SD
Threonine 52 26 217 84
Valine 114 43 331 82
Methionine 14 5 25 9
Isoleucine 79 15 92 22
Leucine 67 26 106 34
Tyrosine 38 11 89 31
Phenylalanine 35 9 88 22
Lysine 131 37 113 36
Histidine 37 12 63 19
Serine 95 29 881 327
Glutamic Acid 125 36 135 50
Glutamine 208 77 355 185
Glycine 826 195 856 432
Alanine 124 32 271 117
Citruline 187 77 137 50
Ornithine 71 36 107 49
Arginine 145 46 125 57
Taurine 84 60 141 114
1 - Methylhistidine 58 14 130 42
3 - Methylhistidine 38 14 98 44
Asparagine 36 14 67 42
TAA 2565 382 4430 1055
EAA 568 159 1125 249
NAA 1378 260 2498 839
TAA = Total Amino Acids
EAA = Essential Amino Acids
NAA = Non-Essential Amino Acids
+ From Slab*
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hard physical work might cause. The relationship between blood
flow and amino acid placental transfer is discussed in section ii,
page llo.
f. The Relationship between Maternal and Fetal Amino Acid
Environments in Animals
Animal studies have produced similar results to those reported
in the human. Reports of free amino acid concentrations in the ewe
show glycine, threonine, serine and alanine to be higher than in man
69
and methyl histidines to be present. Typical concentrations of
leucine, lysine and phenylalanine, the three L amino acids employed
in these experiments being 67 - 26, 131 - 37 and 35-9 umol/1
70
respectively in maternal plasma of sheep maintained under identical
conditions to the sheep used in the experiments, and 106 - 34,
113 - 36 and 88 - 22 umol/1 in fetal plasma.
Free amino acid concentrations for all amino acids are shown
in Table I .
Animal experiments have enabled the effects of nutrition in
pregnancy to be studied more fully. The relative proportion of
infused amino acids being utilised for protein synthesis vary with
71
altered energy and nitrogen intakes. Reilly and Ford (1971) and
72
Slater and Mellor (1972) found the plane of nutrition in sheep
influenced the metabolic rate of both carbohydrates and amino acids.
A low plane of nutrition increased the utilisation of amino acids
in gluconeogenesis and total plasma protein significantly decreased
and although total amino acids remained unchanged the non-essential:
essential amino acid ratio in both maternal and fetal plasma had
1^
72
increased by 20 weeks gestation. The fetal:maternal ratios of
amino acids were similar on both high and low nutritional planes
suggesting that the fetus took a higher percentage of the available
amino acids of the ewes on the low plane of nutrition.
73,74
Pregnancy increased the flux of amino acids, but not glucose.
However, only 3% of amino acids and 40% of glucose were oxidised to
carbon dioxide compared to 62% of amino acids and 65% of glucose in
the non-pregnant state. Setchell et_ al found that both fructose and
75
glucose are converted to glycogen and carbon dioxide in the fetus
but together only accounted for a small fraction of total carbon
76
dioxide from uterus and contents. Anand (1979) using well fed
ewes, found all the fetal glucose to be from the mother, no glucose
being formed by the fetus.
Animal models have been employed in the study of intrauterine
growth retardation by compromising the nutrient supply to the fetus
through either ligation of the uterine vessels or maternal diet
restriction. The effect of this may vary with the time of gestation
77,78,79
employed - late fetal growth being more sensitive to restriction.
Offspring of the two forms, although physically alike, may also
80
differ metabolically, therefore care must be taken in assessing
data from these models.
»♦-
ii PLACENTAL TRANSFER
The rate and degree of transport of amino acids across the placental
barrier is influenced by the structure of the individual amino acids,
blood flow and amino acid concentrations and the metabolic requirements
of the fetus, placenta and to a lesser extent the mother.
Transport of amino acids across the placenta to the fetus, which
takes place against a concentration gradient, is believed to be achieved
26, 75, 76, 77, 78, 79, 80, 81
by the following mechanism:
The first phase is active uptake of amino acids from the maternal plasma
by the syncytiotrophoblast. These amino acids are then concentrated in
placental parenchyma, resulting in placental free amino acid concentrations
above those of both maternal and fetal plasma. Subsequent transfer to
the fetus is therefore by diffusion down a concentration gradient,
the fetus itself providing a genetic "pull" by rapid utilization of
amino acids in protein synthesis.
a. Amino Acid Structural and Transport Groups
Transport of amino acids across the placenta shares character-
88
_ 89
istics with other tissues such as intestine and brain. Four groups
of amino acids have been recognised:
a) neutral straight chain amino acids - alanine, glycine and
serine
b) neutral branched chain amino acids - leucine, isoleucine
and valine
c) acidic amino acids - glutamic and aspartic
d) basic amino acids - lysine, arginine and histidine.
On column chromatography phenylalanine, tyrosine and tryptophan
elute between the neutral branched chain and basic amino acids
whilst methionine, cystine and proline elute amongst the neutral
amino acids. Further classification may be made according to their
90,91,92,93,94
transport characteristics. Neutral straight chain amino acids are
actively transferred by an "A" (alanine) preferring system whilst
neutral branched chain amino acids are exchanged across membranes
26,82
by an "L" (leucine) preferring system, this system being the fastest,
the greater solubility of branched chain amino acids probably
92
aiding their transfer across membranes. These "A" and "L" systems
and a basic amino acid transport system are energy, oxygen and
95 96
sod ium dependent. Energy can be provided by anaerobic processes,
97
particularly in the fetus which is more resistant to hypoxia.
Phenylalanine, methionine and proline probably utilize both the
"A" and "L" preferring systems. Acidic amino acids however, are not
generally transferred intact, but are formed in the placenta by




The transfer systems are stereospecific, L isomers being
selectively transferred and there is competition between amino
acids within a group. Considerable overlap between transport groups
has also been noted. A further late developing transport system for
105-110
glycine and imino acids has been described in the neonatal kidney.
Neutral straight chain and acidic amino acids are metabolically
the most labile, whilst neutral branched chain and basic amino
acids are essential and, in addition to general metabolism, are
utilized extensively in protein synthesis.
I (o
b. Transport of Amino Acids
1) Uptake and Transfer
Placental uptake of amino acids has been studied both in vitro
and in vivo. Active uptake of amino acids is principally a function
of the maternal aspect of the placenta. Microvesicles formed from
the plasma membrane of the human placenta have a greater affinity
(3 fold) for amino acid uptake in comparison with microvesicles
87
formed from the intracellular membranes of the trophoblast, although
the latter have a greater overall capacity (36 times) thus permitting
concentration of amino acids.
Investigation of amino acid uptake into placental tissue slices
111
by Schneider and Dancis showed that the intracellular:extracellular
ratio achieved was determined as much by the efflux rate as the
rate of uptake. Acidic amino acids were rapidly taken up, producing
a high ratio whilst basic amino acids accumulated more slowly because
of efficient efflux. Neutral amino acid behaviour was similar to
that of basic amino acids but no plateau was attained. Leucine
was unusual in that a very rapid efflux rate resulted in a ratio
below one. This could have been a result of the tissue preparation
as previously it had been suggested that the physical structure of the
placenta may be of importance, transport being "enhanced" in an intact
112
human villus compared with that in slices.
The slow but progressive development of high intracellular amino
acid gradients in placental tissue during in vitro experiments because
of ineffectual efflux resembles that of immature tissue, for although
mature tissue has a more rapid uptake efficient efflux rapidly results
in a plateau concentration. Thus, although species (e.g. guinea pig
and man) and individual amino acid (e.g. valine) differences have
113
been noted, fetal tissues generally have a higher concentration of
amino acids than those of adults.
11-
Placental tissue also resembles fetal tissue in that it continued
to function under anaerobic conditions, AIB uptake being only slightly
diminished on replacing oxygen with nitrogen. However, addition of
DNP to the medium resulted in a 40% reduction, and the addition of
96,112
arsenate completely inhibited AIB uptake. This contrasts with
in vivo findings; transfer of amino acids across the placenta of
guinea pigs infused in situ were little affected by maternal
84
hypoxia DNP or KCN until after maternal function was impaired.
Observations on amino acid uptake in placental tissue slices are
in agreement with values calculated from the free amino acid concen¬
trations in the trophoblast and a low maternal veinitrophoblast ratio
were found for acidic amino acids (ratio 1:60 for glutamate).
Neutral straight chain amino acids were intermediate in both concentration
and ratio (1:10 for alanine), the concentration in the trophoblast of
neutral branched chain and other essential amino acids being lower
than acidic amino acids, thus reducing the gradient between maternal
plasma and trophoblast (1:5-9).
This suggests that essential amino acids are readily transferred
but that the acidic amino acids are concentrated in the placenta, a
large percentage of these acidic amino acids probably being a product
of placental metabolism rather than the previously suggested combined
uptake from the uterine and umbilical plasmas.
Further evidence for this selective transfer was provided by the
placental transfer rates of amino acids in the sheep during maternal
82,83
loading with neutral straight and branched chain amino acids. Whilst
only a small increase in fetal plasma amino acid concentration was
found in the former group, indicating only a slow transfer, both the
free amino acid concentration and the umbilical plasma arterial:venous
IS
difference increased in the latter, suggesting both rapid transfer
and increased uptake by fetal tissues. In rats maternal loading
115
with phenylalanine and tryptophan resulted in a lag phase before
fetal plasma amino acid concentrations increased. This was ascribed
to the concentrating of amino acids within the placenta. Similarly
in the previous experiment the attenuated and extended fetal concen¬
tration curve compared with that of the mother could well result
from accumulation of amino acids within the placenta.
Species differences in the rate of transfer of some amino
87
acids are apparent. Basic and neutral straight chain amino acids
are transferred relatively slowly across the sheep placenta, but
more readily across that of the monkey. Essential amino acids
however behave similarly in sheep, guinea pig and monkey. Cystine
116 117
is not actively transferred in most species. Larson e_t al and
118
Matthews and Laster reported that inhibition of transport by the amino
acid itself only occurs at very high (1 mm) unphysiological concen¬
trations, and although effects may be additive these concentrations
were not reached in these loading experiments.
2) Arterial-Venous Differences and Blood Flow
Measurement of uterine arterial-venous differences together
with uterine blood flow enables direct assessment of uterine uptake,
the majority of which is accounted for by the placenta and fetus, only
87 98
5% of the blood flow passing through the myometrium. Holzman ert al
found that in unstressed sheep there was a significant uptake of
neutral and basic amino acids into the pregnant uterus (65% and 20%
respectively of the total), and uptake correlated well with the
uterine free amino acid arterial concentration, the only exception
being glycine which is at a high concentration in sheep plasma.
19
Acidic amino acids, however, were not effectively removed, there being
little difference in the uterine venous and arterial concentrations.
119
Glutamic acid crosses the placenta only slowly or is not transferred.
During the studies of uterine and umbilical arterial-venous differences
no significant transfer occurred, in agreement with previous findings
103
in the rat, but Schneider, using the tissue slice preparation found
49% of the glutamic acid presented to the placenta was taken up.
However, only 10% of this was transferred, this being in comparison
with a 75% transfer of leucine although only 16% of this amino acid
was taken up. In contrast to the slow insignificant transfer of glutamic
acid, glutamine is efficiently transferred, for although placental
amination of glutamate accounts for a proportion, fetal uptake was
found to be in excess of the combined placental uptake of glutamate
from fetal and maternal plasma. This is also true of aspartic acid
98-101
and asparagine.
Perfusion of guinea pig placenta in situ has shown maternal blood
flow to have a significant influence on amino acid transfer, a
84,120
decreased uterine flow reducing the total amino nitrogen transfer.
A 30% reduction in blood flow not only reduced both glucose and amino
nitrogen placental transfer, but neutral branched chain and basic amino
acid transfer was reduced to a greater extent than that of acidic and
neutral straight chain amino acids. Thus poor placental circulation
could create an imbalanced as well as reduced supply of amino acids
to the fetus.
Unlike placental uptake from maternal plasma, blood flow
84
has only a small influence on the release of amino acids to the fetus.
Umbilical arterial concentration is a.more important factor in
determining transfer, an inverse relationship between arterial concen¬
tration and transfer having been documented by Prenton and Young
83 26,82
in guinea pig and sheep.
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Although fetal plasma concentrations of free amino acids are
greater than those of maternal plasma, they are below those of the
trophoblast, the trophoblast:fetal plasma amino acid ratio being
between 1.5 and 2.7:1. Transfer to the fetus is therefore by
diffusion. Supporting evidence for this comes from closed circuit
114
perfusion of guinea pig placenta in situ, the perfusate amino acid
concentration increasing until it approximates that of the placenta,
when transfer ceased or was reversed. Relative concentrations of
individual amino acids in fetal plasma however, are modified by fetal
metabolism.
From calculations of uv-ua differences, the majority of amino
acids are released into fetal plasma, but glutamine, glycine,
ornithine and serine have been found at higher concentration in the
121,122
arterial plasma, this occurring more frequently with increasing
121 121
gestation. Both Prenton and Young and Hayashi et a\_ found that in man
towards term alanine was the only non essential amino acid supplied
in significant quantities. This differs from sheep in which glutamine
is transferred more effectively.
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Other studies by Velazquez et_ al using umbilical arterial-venous
differences in man showed that fetal tissues retained essential
amino acids, with the surprising exceptions of leucine and valine,
but that glutamic acid, glutamine, proline and alanine were released
into fetal blood. These were subsequently removed by the placenta,
although no further transfer to the mother was detected.
Theoretically net transfer from mother to fetus may be calculated
from umbilical and uterine arterial-venous differences if the blood
flow on both sides of the placenta is known. However, the relatively
small differences in concentration (0-17 p mol/1 on the maternal side
2.1
and 12-28 u mol/1 on the fetal side) compared with the standard
error of the amino acid determinations (approximately 5%) makes
92
accurate assessment difficult. Holzman calculated the uterine
uptake of nitrogen in the ewe to be 1.45g Kg ^ day ^ and that of
carbon to be 3.9g Kg ^ day \ This compares with an umbilical uptake
of 1.5g Kg ^ day ^ (fetal weight) of nitrogen and 3.9g Kg ^ day
124
of carbon. However, as the placenta excretes ammonia and urea
(fcftiTiud in the fetus) into the uterine circulation, but has no urea
synthesizing capacity, theoretical calculation of fetal uptake
based on a uterine uptake of 1.45g Kg ^ day ^ and ammonia and urea
excretion of 0.18g Kg ^ day ^ and 0.36g Kg ^ day ^ respectively would
be 1.3g Kg ^ day ^ i.e. 90% of the uterine uptake. The excess over
the estimated requirement of lg Kg ^ day ^ for fetal growth and urea
production could be due to the analytical difficulties and assumptions
made. Alternatively, there may be other forms or routes of nitrogen
excretion.
It should also be remembered that nutrients may reach the fetus
by routes other than the placenta. Both L and D isomers have been
125
demonstrated to cross the chorioamniotic membrane in both directions,
the L transfer being rapid and both L and D isomer transfer being
inhibited by 24 DNP.
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iii FETAL AND NEONATAL AMINO ACID BALANCE
a. Free and Bound Amino Acid Relationships
No correlation exists between the uv-ua plasma concentration
differences of individual amino acids and their concentration in
intracellular fluid or protein. Thus extensive fetal metabolism of
many of the amino acids supplied by placental transfer must occur. Mots.
Acidic and neutral straight chain amino acids are synthesized de_ novo
in fetal tissues than in animals on a postnatal diet. In addition
to this increased demand for essential amino acids, the requirement
of amino acids for growth and the faster protein turnover rate in fetal
than in young or adult animals increase the relative demand for both
essential amino acids and total nitrogen. Thus although an adult
requires only 19% of the nitrogen supply as essential amino acids,
this is increased to 43% in newborn infants.
b. Enzyme Maturation
Early in its life the fetus is dependent for its needs on a
nutritionally balanced supply from the mother of amino acids and also
carbohydrates and lipids. It is not until maturation of specific
enzyme systems that the fetus possesses the potential to modify the
supply to comply with its own requirements. Study of enzyme maturation
is therefore important and classification of amino acids into essential
and non-essential groups not only differs from that of the adult
but also varies with gestation.
Functional maturity is not only dependent on the ability of
the relevant fetal cells to synthesize the enzyme, but also on the
presence of co-factors and other regulatory substances, the presence
of which may in turn be dependent on a mature enzyme system. This
is illustrated in the maturation of phenylalanine hydroxylase
37,126-133
which has been extensively investigated because of its definitive role
in PKU. In human fetal liver phenylalanine hydroxylase has been
reported to be present at 12 weeks gestation, but lack of reduced
cofactor, tetrahydropterin, prevents its expression in vivo.
However, in similar experiments using fetal brain tissue no tyrosine
126
formation was found, implying lack of enzyme. Although lack of
cofactor is the primary factor preventing expression of phenylalanine
hydroxylase in vivo, its lack is probably related to immaturity of
dihydropterin reductase, which has been shown to be lower in fetal
130
than material liver.
Another enzyme in the phenylalanine metabolic pathway which is
functionally late maturing is tyrosine aminotransferase. Like many
enzymes its activity may be regulated by the relative activities
of adenylcyclase and phosphodiesterase, and consequently the
134
concentration of cyclic AMP. Studies in rats have shown that there
is a considerable change in the ratio of these two secondary
enzymes between days 10 and 30 postnatally, adenyl cyclase activity
being relatively low and phosphodiesterase activity high before 19
days gestation. Lack of induction of this enzyme by glucagon, to
which it is sensitive, may therefore be related to the low cyclic AMP
concentrations, as addition of a cyclic AMP cofactor would activate
the enzyme. Although 3'5' cyclic AMP may be the primary signal
regulating enzyme activity it has been suggested the insulin:glucagon
ratio is also important.
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This ratio also changes rapidly at birth, the time at which
these enzymes normally become active. Premature delivery will induce
enzyme development, enzyme activities in the preterm infant being
greater than those of the fetus of the same post conceptual age.
However, the late developing phenylalanine hydroxylase and tyrosine
aminotransferase activities can produce transient phenylalaninaemia
and tyrosinaemia in preterm infants. Similarly late development of
135
cystathionase, the last enzyme of the transsulphuration pathway of
methionine to cystine can lead to high plasma methionine concentrations
in infants on high protein diets.
Arginine and histidine are also inadequately synthesized by the
fetus and newborn, and like tyrosine and cystine are essential amino
136
acids during this period. It has been suggested that the presence
of the urea cycle in the fetus is primarily to increase arginine
production. Also activity of arginine synthetase in rat brain is
higher in the last trimester of pregnancy than after birth. Actual
enzyme concentrations are controlled not only by synthesis but also
137
degradation rates, but initial appearance of activity depends on
initiating factors. As the initiating factor e.g. Cortisol, glucagon,
thyroxine for enzymic activity may be common for many enzymes, it is
138
not surprising that clusters of enzymes become functional simultaneously.
Thus in rats hepatic aminotransferases and deaminases have been found
to develop sequentially in clusters, e.g. aspartic amino transferase
and arginase develop three days prior to birth, serine dehydratase
and aspariginase at birth and alanine and ornithine aminotransferases
in the third week of post natal life.
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Similarly there is a "cluster" maturation of enzymes of
carbohydrate metabolism, their develdpment being important for the
perinatal shifts in energy supply and utilization. In rats
glycogen deposition is possible from the 18th day of gestation when
glycogen synthetase becomes active, but it is not until birth that
gluconeogenic enzymes e.g. phosphoenol pyruvate (PEP) carboxylase and
glycerolkinase become active. Although hexokinase is present in
fetal liver it is not until 15 - 18 days postnatal age that
glucokinase and some fatty acid synthetic enzymes e.g. malic enzyme
become active in preparation for the transition from a high fat
to a high carbohydrate diet.
Although maturation of many of these enzymes can be induced
before their normal time of appearance by exposure to the initiating
factor, not all enzymes are responsive. For example, glucagon
will induce PEP carboxylase and tyrosine aminotransferase activities
but not arginase. Some enzymes require a combined sequential exposure
to initiating factors, glucokinase only being activated by Cortisol
followed by glucagon, but for other enzymes such as arginase the other
factors that must exist have not been determined.
The relative importance of these regulating factors can also
change with age. Insulin is important in the regulation of glucokinase
activity in adult liver, but has only a permissive and not a
regulatory function in the enzymes development.
Thus the preterm birth, or abnormal exposure to the initiating
factor in utero, would provoke early development of many of the
enzymes, perhaps allowing the fetus or neonate to overcome its
abnormal environmental state e.g. fetal malnutrition or postnatal diet.
3.«o
c. Metabolic Disorders
Phenylketonuria provides a natural example for the study of
placental amino acid transfer in man.
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Oral and i.v phenylalanine 150 mg/Kg given to normal women
increased both phenylalanine and tyrosine in maternal and fetal
plasma, with a ua:mv ratio of 1.29 - 2.26 (normal 2.36). This
compared with a ratio 1.45 in a phenylketonuria patient, but the
phenylSlanine:tyrosine ratio in the normal fetus of the PKU mother
was 8.16, compared with a normal ratio of 2.47. Clearly the placenta
does not protect the fetus from maternal amino acid imbalance, but
actually exaggerates the situation as fetal:maternal ratios are
maintained. In addition, the high concentrations of phenylalanine
may interfere with transfer of other amino acids, both across the
placenta and across the blood brain barrier and other fetal cellular
89,134-142
membranes. This action is a probable cause of the fetal mental
143,144 145,146
retardation observed both in man and experimental animals.
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AMINO ACIDS AND PROTEIN SYNTHESIS
a. Protein Precursor Amino Acids
Conflicting evidence for the origin of amino acids utilized in
protein synthesis has been reported. Similarly the rate and
degree to which infused amino acids or amino acids of buffer medit
mi„ with the precursor pool are disputed. As these factors can
influence kinetic calculations based on S.A. measurements of the
precursor, it is important to establish the relative roles of
intracellular and extracellular amino acids in protein synthesis, both
having been reported to be the precursor for protein synthesis.
Evidence for the participation of intracellular amino acids in protein
synthesis came from incubation of rat diaphragm with differing 14C
tyrosine, Li et al finding constant 3H leucine concentrations only
gave a constant moles incorporation figure when intracellular
144
specific activities were employed. However, other studies found that
actual results deviated from the theoretical calculated rate of
synthesis if a total intracellular amino acid pool was assumed,
suggesting heterogeneity within the synthesis pool. Additionally,
extracellular and intracellular amino acids equilibrated exponentially
148,149
whereas incorporation into protein proceeded linearly.
S 150
In contra t Hider et_ aH (1969) studying L leucine and glycine
incorporation into protein of the rat extensor digitorum longus
muscle found 14C incorporation ceased immediately when changing from
a 14C to 3H environment.
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Therefore, there must be a rapid mixing of the amino acids in
the medium with those of the precursor pool - suggesting these are
either of extracellular origin or that a very small intracellular
pool of amino acids exists which is more rapidly labelled and depleted
than the intracellular pool as a whole.
157
Further studies of amino acid flux into cells showed that
although there is a rapid flux of leucine across the membrane and
calculations of synthesis rate based on precursor S.A. would be valid
whether these were of extracellular of intracellular origin,
glycine flux is slow and therefore would produce different values.
As the inherent synthesis rate must be the same for both amino
acids - from calculation it appeared that extracellular amino acids
formed the precursor pool.
150,152,153
A model for protein synthesis has been proposed in which ribonucle
protein in the cytoplasmic membrane was the site of synthesis,
152
capable of accepting both intra and extracellular amino acids.
The complex may be associated both with transport and synthesis,
the bound amino acids being either selected for synthesis, or being
released into the intracellular pool on dissociation of the complex,
the latter offering an alternative explanation to the increased
intracellular amino acid concentration observed when protein synthesis
154,155
is blocked by puromycin.
The fact that intracellular amino acids were only involved in
protein synthesis when extracellular amino acids were absent or at
very low concentration also suggests that although the complex may
be formed from amino acids on either side of the membrane the
extracellular amino acids are preferentially selected. Hormonal
regulation of protein synthesis may also be explained by the hormonal
action on the amino acid membrane complex - either increasing the
proportion entering the synthetic pathway and stimulating
complex formation or promoting the dissociation and increasing
intracellular concentrations.
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The discrepancy between Li's conclusions - intracellular amino
150,151
acids as precursors and Hiders - extracellular amino acids as
precursors for protein synthesis may be due to differing techniques
and preparation, diaphragm muscle having a greater surface area
exposed to the medium and therefore allowing freer access than the
more slowly equilibrating extensor digitorum longus muscle.
Recently further evidence of compartmentation of amino acids
has been obtained from studies valyl t-RNA SAs, which were found to be
156
intermediate between extracellular and intracellular SAs. It has also
been suggested that amino acids released during proteolysis have a
competitive advantage over both free intra and extracellular amino
157,158
acids for utilization in protein synthesis.
b. Turnover and Synthesis
Infusion techniques have been employed to assess turnover and
synthesis rates. Synthesis rates may be calculated from the specific
activities (SA) of the precursor amino acid and the SA of the
incorporated amino acid (Appendix II) and catabolism from the decay
of prelabelled proteins. Assuming that intracellular amino acids
are the precursors for protein synthesis calculations using plasma SA
would reduce the apparent synthesis rate as intracellular amino acids
are the precursors for protein synthesis.
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Early experiments using s. .lenomethionine or C carbonate (labels
arginine) were unsatisfactory because recycling giving improbably long
159,160
half lives. Differences in half lives were therefore found between
those calculated from specific activities and total activities,
159,161
and between those based on protein synthesis and those on catabolism.
Protein, and therefore amino acid, turnover rates alter with
different dietary conditions, but not all proteins are equally
affected: Low protein diets increased the half life of albumin in
rat, whereas high protein diets reduced the half life, but globulin
162
half lifes were unaffected.
Amino balance is also important in determining protein synthetic
rates, the addition of a single amino acid being capable of significan
163
increasing synthesis, particularly if amino acid supply is limited.
Changes in half lives occur because of a shift in the balance
between anabolism and catabolism. Millward found that a protein
free diet slightly decreased the synthetic rate but increased the
161
catabolic rate of liver proteins by 20%. Starvation reduced liver
protein synthesis by 20% and myofibrillar by 50% and although only
a small change in liver catabolism occurred, myofibrillar catabolic
161
rate increased by 75%. Muscle protein metabolism therefore
appears to be very sensitive to dietary control. Children re-utilized
protein extensively whether protein was limited or not, but young
rats' muscle protein gave results similar to previous lysine turnover
164
experiments. In these rats total lysine flux, equivalent to protein
turnover, was 25-30g Kg ^ day , decreasing with increased body
weight and age in the male but not in the female. Six week protein
depletion, but not alloxan diabetes, reduced the flux by 30%. Fetal
31
protein turnover rates are higher than those of the neonate, which are
86 165
higher than adult values, and Meier finding that in the fetus large
proportion of synthesis is devoted to turnover.
c. Serum Albumin
It is synthesised in the liver at one third of its capacity
but extracellular albumin is secreted immediately and only occurs
momentarily, if at all, in the cell. Detectable in man at 32 days
gestation, with considerable synthesis between 14 and 36 weeks, the
concentration increases just prior to birth, then falls within a few
days of birth before increasing again at two weeks. This corresponds
with changing liver amino acid concentrations.
167,168,169
Of the amino acids only tryptophan has been found to be albumin
bound, normally one tenth of the albumin molecules having tryptophan
170
attached. The only report of free tryptophan is in the newborn rat
and this was ascribed to discrete changes at the association site
on the albumin molecules for tryptophan. Fatty acids compete for
171
the tryptophan binding site, which could be important in gluconeogenesis
and energy control. 14 g/day in man are degraded and reutilized -
i.e. a major amino acid source. Albumin synthesis is very sensitive,
172,173
both in vivo and in vitro, to protein or amino acid deficiencies.
During the first week of total starvation the catabolic rate remains
high although synthesis declines rapidly, but on refeeding the reverse
is true, synthesis increasing before catabolism - thus ensuring a rapid
174,175
net increase in albumin. However, albumin catabolism was shown to
be less in malnourished infants than in those recovered from
176
malnutrition and it was suggested regeneration of albumin may be
through decreased catabolism than synthesis.
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The rapidity with which albumin is labelled in the liver,
177
(serum albumin is labelled after only 10 - 15 minutes), results
in albumin accounting for a considerable percentage of the labelled
14
plasma proteins after only short periods of infusion. C leucine
tracer studies of albumin synthesis show newly formed albumin to be
present in the rough surface microsomes, passing after 3-4 minutes
into smooth endoplasmic reticulum before release approximately 15
178 179
minutes later. Glaumann, 1970 reported similar results, with
release being independent of synthesis.
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However, Geller et al and Judah and Nicholls, unlike Peters
179
and Glaumann found no fraction of intracellular albumin was prefer-
182
entially labelled, this being in agreement with Schreiber j2t al_
183
and Rotermund who found plasma albumin increased synchronously
with a decrease in smooth endoplasmic reticulum activity.
181
Judah and Nicholls found that the synthesis of albumin involved
production of an albumin precursor - proalbumin - which, although
immunologically inseparable from albumin, had an oligopeptide, released
184
by tryptic digestion, on the N terminal end. It was further reported
that the conversion of precursor to albumin was the rate limiting
step of albumin secretion, the precursor being the most rapidly turned
181
over and major fraction accounting for 10 - 20% of total activity.
The amino acid sequence of the polypeptide was found to be arginine -
185,186
glycine - valine - phenylalanine - arginine - arginine, and a
pentapeptide glycine - valine - phenylalanine - arginine - arginine
187
has been reported at the N terminal end of albumin in rat liver
microsomes. Further evidence of an albumin precursor has been
188 189
reported in human and rat liver cell suspensions.
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v ENDOCRINE CONTROL OF GROWTH
A brief synopsis of endocrine mechanisms for growth control in
the fetus is given in order that the position of insulin may be
related to overall hormonal control.
4,190
Growth hormone does not cross the placenta and appears to have
little influence on fetal growth.
Human chorionic gonadotrophin and human placental lactogen
(HPL) present at very low concentrations in the fetus appear to have
little influence on growth, although placental weight correlates with
191
HPL release.
Oestrogens correlate with placental weight. Oestriol concentration -
and the adherence to a normal pattern of increasing concentration
with gestation - particularly from 26 weeks to term, have been shown
to correlate with fetal birth weight.
Androgens
Testosterone, secreted from the 9th to the 15th week of pregnancy
is essential for the development of the Wolffian duct and normal
192,193
male genitalia. The slightly greater mean birth weight of males
compared with females of the same gestation would suggest that fetal
androgens have a similar effect on fetal growth as they have at puberty
in the adolescent male.
191
Corticosteroids
An accelerated increase at 35-37 weeks gestation correlates with
storage of glycogen in the liver and maturation of the lung, suggesting





The birth weights of anephric infants are low, possibly being
caused by 1:25 hydroxycholecaliferol deficiency and reduced fetal
swallowing of amniotic fluid.
Pituitary Hormonal Function
Species variation is apparent in the fetal requirement for a
normal functioning pituitary gland. In man evidence (derived
from anencephalics and acephalics) for a hypothalmic - anterior
pituitary axis control of growth is equivocal but in lambs the
anterior pituitary is essential for normal fetal growth and functions
independently of the hypothalmus, its absence resulting in hypothyroid
4,190
lambs. If the pituitary is absent the adrenal is most reduced in
size and the thyroid least. Absence of the adrenals has no effect
on lambs birth weight but may have a slight affect on birth weight
in the human.
Thyroxine
Absence of the thyroid has an effect on growth in some species
5,194
of long gestation. Athyrotic fetal rats do not show any signs of
thyroxine deficiency possibly because of thyroxine's relatively long
half life and the rats short gestation. Lambs with the thyroid
removed at 80-96 days have reduced body and skeletal growth with
delayed maturation and skin development. In man the evidence is
less clear. Thyroxine is released in response to thyrotrophic hormones
released from the pituitary. Chorionic thyrotrophic hormone,
produced in small amounts in man but not sheep, may be responsible
for some of the species difference observed in fetal development
related to pituitary absence. Also placental transfer of thyroxine
may occur in some individuals in some species, there being no transfer
in lambs but a limited transfer in the rhesus monkey.
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Insulin
Insulin is known to have an important role in fetal growth
and both maternal hyperglycaemia and hypoglycaemia are associated
195
with an increased rate of fetal and perinatal mortality. Maternal
pancreatic insulin increased during pregnancy but maternal insulin
196
does not reach the fetus. Infants of diabetic mothers are macrosomatic
withstanding acute hypoglycaemia well, but if poor maternal diabetic
control results in chronic hypoglycaemia a decreased growth rate
34 197
could occur. Infants with pancreatic agenesis who therefore had
little or no insulin during fetal development, were growth retarded,
with a reduced content of DNA in muscle, liver and brain, a reduced
protein:DNA ratio in muscle and an enlarged fatty liver.
Insulin production and secretion is independent of hypothalmic
and pituitary control, although growth hormone and an intact
hypothalmus may have a permissive role in fetal pancreatic develop-
4,190
ment. A normal human fetus of a normal mother has 2% endocrine
tissue, of which 40% are £ cells in the pancreas. Cord blood has an
+ 198
insulin concentration of 8.2- 2.8 uU/ml. In infants of gestational
diabetic mothers endocrine tissue is increased to 8 - 10% of which
60% is cell tissue and cord insulin values are 53.5 - 29.4/iU/ml.
The percentage endocrine tissue and increases in cord insulin are
directly proportional to the excess in birth weight. However,
whereas anencephalic infants of normal mothers have normal pancreatic
development, anencephalic infants (with no residual hypophysis or
hypothalmus) of gestational diabetic mothers do not show the
expected increase in pancreatic endocrine tissue and insulin
secretion. Thus modification of the cell response to glucose by
the hypothalmus of hypophysis could be a controlling factor.
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Insulin secretion in adults is regulated by nutritional, hormonal
199,200
and neurohumoral action. The actual release mechanism Malaisse
suggests has three components, recognition of glucose (or other
+ 2+
stimulus) by the cell, increased intracellular K and Ca and
finally release of insulin. Cyclic AMP may have a secondary role
and ATP, ADP ratio or concentrations may provide a feedback control.
Fetal release is also dependent on maturity of the release mechanism.
Response to the insulin secreted may also vary - end organ sensitivity,
insulin degrading activity and corticotrophin - glucagon release
all influencing the degree of response. The insulin release
201,202
response differs from species to species and may vary with gestational
age. In man although insulin is present in fetal pancreatic islets
by 11 weeks there is normally no response to glucose until 32 weeks
195
gestation. In fetal lambs insulin is present in islets and can be
detected in plasma at 42 days. Differences in gestation may explain
203,204,205 206
the lack of response which have been reported in man and lambs.
Although the insulin release has been found to correlate with glucose
207,208,209,210
in both species the response is slower i.e. less sensitive than in
the adult. The slow increase of plasma insulin during infusion of
210
glucose and to a lesser degree with fructose in fetal lambs (unlike
the newborn in which there is a rapid rise of insulin) was unaltered
by glucagon, isoprenaline and aminophylline suggesting that the
cyclic 3'5' AMP dependent part of the insulin secretory mechanism
may not be developed until near term. Correlation of insulin and
glucose during surgery on the fetus also suggests that either the
adrenal medulla does not respond to surgical stress with adrenalin
release or that insulin secretion is insensitive to adrenalin inhibition.
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Although arginine produces a brisk transient increase of
glucagon in fetal plasma (though no glucose increase accompanies
it) neither hyper nor hypoglycaemia results in any change in an
211
exteriorized lamb fetus. These findings suggest that there might be
differences in maturation of responses to various stimuli for
glucagon secretion. At insulin levels 20-50 times the normal
212
physiological range glucose utilization increased and concentration
decreased in fetal lambs, but umbilical blood flow, fetal oxygen
consumption, maternal glucose and placental urea clearance were
unchanged. Smaller doses had little effect.
The duration rather than the degree of hyperglycaemia may be
important in the human fetus, prolonged hyperglycaemia resulting
213
in fetal insulin release.
In the human infant insulin secretion in response to hyperglycaemia
214
is delayed, though tissue response to insulin is probably normal,
and at term plasma levels (5 juU/ml) exceed normal adult fasting
levels. At delivery, fetal glucose is 70-80% that of maternal values,
but then decreases rapidly during the first two hours after birth.
Glycogenolysis in liver is depressed to 80-90% for two hours but in
muscle the decrease is greater, 50-85% and lasts longer, 1-3
days. Exogenous glucagon will increase blood sugar and decrease free
fatty acids, therefore although the mechanism is intact, gluconeogenesis
is inadequate. Gluconeogenesis from amino acids increases only slowly
and increased catecholamine secretion results in the immediate post¬
natal secondary energy substrate being fat-plasma free fatty acids,
glycerol and ketones peaking at 24-48 hours. The high amino acid
concentrations during parenteral infusion of L amino acids may resemble
the hyperaminoacidaemia of obesity. In adults this hyperaminoacidaemia
215
correlated with insulin. However, despite a greater increment in
38
insulin concentration on infusing glucose only the same decrease
of amino acids was noted. This exaggeration of the JS cell response
could be due to either continual stimulation (because of hyperamino-
acidaemia) causing secondary changes, or to the combined exogenous
and enhanced endogenous amino acids resulting in increased secretion.
216
Transfused infants with increased blood glucose and preterm
217
infants infused with arginine (0.5 g/kg) had an increased plasma
insulin concentration, the latter also having increased plasma
growth hormone concentrations. Infants parenterally fed with
high concentration glucose solutions have a transient increase in
218
blood insulin levels - which rapidly return to normal. However,
sudden withdrawal of glucose rapidly produces hypoglycaemia indicating
that adaptation to the high glucose intake had occurred. In preterm
infants the initial response is slow, but becomes brisker within
219
a few days.
The site of insulin action in target tissues has been found to
220
be associated with the cell membrane. The binding site is saturable,
221-226
the reversible binding reaction being time and temperature dependent.
In the placenta both a high affinity low capacity and low affinity
226
high capacity binding site have been reported, the sites being relatively
exposed. Small differences between species in binding site character¬
istics observed in placental but not liver or adipose tissue probably
reflect differences in adjacent membrane structures, but differences
in binding capacity also occur - rabbit, rat, mouse and hamster
having only low capacity and guinea pig and monkey having a higher
capacity similar to the human situation. Insulin degrading activity -
two soluble enzymes and an acid precipitated enzyme - were found in
227
placental tissue.
Precipitated enzyme, probably membrane bound and closely
linked to the receptor site, might solubulise the insulin (and
probably glucagon) complex, rendering it sensitive to the two
soluble enzymes. Insulin degrading activity in the placenta
may account for the diminished sensitivity to exogenous insulin
in pregnancy, particularly in the latter half, and may be implicated
in the regulation of overall metabolic economy. Its action may
also contribute to gestational diabetes. In addition it may prevent,
again particularly in the later stages of pregnancy, intact insulin
228
reaching the fetus, the physical barrier role present in early
pregnancy being replaced by enzymatic activity.
UD
vi AMINO ACIDS AND INSULIN
Amino acids may be utilised in protein synthesis, participate
in transamination reactions or be oxidised to carbon dioxide.
Availability of energy substrates, and individual amino acids, as
well as the hormonal status of the intact animal are important in
not only determining the relative entry rates of amino acids into these
pathways, but also in controlling the proteolytic rate to meet basic
metabolic demands.
a. Amino Acid Metabolism: its relationship with energy balance
Catabolism
Amino acids are important gluconeogenic precursors and in
circumstances where energy substrate supply is limited will be
diverted from synthetic to catabolic pathways. Study of control
mechanisms has been largely confined to adult animal studies,
but the poor musculature and wasted appearance of light for date
infants, in which, possibly, placenta substrate transfer may have
been inadequate for growth, suggest that similar mechanisms might
operate in the fetus in utero. Postnatally, the relatively high
caloric requirement and immaturity of the preterm infant may result
in a prolonged catabolic phase.
Glucose production and release from the liver is maintained at
the expense of muscle mass. In adults 50% of hepatic glucose output
229
is from amino acids, but in the fetus a continual as opposed to
sporadic post prandial nutrient supply may alter this proportion.
However, if the placental supply fails, recycling of amino acids
from muscle to liver would be necessary.
l+l
Trans: '.ination reactions normally result in the predominant release
230
of alanine and glutamine, a large proportion of the latter subsequently
231
undergoing transamination with pyruvate in the "gut to form alanine.
During starvation hepatic uptake of alanine (along with lactate,
230
pyruvate and nine other amino acids) is increased. This lowers
the arterial alanine concentration and thereby reduces the
subsequent uptake, thus sparing amino acids from excessive catabolism
and promoting an increase in fatty acid metabolism. Renal retention
232
of alanine also helps the energy balance. Iso-caloric protein free
diets, however, result in a raised alanine concentration as gluconeo-
233
genesis reactions are limited.
Transamination in the muscle and gut of amino acids and pyruvate,
followed by release of the resultant alanine would not give any
net gain of gluconeogenic precursors after deamination of alanine
in the liver. Transamination of other TCA cycle intermediates must
229
therefore occur. In addition to its role in gluconeogenesis the
alanine released from muscle may be part of an ammonia transport
234,235,236
system between muscle and liver.
Short term fasting in obese and normal adults produces a
transient increase in plasma branched-chain amino acid concentrations
alpha aminobutyric acid, phenylalanine, tyrosine and blood ketones,
232
these all being very sensitive to insulin changes. Rapid onset
237
of hypoinsulinaemia in the first three days of starvation may be
the basic cause of this initial hyperaminoacidaemia. Plasma branched-
chain amino acid concentrations may also increase because of increased
competition between branched-chain amino acids and the increased
concentration of non esterified fatty acids for coenzyme A. With
kX
ccmtinued fasting, amino acids in plasma fall with the exception of
threonine, serine and glycine which increase, possibly because of
diminished utilisation of glycine in nucleic acid synthesis.
238,239
Pregnancy exaggerates and accelerates these responses, an
immediate increase in glycine and later threonine and serine, and a
rapid fall in other amino acids - particularly alanine being apparent.
Exercise will also increase both alanine and pyruvate concen-
240 241
trations and may release insulin previously bound in muscle tissue.
231
BCAA are selectively taken up by muscle and brain but not liver.
During periods of limited substrate supply oxidation of BCAA
242,243
also occurs in muscle, but not liver or brain. Changes in oxidation
244
and protein synthesis rates are independent of each other and are
242
not synchronised. Oxidation increased 24 hours prior to a decrease
in protein synthesis in fasted rats, although both returned to
control values with 24 hours of refeeding. Fatty acids will stimulate
245
oxidation but this effect can be inhibited by albumin.
Inhibition of oxidation by ketones and alanine may be particularly
important for nitrogen preservation during prolonged starvation and
in diabetes rapid BCAA oxidation may limit gluconeogenic precursor
246
supplies.
When nutrition is adequate and amino acids are not required
for gluconeogenesis, they may be directed into synthetic pathways.
This situation is essential in the fetus and neonate if normal
growth and maturation are to occur.
1*3
Anabolism
Increased net protein synthesis can result from increased
synthesis, decreased catabolism or a combination of both.
The concentration of amino acids themselves has been shown
to exert a powerful effect on the rate of protein synthesis.
Increased amino acid incorporation into protein has been detected
247,248 249,250 246,251,252
in in vitro preparation of rat liver, heart, muscle, and of human
253,254
skeletal muscle when these preparations were incubated or perfused
247
with amino acid enriched media. Jefferson and Korner, reported
that increased incorporation into rat liver protein was dependent
252
upon the availability of eleven amino acids, but Buse and Reid
found leucine availability alone to be responsible for the stimulation
of lysine incorporation into rat diaphragm protein. Differences
in technique and possibly in Jefferson's study, some amino acids
being present in concentrations near to their limiting concentration,
could explain some of the discrepancies. The stimulation by isoleucine
plus valine in addition to leucine may be because of increased
competition for the enzyme alpha-ketodehydrogenase catalyzing the
246
degradative step common to all three amino acids. A leucine sparing
252
mechanism might also account for the enhanced incorporation observed
245,251
in previous experiments with palmitate and acetate. The observation
that the intracellular leucine concentration of rat hearts decreased
to less than 0.21 mM without glucose or palmitate in the perfusing
medium, and that under these conditions incorporation of amino acids
255
into protein was low is in agreement with a regulatory role of leucine.
256
This role, however, is disputed by Millward j2t aT (1976) who argues
that free BCAA are raised in skeletal muscle in starvation and diabetes
kit-
but decreased in a perfused rat hemi-corpus in which protein
synthesis was stimulated by insulin. BCAA would in fact be
expected to increase under conditions promoting proteolysis as
there is a relative abundance of BCAA in protein compared with
concentrations in the free amino acid pool. An increase in
oxidation of BCAA - which occurred 24 hours prior to a decrease in rat
242
protein synthesis in Goldberg's experiment could decrease the amino
acid concentrations. Thus depletion of a critical compartment
rather than the total free amino acid pool may be the signal for
proteolysis to accelerate. Protein synthesis may be accelerated
through a decrease in the catabolic rate.
Increased amino acid concentrations will inhibit normal amino
257 252,253
acid release from tissues both in vitro and in vivo, this again
246,252
being associated with leucine and BCAA concentrations. An increase
in vivo of a rate limiting amino acid for protein synthesis, or
an increase in arterial alanine concentrations because of inhibited
or reduced hepatic conversion of alanine to glucose may provide
258
feedback loops to limit proleolysis.
Alternatively, or in addition high amino acid concentrations
259
may protect the cell against increased lysosomal activity, a signifi¬
cant positive correlation between cathepsin D concentration and
253
protein degradation supporting this concept of stabilisation of
the lysosomes.
The stimulatory action of amino acids may operate through their
260
influence on ribosomes. Rat liver polysomes had only a limited
14 . . .
capacity to incorporate C leucine into protein if no amino acids
261
were present in the incubation medium, but a greater capacity was
demonstrated if a complete mix of amino acids were included.
Possibly the availability of certain amino acids, which may vary
depending on the type of protein to be synthesised could stimulate
ribosomes to become or remain attached to mRNA - polysome profiles
of liver incubated without amino acids showing a decrease in large
aggregates and an increase in monomers and dimers compared to
247
controls with amino acids present, and liver ribosomes of fasted
262
rabbits being disaggregated. Stimulation appears to be due
263
to a factor in "cell sap" rather than the ribosomes themselves,
264,265
with the action being subsequent to amino acyl tRNA formation.
It is suggested that stimulation of inactive ribosomes with tRNA
already attached may be responsible for increased synthesis, unit
synthesis per ribosome being increased.
In addition to increased availability of amino acids for
protein synthesis, in the well nourished animal there is a more
effective stimulus for release of anabolic hormones.
b. Amino Acid Metabolism: protein synthesis and its relationship
with insulin
Insulin has been shown to stimulate the cellular uptake of
266,267,268,269 154,270,271,272,273
amino acids and to increase protein synthesis in vitro, intracellular
amino acid concentrations increasing if protein synthesis was
inhibited or crocodile tissue with a slow metabolic rate was
274
employed.
Uptake of amino acids may be promoted through an increased
affinity for or synthesis of a carrier protein as a time dependent
inhibition of the stimulatory action of insulin in vitro has been
272,275,276,277 268,269
observed. In chick embryo hearts AIB uptake was shown to be by
both a saturable and non saturable system, but only the former was
k\a
278
stimulated by insulin. In rat calvaria Phang demonstrated cyclic AMP
would stimulate uptake and suggested that the same mechanism may
be involved although cyclic AMP acted at a different site to that
of insulin. Increased utilization of amino acids in protein synthesis
268
or accelerated oxidation may increase uptake by reducing the concen¬
tration gradient between intra and extracellular fluids.
Although increased intracellular amino acid concentrations
could themselves stimulate protein synthesis, it has been shown
that this is not the sole mechanism by which insulin promotes protein
synthesis. However, high amino acid concentrations have been found
279 253
to impair the in vitro response of rat and human skeletal muscle
to insulin, in the latter study amino acids at six times normal
plasma concentrations diminishing the enhanced incorporation of amino
t
acids from 133% to 116% the rate without insulin, whilst high amino
acid concentrations increased the rate by 75%. An investigation into
the relationships between in vitro and in vivo insulin stimulation
254
was made by Lundholm and Schersten, who infused glucose or saline
into patients prior to muscle biopsy. Subsequent incubation at
normal and high amino acid concentrations showed leucine incorporation
to be the same in both tissues, with no significant difference
in the percentage stimulation by insulin at the two concentrations
of amino acids. This would indicate that factors other than amino
acids supply must be relevant as the stimulation of amino acid in vitro
should have been greater in the saline infused tissue if this were
the sole mechanism.
This is supported by the observation that incorporation of
amino acids into tissue was stimulated by insulin during incubation
246
in a Kreh^,^-Ringer buffer without glucose or amino acid supplementation.
/
Additionally the greater correlation found between L C leucine
incorporation into human skeletal muscle and RNA concentration in
basal and insulin stimulated conditions than when stimulation was
with high amino acid concentrations indicates insulin has a
151
secondary separate action on protein synthesis.
Insulin will influence the rate of proteolysis but it is not
as potent a stimulus as amino acids, which will reduce proteolysis
257
when there is already maximum inhibition with insulin. The effect
246
is also altered by prevailing substrate supplies. Fulks found that
insulin produced equal effects on degradation and synthesis in
normal and fasted rat diaphragm, but glucose only enhanced the
insulin inhibition of proteolysis. However, although cyclohexidine
258
increased protein turnover rate by 50%, Rannels a_l demonstrated
that the percentage inhibition if insulin was present was the same.
In vivo, infusion of insulin produces a marked decline in plasma
BCAA methionine tyrosine and phenylalanine, suggesting a reduced
231
release by muscle.
Stimulation of lipogenesis by insulin, like proteolysis is
243
dependent on the energy balance. In fasted and control rat tissues
glucose and insulin were effective, but there was no response in
fasted refed rats in which both lipogenesis and leucine concentrations
were already increased.
In pancreactectomised rats, insulin stimulated leucine
280
incorporation into liver proteins. Similarly, diabetic muscle has
been found to have a reduced capacity for incorporating methionine
281 282
into protein and to have fewer normal polysomes than control tissue
k*>
both of these defects being corrected by insulin. Addition of
glucose to diabetic rat tissue in vitro increased incorporation of
glycine into glutathione towards normal and with the addition of
283
insulin, normal control rates were achieved. However, without
substrate and in normal tissue insulin had no effect and in tissue
from starved but normal rats glucose but not insulin was necessary
to achieve normal glycine incorporation. Both adequate substrate
and insulin (which possibly has a delayed action) appeared necessary
for protein synthesis. Similarly increased glucose utilization,
14 . . . .
glycogen formation and C alanine incorporation into protein m
284
insulin treated rat diaphragm was supressed by glucose addition.
Insulin stimulation of protein synthesis however, is not dependent
on glucose concentrations, stimulation after depletion of endogenous
285,286
substrate being the same as in control tissue.
The infusion of glucose or insulin creates in part the status
of the fed animal. In man, infusion of glucose (25 mg/Kg/hr)
causing a five fold increase in plasma insulin almost completely
r
inhibited hepatic glucose output and reduced the fractional extraction
230
rate of amino acids. Slower glucose infusion (2 mg/Kg/hr) reduced
hepatic glucose output by 85% but other parameters remained unaltered.
287,288 289
Similar results were found in muscle of man and newborn lambs.
In contrast, studies on hepatic glucose metabolism in adult
290
ruminants found that although insulin controlled gluconeogenesis in
peripheral tissues, glucagon alone was responsible for the increased
hepatic uptake of amino acids for gluconeogenesis. The apparent
effect of insulin in non ruminants, it was suggested, was caused by
decreased glucagon secretion during the glucose infusions employed
l+q
291
to increase insulin concentrations. Prior also found that glucose
infusion would decrease plasma essential amino acids to 65% and non
essential amino acids to 81% of control values in non pregnant
ewes but that exogenous insulin given either as an injection or
continuous infusion had little effect on concentrations. Simple
provision of an energy source did not appear to be the explanation
as acetate was less effective than glucose.
Failure to halt hepatic output of glucose in insulin dependent
287
diabetics despite high glucose levels would also indicate that glucose
alone cannot be the controlling factor for gluconeogenesis. However
liver appears to be the major organ maintaining homeostasis and its
sensitivity may be enhanced by the relatively greater insulin and
glucagon concentration in portal than peripheral blood.
Thus, although insulin is possibly the major hormone for the
control of glucose homeostasis there appear to be quantitative
differences in the response of the homeostatic control mechanisms.
Also, the sensitivity of hepatic tissue to insulin might be less in
the newborn. (See page ).
292
Changes in plasma glucose with insulin may not be apparent
as the red blood cell may carry glucose from the capillary bed of
muscle when insulin concentration is low, but release glucose to
plasma and thus to tissues when insulin concentrations increase.
Likewise, plasma amino acid measurements may not accurately reflect
293
tissue availability. Elwyn ejt a_l (1968) report that glutathione
synthesised in gut and liver is transported to peripheral tissue
via erythrocytes and a high positive association exists between
hepatic protein breakdown and a high amino acid concentration and
<Jb
nitrogen transport in the erythrocyte. Plasma amino acid concen¬
trations were lower in the hepatic than portal veins of dogs but the
reverse was true of erythrocytes amino acid concentrations. Likewise
the greater concentration of amino acids in the portal vein than
artery was reversed in erythrocytes. A large contribution by the
red blood cell to net transport may therefore be present if
concentrations of amino acids are high in erythrocytes and if there
294
is a high haematocrit. Anderson (1974) found no correlation between
the post prandial decrease in plasma or erythrocyte amino acid




This chapter includes laboratory methods employed during the
investigation of the effect of insulin on both placental transfer in
sheep and plasma amino acid concentrations in the neonate.
Individual experimental details are to be found in the respective
14 . 14 ...
sections for tritium, C and insulin and C amino acid infusions
and the neonatal section.
€1
Biochemical Analyses
Materials Unless otherwise stated reagents were A.R.
quality supplied by B.D.H.
i. Haematocrit
Microhaematocrit determinations were made using 75 mm
capillary haematocrit tubes, sealed in the flame of a
bunsen burner and spun in a Hawkesley microfuge for five
minutes. The haematocrit value was read from the Hawkesley
microhaematocrit reader.
ii. Plosmo Glucose
Glucose in blood was determined by the enzymic method
of Raabo and Terkildsen, 1960 '. The method involved
oxidation of glucose to gluconic acid and hydrogen peroxide
by glucose oxidase (0.75 g in 250 ml phosphate buffer
6.6 mmol KaH^ P0^ ^0 per Ilitre) at pH 7. In the same
buffer peroxidase iwas: included (3.7 mg) so that the
oxidation and hence colour production of the dye o-
dianisidine (500 mg in 100 ml acetone) may be coupled to the
glucose oxidation.
An enzyme dye reagent was prepared - 1 ml o-dianisidine
to 150 ml enzyme solution. 400 /il polythene tubes with 100
/ttl saturated sodium fluoride were dried at 70°C overnight.
These were more than half filled with blood and then spun in
a Beckman/Spinco microfuge for 2 minutes.
*3
♦
20 jul plasma was pipetted into a 10 ml glass test tube and
5 ml enzyme-dye reagent added. After mixing,the tube stood
at room temperature for 40 minutes out of direct sunlight
before reading against a reagent blank at 500 nyu in a Pye-
Unicam SP600. Glucose standard solution (5.5 mmol/1) was
used to calibrate the method. Reagent, glucose and where
possible sample values were determined in triplicate.
A modification of the method was used if haemolysis was
present. Proteins were precipitated by the addition of 100
3 peicent perchloric acid to 20 jul blood or standard and
50 Jul of the supernatant was mixed with 5 ml enzyme-dye
reagent and read as before.
iii. Total Proteins
Total protein was measured using a modified biuret reagent *
method of O'Brien and Ibbott 1964"" "using a Beckman/Spinco
Model 150 Ultramicro Analytical System.
5 jul sample, water (blank) or standard (bovine albumin
60 g/1 Armour Pharmaceutical Co. Ltd.,) were pipetted in
triplicate into 400 jil micro test tubes. 200 jul of the biuret
% ...
reagent and 50 jul 25 per cent sodium sulphr.fce solution were
added and the tube contents mixed well. Absorbance values
at 540 nip were read in the colorimeter after 30 minutes.
iv. Total Lipid
Plasma total lipid concentration was measured using a
Boehringer Mannheim Biochemica Test Combination Kit. Plasma
(0.5 ml) or 0.5 ml standard solution (1000 mg total lipid/
100 ml) were mixed well with 2 ml AR concentrated sulphuric
acid in a test tube. After heating in a boiling water bath
* See appendix 2
ml
for exactly 10 minutes the tubes were cooled. 0.1 of these
plasma or standard solutions and a further 0.1 ml AR
concentrated sulphuric acid (blank) were added to 2.5 ml of
the colorimetric reagent (14 mol/1 phosphoric acid, 13 mmol/1
vanillin) and the tubes well mixed. After standing at room
temperature for 30 minutes, colour development was measured
at 530 nju on a SP600 spectrophotometer.
Sample total lipid concentration (c) was calculated from
the equation:
C = 1000 X E sample mg/100 ml (E = extinction)
E standard
.Non-Esterified Fatty Acids
A colormetric method using Doles extraction mixture
and a cobalt reagent composition was used to measure plasma
free fatty acid concentrations. (Reagent composition -
Appendix 3 ). Plasma 50 pi was added to 250 pi Doles
extraction mixture - (40:10:1 v/v/v isopropanol:hexane:
IN f^SO^). A blank - 40 jul water and 250 jul Doles extraction
mixture - and standards 50 jul water and 250 pi Doles extraction
mixture containing either 20 or 40 jumol/1 palmitic acid were
also prepared.
All tubes were stoppered and mixed with a whirlimixer
before standing 5 minutes at -20°C. Heptane (300jul) followed
by 500 jul water were added to the tubes which were remixed
before centrifuging for 2 minutes at 3000 rpm. The upper
heptane phase (300 jul), 400 jul chloroform:hexane (5:1 v/v
and 500 pi of the cobalt reagent were then thoroughly mixed
S5
with a whirlimix for 3 minutes, before centrifuging the stoppered
tubes at 2500 rpm for 15 minutes. 500jul from the upper
chloroform-hexane phase was then mixed with 750 jul of indicator
solution (freshly prepared 0.016 per cent alpha nitroso-JS-
naphthol in 96 per cent AR ethanol) and the colour read 30
minutes later at 500 mju. Non esterified fatty \NEFA) acid con¬
centration was calculated from the formula.
NEFA (mmol/1) = Sample reading - blank reading x 0.6X5
(20 mmol/1 std - blank reading)
+ (40 mmol/1 std - blank reading)
vi. Osmolality
Plasma and urine osmolalities were measured on 0.2 ml
samples by freezing point depression using an Advanced osmometer.
vii. Ultrafiltration
Sartorius ultrafilters and ultrafiltration apparatus
were employed. 0.5 - 1 ml plasma was placed in a stainless
steel pressure filter holder with a cellulose nitrate filter -
Sartorius No. 121 - 36 in position. Using oxygen-free nitrogen,
compounds with a molecular weight below 10,000 were forced
through the filter overnight at a pressure of 40 lb/sq/in.
viii. Sephadex
0.5 or 1 ml of (plasma) was pumped on to a 50 cm G200
superfine Sephadex column at a pump rate of 7 ml/hr. Protein
fractions were eluted with a phosphate buffer (Appendix 4)
at pH 7.4 and collected at 30 minute intervals. The absorbance
at 280 nyu was recorded.
ix. Free Amino Acid Concentration Analysis
Free amino acid concentrations were measured by ion
exchange chromatography (Cockburn et_al 1971) using a
modified Teqhnicon Amino Acid Autoanalyser. Water jacketed
twin capillary columns 140 cm in length, 6 mm internal
diameter were packed with Chromasorb B resin - an anionic
sulphonic acid resin of beads 17 p % 2 i-n diameter. Buffer
(for composition see Appendix 5) increasing in pH from
2.85 to 6.25 was pumped at high pressure simultaneously down
both columns from a nine-chambered autograd -
AUTOGRAD
Chamber 1 - 42 ml buffer pH 2.85 plus 3 ml AR methanol
Chamber 2 - 43.5 ml buffer pH 2.85 plus 1.5 ml AR methanol
Chamber 3 - 45 ml buffer pH 2.85
Chambers 4-5 - 45 ml buffer pH 3.75
Chambers 6-9 - 45 ml buffer pH 6.25
For the first 5h hours the water jacket temperature
was 34°C and thereafter 70^C resulting in pumping pressures
of 600 - 700 lb/sq/in and 300 - 400 Ib/sq/in respectively.
The column effluent was passed through a manifold
proportionating pump before mixing with ninhydrin (com¬
position Appendix 6 ) and oxygen free nitrogen. After passing
through 3 m glass coils in an oil bath at 90°C the effluent
was cooled in water jacketed coils before passing through 2
continuous flow colorimeters. The OD at 570 np and 440 np
was charted using an Elliot 4 point multiphasing recorder.
The concentration of individual free amino acids was
calculated from the area under the 570 mu peak (proline
and hydroxyproline 440 mp) and relating this to the area of a
norleucine (NLE)internal standard peak. Norleucine was used as an
internal standard in all amino acid concentration determinations,
the colour index (i.e. relationship between the peak areas of
0.04 jumol norleucine and a known amount (usually 0.04 pmol) of
each amino acid having been previously determined.
Sample Preparation
Where sample volume permitted, 0.2 ml plasma or 0.2 ml blood
plus 0.2 ml H^O were pipetted into a pyrex test tube. Fetal
plasma free amino acid concentrations, because of the small
volume of samples, were normally measured on 0.1 ml sample.
To the sample was added 0.05 ;umoles norleucine contained in
either 0.1 or 0.2 ml HC1/0.17N, the volume depending on the
internal radioactivity/norleucine standard solution used (see p
After mixing, a volume equivalent to the sample volume i.e. 0.1
or 0.2 ml of 0.6 mol/1 sulphosalicylic acid was added to the
sample and the tube contents mixed by means of a whirlimix.
After allowing 10 minutes for protein precipitation, the tubes
were centrifuged at 3000 rpm in an MSE bench centrifuge for
5 minutes. The supernatant was decanted and the pH adjusted to
pH2 with 75jul of 2 mol/1 LiOH. l^O. The sample was applied
in a 25 per cent sucrose solution to the top of one of the
columns and the chromatograph run overnight. 10 /il maternal,
20 _pl fetal hydrolysis samples with NLE as internal standard
were applied in sucrose to the columns without pH adjustment.
• 5%
VOLTAGE
Diagram to show the effect of quenching on the pulse




The activity (Ax) of any sample may be calculated from the
formula:-
Ax = Counts per minute recorded
efficiency of counting.
The efficiency of counting in any system is reduced if
either colour or chemical quenching is present. As almost all
biological materials produce quenching it is necessary to
ascertain the amount of quench for each sample system. By
reference to a prepared calibration graph of degree of
quench versus efficiency, the activity of a sample can be
determined.
Measurement of Quench
The net result of quench is to shift the amplitude spectrum
of a particular isotope to lower voltage levels. Although with
14
the C isotope this can be partially compensated for by
shifting threshold and window settings, usually by increasing
the amplifier gain (in diagram 1 from T1 W] to T2 W2) so that
the spectrum is measured at a lower pulse height - the
3
quenching of y which is a weakly energetic isotope is not
overcome.
In most experiments quenching was ascertained by use of an
automatic external standard. The ratio (A.E.S. ratio) of net
counts of the external standard recorded with the sample vial
between the external standard and the photomultiplier detector
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Thus A.E.S. ratio =
(C/min of external standard + c/min sample) - c/min sample
c/min external standard.
Although two counting periods are required to ascertain the
net counts of the quenched external standard, the first measure¬
ment being of c/min standard and sample and the second of c/min
from the sample alone, the high activity of the external
standard allows short counting periods- 1 minute. A calibration
« r .. A t? c* • .observed c/min. .graph of the A.E.S. ratio versus efficiency ( —) is
expected c/min
prepared to determine the corrected activities of the samples.
Calibration Graph:
These were prepared by adding small volumes (50^1) of eithe
14 3 .
a C or H labelled aminoacid solution of known high activity
14 3
(0.5^i Ci/ml C or 2 p. Ci/ml H) to several non-radioactive
samples at 0.5, 1 and 2 times the sample volume for 20 minutes
in triplicate and counting these vials after addition of the
relevant scintillant - NE260, NE262 or Instagel. Examples
3 14
of calibration graphs for NE260 and plasma ( H and C and for
3 1A
dual counting, H and C together) are shown opposite.
Calibration graphs for other scintillator - sample systems showed
only minor variations.
Dual Labelled Samples
If the spectra of two isotopes is sufficiently dissimilar
it is possible to measure the relative amounts of activity from
each isotope. This is done by measuring the activity at 2 window
settings such that in one the isotope emitting at a lower pulse
3
height (in these experiments H) is measured with little con-
14
tribution from the second isotope ( C) which gives a pulse
amplitude spectrum at a higher voltage.
Optimal settings of the window must maximise the counts in
3 .... 14
the H window whilst minimising the counts from C in this same
window. Window settings may not therefore be at the maximum
tritium count rates (i.e. efficiency) as too great a "carry-
14
over" from C may occur at this setting. After a trial of a
variety of different window settings it was found that the
factory settings gave optimal results.
«•
14 3
Activity of C and H isotopes were calculated from the
formula
= c/min channel (Cl)
Efficiency of '^C in channel (El)
3U , . 3U , .Cl X efficiency '^C in 3HH = c/mm H channel ( i )
El
_ . _ . _
Efficiency of H in H channel
The high degree of colour quenching of whole blood did
14 3 . . 14
not allow differentiation of C and H activity. The C
spectrum was shifted so that the overlap with the tritium
spectrum was too great to permit separation of the spectrum
Sample Counting
A Packard 2425 scintillation counter was used for all
14
determinations. C samples were counted on the machine set
14
C windows,Gam 5 per cent lower window 20, upper window 1000
3
as was H}Gam 50 per cent, Lower window 40 upper window 1000
14 3
and dual C/ H - machine factory pre-set. The automatic
external standard was used in all cases for correction of
quenching and efficiency. Samples were counted for 20 minutes.
a. PLASMA
Total Plasma Activity
Plasma 0.5 ml was pipetted into a counting vial and 10 ml
NE 260 scintillator added. All maternal and fetal samples
were counted.
Plasma "Water" Activity
In years I and II plasma 0.5 ml was deproteinised using 0.5
ml 0.6 M sulphosalicylic acid. The sample was whirlimixed and
then stood 10 minutes at room temperature. After centrifuging
in a bench centrifuge at 3000 rpm for 5 minutes, 0.5 ml of
the supernatant was counted with 15 mis NE 260 as scintillator.
Some fetal samples, because of the small volume of plasma
available, were prepared from smaller volumes in a similar
manner with the same proportions of reagents. In year III,
plasma was deproteinised with solid sulphosalicylic acid -
30 mg per millilitre. After mixing, standing and centrifuging
as in years I and II, the supernatant was decanted into a vial
for counting. The precipitate was washed with 1 ml distilled
water and the washing process repeated. Three washings of the
precipitate were carried out, and the total counts of the 4 vials
added to give the plasma water content.
Plasma "Water" Specific Activity
Selected sample® - 1 ml maternal plasma or 0.5 mis fetal
plasma - were prepared in a manner identical to that used for
amino acid determination. An internal radioactive amino acid was
employed to correct the results based on recovery of that amino
acid. The radioactive amino acid used varied with the amino
acid infused into the sheep, the amino acid radioactive standard
being chosen both to give good separation from the infused
amino acid on elution and to be unrelated metabolically i.e.
valine was not used for leucine infusions.






In the same radioactivity standard solution norleucine was
included as the internal standard for concentration measurements,




























centration and radioactivity measurements.
Composition of these standards is given below:
1A
L- C - Valine - 0.25 jumol/ml Norleucine 12,385 d/min/ml
14 .
L- C - Leucine - 0.50 jamol/ml Norleucine 12,600 d/min/ml
14
L- C - Phenylalanine - 0.50 yamol/ml Norleucine 20,340 d/min/ml
The supernatant from the same precipitated sample was applied
equally to both columns, concentration and radioactivity
measurements on the same sample being obtained from the same
overnight autograd buffer gradient. The affluent from the
"specificactivity" column was diverted to a fraction collector
after passing through the manifold tubing, but before mining
with ninhydrin. The time difference between the amino acid
peak appearing on the recorder and the collection of the peak
in the fraction collector had been previously measured, so that
the amino acid recorded chart could be used to determine the
contents of the fractions. Fractions were collected originally
at 15 minute intervals in test tubes, and later, when an Isco
model 328 fraction collector became available in Year III at
10 minute intervals directly into disposable scintillation vials.
Where necessary, fractions of approximately 3.5 ml were
decanted into disposable counting vials and 15 ml NE 262
scintillator used to rinse out the test tube and add to the vial.
10 ml NE 262 scintillator was added to the fractions collected
directly in the vials,
b. HYDROLYSATES
The protein precipitates from the "specific activity"
measurement samples were washed by whirlimixing and centrifuging
fe6>
three times with saline - 1 ml volumes for maternal and 0.5 ml
volumes for fetal samples. The washings were drained into
counting vials and 15 ml NE 262 added before counting to ensure
radioactive material of the supernatent had been removed. The
thick walled pyrex test tube which contained the precipitate
was drawn/using a glass blowers flame to give a narrow neck /out
through which 0.5 ml water and 0.5 ml concentrated Aristar
hydrochloric acid containing 0.2 per cent phenol were added.
The tube contents were frozen in an acetone/solid CO^ bath and
the tube evacuated using a vacuum pump. The contents were
allowed to thaw then refrozen and the tube re-evacuated. The
neck of the tube was sealed with a gentle flame while the
contents were still frozen and the tube under vacuum.
Samples from one experiment were all hydrolysed together in
a domestic pressure cooker at 105°C for 20 hours. Each vial was
opened and the contents made up to 2 ml with distilled water in
a 10 ml measuring cylinder. The contents were well mixed
decanted into a small test tube and centrifuged for 30 minutes
at 3000 rpm in a MSE bench centrifuge. The supernatant was
stored at -70°C until analysed.
Hydrolysate Total Radioactivity
Hydrolysate 0.5 ml with 10 ml NE 260, was counted in
disposable vials.
Hydrolysate Specific Activity
0.1 ml of the maternal plasma hydrolysate, or 0.4 fetal plasma
hydrolysates were added to a radioactivity/norleucine standard
as previously described ( see p U.U ). The pH was adjusted with
2 mol/1 LiOH until alkaline afterwhich 60 jul . ^sulphosalicylic
acid was added. This was put on the column and the specific
activity determined as for plasma water ( p yp, )
e. WHOLE BLOOD
Total Radioactivity
itiscolourisation before counting was necessary because of
strong colour quenching.
Maternal
0.2 ml blood was pipetted into a counting vial and the
pipette washed with 1.5 ml 1:1 v/v soluene 100 (Packard):
isopropanol. The contents were swirled then 0.6 ml hydrogen
peroxide (30 per cent w/v) added and the sample again well
mixed. After standing for one hour at room temperature, the
blood was decolourised. 15 ml of 1:9 v/v 0.1 NHC1:Instagel
(Packard) was added and the yellow tinged solutions counted.
Fetal
Preparation was as for maternal samples but only 0.1 ml
volume fetal blood and 0.5 ml hydrogen peroxide used.
Deproteinised Blood
0.4 ml blood were pipetted into a thick walled test tube and
the pipette washed with 0.4 ml saline. The blood was deproteinised
as for plasma with 0.4 ml 0.6 mol/1 sulphosalicylic acid. 15 ml
of NE 262 scintillator were added to the decanted supernatant and
the vial counted,
xi. Tissue Counting
Tissues were stored at -70°C and were removed one at a time
for sampling. Disposable vials were preweighed to 4 decimal places.
w.
Thin slivers of tissue were shaved with a scalpel from the
frozen tissue and placed on the bottom of the preweighed vial.
Vials were reweighed and the tissue weights recorded - between
40 and 200 mg depending on the tissue type,after which tissues
were immediately replaced in the deep freeze.
Soluene 100 was added to the vials, 100 pi to 10 mg tissue
with a minimum volbine of 500 jul so as to cover the bottom of the
vJLal. The vial was swirled and/or tapped to release any ad¬
hesions between tissue and vial. After overnight digestion at
room temperature, and if necessary warming the following
morning, Instagel 10 ml was added and the samples counted,
xii. Autoradiography
Prepared slides of tissue were dipped for 5 minutes in
xylene, twice in ethanol and once in 70 per cent v:v ethanol:
distilled water. The slides were rinsed under the tap.
In the darkroom Ilford photographic emulsion K5 (grain size
0.20 p highest sensitivity) was prepared: 1 part 1 per cent glyce
2 parts emulsion in a 100 ml beaker. This was warmed without
stirring under the tap until all the emulsion was dissolved.
A single slide holder was filled to overflowing (to remove any
airbubbles) and placed in a water bath at 43 - 45°C. The slides
%
were dipped singly into the emulsion. After removal, the back
and sides were wiped and the tissue side dried using cold air
from a hairdryer. When all slides were dipped and dried they
were placed in a "baffle box" - which admitted air but no light
- for 2-3 hours to thoroughly dry. They were subsequently
wrapped in tin foili and stored 3-6 weeks at 4°C, during which
time radioactivity ionized and reduced the silver halide (AgBr„-
AgO) to produce black grains in the emulsion. By conventional
staining with eosir. (part xiii) to differentiate the cells,
the distribution of activity ir. the tissue could be examined.
VI
xiu Haematoxylin and Eosin. Counterstaining Autoradiographs.
Method
The fixed autoradiograph sections were washed and dried
before staining for 3 minutes in Mayer's acid haemalum.
After washing well in tap water the sections were dipped
for 5-10 seconds in 1 per cent acid alcohol (l per centvyV
HC1 in 70 per cent alcohol). Sections were again washed in
tap water before "blueing up" in Scott's Tap water substitute
(weak alkali), afterwhich they were again washed in tap water.
Counterstaining was done by staining with 1 per cent Eosin
for 1 - 2 minutes. After washing^sections were dehydrated
in several changes of absolute alcohol before clearing in
xylene and mounting in synthetic resin.
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Chapter III
ANIMAL EXPERIMENTAL METHODS AND RESULTS
This is divided into 4 major parts. Details of animal care,
surgery and preliminary treatment of samples prior to storage which
are common to all experiments are given in the first section.
Experimental details, results and evaluation of these for the
. . 14 . ... 14
tritium and C labelled amino acid and insulin with C labelled
amino acid infusions are given in parts 2, 3 and 4.
A summary of haematocrit values is given for each experiment.
Individual results can be seen in Appendix k
Also in the appendices are tables summarising the data from all
experiments. Appendix^ gives the rate of increase in blood and plasma,
appendix £ the radioactivity level at plateau or maximum activity
reached and appendix 1 the total plasma protein (where measured).
>1
PART I
Experimental Methods Employed in All Experiments
I
The validity of in vivo experiments depends upon the quality
of the animal preparation used in the study. Sheep employed in
these experiments were housed and cared for in the Fetal Physiology
Department of the Animal Diseases Research Association, Moredun.
Handling and feeding techniques previously shown to produce
"
2,-3
minimal stress condition^ were used to maintain the sheep
in as normal a physiological and metabolic condition as possible.
The monitoring of the animal preparations, and factors affecting the
physiological and metabolic state of the animals are now discussed.
Physiological Monitoring
The physiological state of both the mother and catheterised fetus
must be monitored to ensure that the following criteria are fulfilled
before commencing metabolic studies:
a) the stress effects of anaesthesia and surgery have passed
b) the physiological state is stable and not detriorating
and c) a metabolic steady state has been achieved.
The sheep in these experiments were maintained at the Moredun
Research Institute at the same time and under the same conditions as
similar preparation which were used to study various aspects of fetal
physiology and to define when the above criteria have been established.
The sheep were at least 11 and usually 14 days passed the time of surgery
and therefore the first condition was satisfied. Regular PCV, glucose
fructose, insulin and some other parameters showed little variation
after any changes associated with surgery, and all values were within
the well established ranges for preparations of this type.
* see page 2S)h
** personal communication from Dr Mellor
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M 27.1 - 1.0










M 2.87 - 0.41











F 4.76 ± 1.25 6.49 5.11 3.66 6.32
Amino Acid (^jnol/1)
M phe 35-9
F phe 88 - 22
M leu 67 - 26











* gestation at time of experiment
** corrected lamb weight for time of experiment
(weight gain = 73 gms per day) WWA\or
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Ins CI Ins C2 Ins C3 Ins C4 Ins C5
Amino Acid Infused Lys Phe Leu Lys Lys
Infusion route M F F F F
Gestation (days) 122 121 126 125 124
Days post surgery 14 11 16 15 15





Placental weight (g) iiji
•*4 + pcv %
M 27.1 - 1.0 32.5 28.5 32.0 32.0 32.5
F 36.7 - 0.9 39.0 34.5 37.0 37.0 38.5
"^Glucose (mmol/1)
M 2.87 - 0.41 3.47 2.99 3.11 3.44 3.27
F 0.74 - 0.18 0.99 0.80 1.44 0.85 1.44
"^Insulin (ng/ml)
M 0.37 - 0.014 1.37 0.65 1.00 1.37 0.43




F phe 88 - 22 85.2
M leu 67 - 26
F leu 106 - 34 81.1
M lys 131 ± 37 82.0
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Values for these parameters prior to starting experiments are given in
Tables 2' and '»> , together with published values established at the same
ID, ■300-303
centre. Furthermore, studies from the centre have shown that there is
little variation in the mean of these parameters either within a year or
between years.
Thus as no value fell outside the range observed in successfully catheter-
ised fetuses in a stable physiological state it is reasonable to assume
that these animal preparations also met the required criteria. Metabolic
steady state was achieved by introducing hourly feeding at least 7
days prior to experiment.
Although all these fetuses had values for the measured parameters
well within the ranges, it should be noted that the naturally occurring
303
wide range of placental weights, which can influence parameters results
in a wide range for these values. Failure to recognise the effects of the
wide range of placental weights could therefore result in some preparations
being judged "abnormal" when in reality their condition was "normal"
for a placenta of that size. Thus the concept of normality is difficult
to apply, and the suitability of animal preparations should be judged
by the aforementioned criteria. Comparison of data between centres may
therefore not be possible and any parameters e.g. pH pCC^ pC^ and lactate,
in addition to those used in these experiments, may be used, provided
that the stable state can be defined.
Plasma amino acid concentrations were not examined until the start
of the experiment, a time when.the lowest concentrations are observed
(i.e. approximate -20 days from birth). From data of previous similar
experiments (with the exception of once daily feeding) mean phenylalanine
concentrations (- SD) would be between 70 and 76 umol/1 and leucine
and lysine concentrations between 81 and 100 umol/1 and 69 and 93 umol/1
respectively. Values for phenylalanine leucine and lysine plasma
T5
free amino acid concentrations in hourly fed fetuses between 125 and 134
days gestation were 93— 1.2 (S.E.M.) 80 - 1.9 and 78 - 2.0 umol/1
respectively.
In conclusion, as all values of the measured parameters were
reasonably constant and fell within the expected range for this type
of animal preparation, it was assumed that a stable physiological state
had been attained. Additionally sufficient time elapsed for recovery
from surgery and to establish steady state metabolism after commencing
hourly feeding.
Pre-experiment care preparation and conditions
Scottish Black Face ewes were housed in an unheated room
temperature 12-17°C with constant artificial light. Here they
were handled daily for 4-8 weeks prior to surgery. They were
fed Ruminant A diet (Seafield Mill, Midlothian) which was
divided into 24 portions, each portion being delivered to them
every hour by an automatic feeding device.
Surgery
At approximately 105 - 110 days gestation, umbilical arterial
and venous catheters were inserted by Dr. Mellor
Two weeks before surgery the sheep was completely shorn
posterior to the last rib and 48 hours before surgery food,
but not water was withheld. Anaesthesia was induced with
IV pentobarbitone sodium and 100 per cent*oxygen was ad¬
ministered by endotracheal tube. Surgery was performed under
sterile conditions in a surgical theatre. Iodine antiseptic
solution 0.05 per cent tf/v chlorhexidine and 0.1 per cent Wv
thiomersal solution (50:50 acetonerethanol) were used
Ilo
successively on the whole of the operative site. The pregnant
uterus was exposed by an oblique abdominal incision and the
main umbilical arterial branches and venous tributaries of coty¬
ledons at each end of the fetus located by palpation.
Vinyl tubing (0.5 mm I.D. 0.9 mm O.D. or 0.4 mm
I.D. 0.8 mm O.D. ) attached to 60 - 85 cm of larger diameter
vinyl tubing (0.63 mm I.D. 1.4 mm O.D.) was threaded into a
small tributary and secured so that its tip lay about 5 cm
inside the major vessels. A retaining cuff of vinyl tubing
(1.4 mm I.D. 1.9 mm O.D.) was placed over the junction of
the two types of tubing. To the free end of the larger
diameter tubing a three-way luer tap was attached.
The uterus was replaced in the abdominal cavity and the
incision closed with catgut sutures. 3 - 5 cm of the catheters
were left exposed by dorsally extending the anterior end of
the skin incision by about 8 cm and closing this over the
catheters with silk sutures. To protect the catheters a
large bandage of two thicknesses of lint was secured over
the animal's back with strips of 7.5 cm bandage, so that most
of the ventral and lateral abdomen was covered.
After surgery the sheep remained in a heated room
(22 - 25°C) for 2-3 days. After regaining consciousness,
chopped hay and grass were fed for the first 9 hours and
thereafter pelleted food. For 1 - 2 days 0.9 per cent w/v
saline was given in place of water to help restore fluid and
electrolyte balance. 20 - 30 mg/kg procaine penicillin with
20 - 25 mg/kg dihydrostreptomycin or 5 - 7 mg/kg oxytetracycline
hydrochloride were given for 3 days and skin sutures removed
after 2 weeks. Fetal blood was sampled daily to monitor the




The experiments in all but one acute study involved continuous
infusion of radioactive material for four or ten hours. During
this time the sheep was kept in the pen to which it was accustomed
and a dividing barrier was placed across the pen so that the animal
could lie or stand but not turn round. The sheep had been similarly
restricted in the preoperative conditioning period.
Precalibrated syringe infusion pumps were placed on a shelf above
the animal. An infusion line (7 - 10 m vinyl tubing 0.9 I.D. 1.5
O.D. Portex Ltd.) sterilized by rinsing with 0.1 per cent w/v
thiomersal solution (50:50 v/v acetone: ethanol) was attached to
the syringe containing the radioactive tracer solution. Residual
thiomersal solution and air were expelled from the line with
sterile isotonic saline solution before attaching to the vascular
catheter.
In fetal experiments both umbilical venous and arterial routes
were used for infusions, the route depending upon the ease with
which fetal blood could be withdrawn. Preferentially the umbilical
venous route was chosen (this being the route by which nutrient
substances are transferred from the mother). If blood sampling
was difficult from the arterial catheter, the infusion was given
into the artery and the samples obtained from the umbilical vein.
Experiments in which saline or insulin were infused simultaneously
with the radioactive tracer amino acid had a Y junction (Portex)
to connect the two syringe infusion lines positioned about half¬
way between syringe and entry into the umbilical catheter.
In maternal infusion experiments both left and right jugular
veins were calculated, samples being withdrawn from one and radio¬
active material being infused into the other. Only one jugular
vein was cannulated if infusion was into the fetus.
li
At the end of the syringe stroke the syringe was filled with
isotonic saline and infusion continued until the dead space between
the syringe and umbilical catheter had been cleared.
At predetermined intervals during the infusion, maternal
and fetal blood samples were obtained by the following techniques
Maternal Blood Sampling: After removing the catheter plug drops
of free flowing blood were discarded to clear the cannula of
any static blood. A sterile 10 ml syringe (Plastipak, Becton
Dickinson & Co., Ireland) was filled with the maternal jugular
vein sample. The cannula was flushed with a small quantity of
heparinised saline and the cap replaced.
Petal Blood Sampling: All syringes (5 ml Plastipak) were
individually packed in autoclavable nylon bags and sterilised in
an autoclave before use. 0.1 per cent thiomersal solution (50:50
w/v acetone: ethanol) was used to drench the catheters and
surrounding skin and the following technique adopted to prevent
contamination of fetal samples:-
The catheter was flushed with 0.5 - 1 ml isotonic saline
(volume of catheter and tap 0.5 - 0.7 ml) and 0.75 ml of fetal
blood withdrawn into the same syringe and the syringe discarded.
The fetal blood sample, usually 2-3 ml in volume, was withdrawn
slowly into a fresh syringe containing o.25 mg dry heparin. 3.0
ml isotonic w/v saline was flushed through the catheter followed
by 0.75 - 1.0 heparinised saline solution (3 mg heparin.:/100 ml
saline solution). Thiomersal was again used to wash thq




After the final samples had been collected, nembutal was
administered via the maternal jugular cannula. Approximately 300
ml of maternal blood was taken and mixed with 15,000.units of
heparin in a 500 ml bottle. The sheep was removed from the pen
and immediately the animal was unconscious the abdomen was opened
and the uterus dissected. The position of the catheter tips in
the fetal vessels was determined and approximately 100 ml blood
was withdrawn from the fetal catheter and placed into a 500 ml
bottle containing 5,000 units heparin. Amniotic and allantoic
fluids were sampled by withdrawing fluid into 50 ml syringes and
capping these. Placental cotyledons were collected in polythene
bags. The lamb or lambs were freed from the surrounding membranes
and weighed in a plastic bag. Samples of fetal tissue were
removed by dissection and where possible fetal urine was obtained
by bladder puncture. Duplicate tissue samples were placed in
universal containers or pots, the sample for autoradiography being
place in 1.5 per cent glutaraldehyde as fixative. All tissues
and samples were taken to the Paediatric Laboratory, Simpson
Memorial Maternity Pavilion, where the terminal blood samples from
mother and fetus, and amniotic and allantoic fluids were centrifuged.
Plasma was collected from the blood and any extraneous matter
was removed from the amniotic and allantoic fluids. All tissues
and samples were stored at -70°C until analyses were carried .
out.
PRELIMINARY TREATMENT OF BLOOD SAMPLES
a. Maternal
Of the 10 ml blood taken, approximately 8 ml was expelled
from the syringe into a 10 ml lithium heparin tube (Stayne
Laboratories Ltd.) for separation into plasma and red blood
cells. 2 ml was placed in a 2 ml lithium heparin tube for
whole blood analysis, haematocrit and haemoglobin determinations
and 0.5 - 1 ml into sodium fluoride .tubes for blood glucose
determination when this was indicated in the experimental
procedure. All samples were well mixed in the tube to
prevent clotting. Plasma was separated from the blood by
centrifugation as described for the fetal samples.
b. Fetal
1 ml of fetal blood was expelled into a 2 ml lithium heparin
tube and 0.5 - 1 ml into a blood glucose tube as for the maternal
samples. The remainder was immediately centrifuged; in years
1 and 2 in an MSE bench centrifuge at 2000 rpm for 15 minutes,
and in year 3 in 2 ml polythylene tubes in a Beckman Microfuge
at 13,000 rpm for five minutes.
The separated plasma was initially stored at -20°C and the
RBCS, whole blood and blood glucose tubes were stored at
4°C. After completion of the experiment, or the evening
of the infusion, whichever was the sooner, samples were
taken to the Simpson Memorial Maternity Pavilion where plasma
was stored at -70°C and the other samples at 4°C until analysed.
TABLEHI
PhysicalDeta lsofSheepandRou efInfusi nEmployed
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PART II
Tritium Labelled Amino Acid Infusions
Tritiated phenylalanine was employed both to establish that
250 jiCi infused for 4 hours at 50 ^uCi/hour after an initial
bolus of 50 yuCi would produce measurable activity in both fetal
and maternal plasma, and that activity would reach a plateau in
plasma water within the time of infusion.
Two preliminary maternal infusions were undertaken, but only one
provided fetal samples. In a single fetal infusion, maternal samples were
continually available, and fetal samples from day 1. A fourth experiment
to study the distribution of activity following a bolus injection was
carried out.
3
L Phenyl (2,3 - H) alanine from the Radiochemical Centre,
Amersham was used in all experiments. This amino acid had a
specific activity of 15.6 Ci/nnnol and a radioactive concentration
of lmCi/ml.
None of the animals were sacrificed so tissue was not
available for autoradiography or total tissue counting.
Table HI gives details of the animals used in the experiments
and the routes of infusion.
As the fetal weight was unknown no estimate of the
total activity in fetal plasma could be made. Also, as few
measurements of S A were made, and there appeared to be both
a large contribution to plasma water activity from sources
other than the infused amino acid and loss of activity
on amino acid incorporation into protein, flux and incorpora¬
tion rates were not estimated.
S3
Fig It
Activity in maternal (•-) and fetal (0-) total plasma*
and maternal (0 ) and fetal (0 ) deproteinised
ft 3
plasma"for 4 hours after a 250 ja Ci L H 2 - 3
phenylalanine bolus injection into the maternal
jugular vein.
* In all graphs
represents radioactivity present in plasma protein
and plasma water.
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Fig 1ii
Activity in maternal (•-) and fetal (0-) total plasma
and maternal ($ ) and fetal (0 ) deproteinised
3
plasma following a 250 p. Ci L H 2 - 3 phenylalanine
bolus injection into the maternal jugular vein.
<§s




L H Phenylalanine 250 p. Ci in 5 ml of isotonic saline injected
within 15 seconds through a right superior vena caval cannula
inserted into the right atrium. After one minute the first active
maternal blood sample was taken from the left maternal jugular
vein at 08.01 hours. Maternal samples were taken at 30 second
intervals for 10 minutes and at one minute intervals between 10
and 15 minutes post injection. Samples were taken at 20, 25
and 30 minutes and then at 10 minute intervals for the next
hour (1^ hours post injection). Half hourly samples were
taken until 5 hours post injection and hourly samples from 5
to 10 hours. A 12 hour and 16 hour (24.00 hours) sample
were taken on the day of the experiment and 12 hourly samples
from 25 hours (i.e. 09.00 hours the following day) until 72 hours
post infusion. The sampling was continued on a daily basis
for a further 3 days.
Fetal samples from fetus B were taken from the umbilical
arterial catheter until 4 days post injection, when umbilical
venous samples were obtained. The first fetal sample
radioactive was taken at 15 minutes, the second at 30 minutes
and then at 1,2,4,8,16 and 25 hours after the injection and
daily at 09.00 hours until the end of the experiment.
Results
Total radioactivity in plasma and plasma water during the first
3
240 minutes following the 250 uCi L H phenylalanine injection is shown
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Fig liii
Calculated activity (•) from the formula Y = X} + X^e ^2t + xjt~^'3t
where X1 = 10,561 - 736
X2 = 29,101 - 3171
X3 = 8830 - 515
X2 = 0.140 - 0.017
X3 = 0.948 - 0.114
and measured activity (x) in maternal plasma after a bolus
... .3
injection of 250 Ci L H 2 - 3 phenylalanine.
<51
Compartmenta1 Analysis
A computer was employed to examine the decay curve of
radioactivity in an attempt to assess the number of pools of
aminoacid with which the injected material may mix.
The best mathematical "fit" to the curve was obtained from the
equation Xj + X? e-^ + (i.e. 2 exponentials
plus a constant). Values for X and X and a plot of this calculated
curve together with the measured curve are shown in Fig 1 iii. This
could represent constant metabolism of phenylalanine (X^ coupled
with rapid but decreasing removal from the plasma to maternal tissue
cells (X^) and slower removal to the fetus (X^) • Other formula
fitted to the curve included X + Xje 2 , X^e 1 +
X2e 2 and ^jg-Xj t + y^
•Jim J
Discussion
From experiment T'l ,
tritiated phenylalanine, injected as a bolus into the: maternal
circulation appears to equilibrate rapidly (Fig k i and ii).
3
A plateau concentration (12.00-13.00 X 10 d/min/ml) of total
activity in maternal plasma was reached within 12 minutes. During
this time 90 per cent of the label was found in the supernatant
of the protein precipitated plasma i.e. plasma water, probably as
the free amino acid. Although a constant level of total radio¬
activity was maintained for six hours, one hour post injection
the proportion of activity present in the supernatant had declined
to less than 50 per cent. After six hours it was less than 15 per
cent. Thus the proportion of bound activity incsa&ssi whilst
activity associated with the free amino acid declined:, Frcm
six hours„ total radioactivity also'diminished.
During the initial mixing phase transfer of the amino acid
to the fetus pccurred, the 15 minute fetal plasma sample having
3
an activity of 3.80 X 10 d/min/ml. Little further transport
occurred after this, probably a result of the fall in maternal
concentration of labelled free plasma water amino acids - maximal
3
fetal values being found at three hours(5.2 X 10 d/min/ml).
The proportion of bound radioactivity remained constant at
approximately 50 per cent of the total activity. From four
hours fetal plasma water had a slightly higher activity (2.00 X
3 3
10 d/min/ml) than maternal plasma water (2.00 X 10 d/min/ml de-
3
creasing to 0.50 X 10 d/min/ml) reflecting equilibration of
free amino acid between and within both maternal and fetal plasma
free amino acid pools, fetal plasma amino acids being at a higher
concentration than those of maternal plasma. Maternal total
Activity decreased slowly whereas fetal total activity slowly
increased, until by day six both had similar activity -
3
5.80 X 10 d/min/ml. From these results a 250 >J^Ci bolus injection
would not be expected to influence a constant infusion experiment
beyond two hours. If the bolus injection were smaller and the
subsequent infusion was at a rate appreciably in excess of that
of the decreasing activity from the bolus injection, the time to







Maternal Infusion L H Phenylalanine
3
L H Phenylalanine 250 jx Ci was diluted to 50 ml with
sterile isotonic saline.
At zero t^ime minus 15 minutes baseline maternal samples
were taken and at zero time minus 5 minutes (14.45 hours) a bolus
of 10 ml tritiated phenylalanine solution was injected. Infusion
at a rate of 10 ml (50 jx Ci/hour) into the maternal jugular vein
was commenced at 14.50 hours and continued for four hours.
Maternal samples were taken at 30 minute intervals over the first
four hours and then at 7, 9 and 19^ hours after the bolus
injection. Fetal samples were not available.
Experiment T3
3
Maternal Infusion L H Phenylalanine
3
L H Phenylalanine 250 jx Ci in 50 mis isotonic saline was
infused into the maternal venous catheter after both maternal
and fetal baseline samples had been taken. A bolus of 10 ml
was injected between 14.23 and 14.30 hours and thereafter a
continuous infusion of 50 yu Cx -(10 ml/hour) was continued
until 18.32 hours. Blood samples were collected at 30 minute
intervals throughout the infusion. At 19.12 hours (4 hours
42 minutes after the start of infusion) an allantoic fluid
sample was obtained and at 4^ and 8 hours post infusion
maternal and fetal samples were taken. Thereafter, maternal,
fetal and allantoic fluid samples were taken at approximately
09.00 hours during the next four days.
^0
50 Y ci L H 2-3 phe
























Activity in maternal total (•-) and deproteinised
plasma (0 ) during and after infusion of 250^Ci
3




50 ji Ci L H 2-3 Phe
iI^H ?-3 Phe i n f us i >n
Hours
Fig 3
Activity in maternal (•) and fetal (0) total plasma
and in maternal deproteinised plasma ( ) during and
3
after infusion of 250 p Ci L H 2 - 3 phenylalanine
into the maternal vein. Amniotic fluid activity




Infusion of L H phenylalanine into the maternal jugular vein -
experiment T2 (Fig 2) and experiment T3 (Fig 3) resulted in an initial
rapid increase in radioactivity in both maternal plasma water and total
plasma fractions. However, although it appears possible to infuse
amino acids at a rate sufficient to permit equilibration of the plasma
water free amino acid pool after I5 hours, the total (i.e. protein/
peptide) pool is clearly not saturated and incorporation of labelled
amino acid into protein or peptide is occurring at a near linear rate
3
throughout the infusion period, activity increasing at 3.01 x 10
3
d/min/ml/hr in experiment T2 and 3.02 x 10 d/min/ml/hr in experiment T3.
In experiment T3 thirty minutes after starting infusion total plasma
activity of the fetus already exceeded that of maternal deproteinised
plasma, demonstrating rapid transfer. Fetal total activity continued
3
increasing at 1.12 x 10 d/min/ml/hr during the infusion period.
Fig U
Activity in maternal total plasma (•-) during and
3
after 500 ju Ci L H 2 - 3 phenylalanine infusion
into the umbilical vein and in fetal total plasma




Fetal Infusion L H Phenylalanine
Experimental Details
3
L H Phenylalanine 500 jd Ci in 50 ml sterile isotonic saline
were infused into the fetal vein. A baseline maternal blood
sample was taken and a 10 ml bolus injection into the fetal
venous catheter given over A minutes (from 09.26 - 09.30 hours).
Infusion at 10 ml (100 ji Ci/hour) was commenced and continued
for four hours. Samples were taken at 30 minute intervals
for 5 hours and thereafter at 11% hours and daily at 09.00
hours for four days. Fetal samples were only obtained from
2A hours onwards.
Results
Retrograde amino acid transport from fetal to maternal
circulation was demonstrated in experiment T/j. (Fig This
"back" transfer, detected by increasing radioactivity in maternal
total plasma samples, continued at approximately the same rate
3 3
0.60 X 10 d/min/ml between 0 and A hours and 0.5A X 10 d/min/ml
between 2 and A hours and for two hours beyond the end of the
infusion probably because relatively high concentrations of
labelled amino acids are maintained in the fetal plasma relative
to those of maternal plasma - (S.A. fetal plasma would exceed




Maternal and Fetal H Infusion
Tha bolus injection
(50/a Ci) obviously accounted for a large proportion of the
early increase in activity with, as in experiment T4, approximately
50 per cent of the total activity being in plasma water at 30
minutes. The decrease in plasma water activity at one hour could
be due to equilibration between the decreasing contribution of
activity from the bolus injection and the increasing contribution
from the constantly infused phenylalanine, bi|t could also ba
caused by changes in the metabolic equilibrium (page 239).
In both maternal infusions there was a rapid decrease of
radioactivity in plasma water and total radioactivity ceased to
y
increase when the infusion stopped. In experiment T3, the increase
in fetal total radioactivity was also reduced at this time,
suggesting transfer of labelled amino acid decreased. This is in
contrast to experiment T4, fetal infusion, in which reverse transfer
from fetus to mother would appear to continue, probably a result of
diffusion from the higher concentration fluid (fetal plasma) to the
maternal environment of lower concentration and radioactivity.
Activity measurements in allantoic fluid in experiment
T3 would indicate that although transfer occurs into this ^
compartment, equilibration is slow - activity in maternal and
fetal plasma being relatively stable from four hours onwards
but allantoic fluid activity increasing until day 2. However,
a decreasing fluid volume would have the same effect and S A-
measurement (requiring a higher level cf activity) would be
necessary to establish the time to equilibration.
%
From these
experiments the following conclusions can be drawn:
1. 250 p Ci is sufficient to give measurable activity
in fetal plasma and to demonstrate "back" diffusion
, to maternal plasma, although levels are low for S.A.
measurement.
2. A bolus injection of 50 p Ci does not have any influence
on results after \% hours.
3. Plateau activity is found in the plasma water fraction
of the infused animal - i.e. ewe or fetus, from two
hours after the bolus injection until the end of
infusion.
4. Deproteinized fetal plasma has a higher concentration
of labelled amino acids than the deproteinized maternal
plasma.
5. The increase in protein bound activity is linear
throughout the experiments.
%
6. The experimental design produced no problems in the
management of the sheep or sampling from the implanted
catheters.
V











PhysicalDetailsofS ceoanaR uteOInfusionEmploy d Sheep No. H263 H343 11330 H285No.of fetusesCondi¬ tions live live live live
Weight kg 4.28 4.05 4.07 3.98
Gest, Days 126 127 130 126
Dayspost operative 20 16 15 16




L C Amino Acid Infusions
Maternal and fetal infusions similar to those of Year One were
1A . . .
repeated using L C phenylalanine. Additionally a simultaneous
1A 3
infusion of L C into the mother and L H phenylalanine into the
1A
fetus was carried out. Infusion of L C leucine into the maternal
jugular vein was also studied.
In addition to measurements of radioactivity in total plasma,
plasma water and blood, S A was determined in plasma water of the
phenylalanine maternal, fetal and dual infusions. Plasma protein
was hydrolysed in selected samples of the phenylalanine maternal and
dual infusions. Measurements of radioactivity in those hydrolysed
samples are presented together in the last part of this section.
1A 7—
L (U - C) Phenylalanine specific activity 522 mCi/mmol
with a radioactive concentration of 50 ;uCi/ml was used in all
phenylalanine experiments.
L (U - ^C) Leucine, specific activity 32A m Ci/mmol
with a radioactive concentration of 50 ja Ci/ml was used in
experiment 3. Labelled amino^cids were obtained from
Radiochemical Centre, Amersham. Tritiated L phenylalanine
was prepared as described in Part 1 .
Table IV gives details of the animals used in the
experiments and the type and routes of infusion.
At the end of the experiment the animals were sacrificed.
m
Allantoic and amniotic fluids were obtained, blood films of
maternal and fetal blood made and the following tissues
taken from the lamb:- thymus, thyroid, lung, heart, liver,
spleen, adrenal, kidney, muscle, brain, placental cotyledons.
Fetal urine was obtained when present.
14





Maternal Infusion LU C Phenylalanine
14 . .
C L Phenylalanine 250 Ci in 25 ml of isotonic saline
was infused into the maternal jugular vein by syTinge pump
at 5 ml (50 jj Ci/hour) for four hours. A bolus of 5 ml was
given from the syringe immediately prior tp commencement of
infusion at 11.15 hours. Maternal samples were taken from
the other jugular vein and fetal samples via the umbilical
vein cathetef. Maternal and fetal blood samples were taken
at 1, 1^. 2, 3, 4, 5, 6 and 11 hours and daily at 09.00
hours for a further nine days. In addition maternal samples,
but not fetal samples were taken at 2-^, 3-k, and 8 hours.
At sacrifice fetal urine was not obtained.
Experiment C2.
14
Maternal Infusion LU C Leucine
14
LU - C Leucine 250 p Ci in 25 mis isotonic saline was
infused and samples collected as in experiment CI The infusion
was commenced at 11.10 hours after a bolus injection of 5 ml.
An additional blood sample from both mother and fetus was
taken at 15 minutes, and the sample equivalent to the 11
hour sample was taken at 10 hours. The animal was sacrificed






















Maternal (•) and fetal (0) plasma total (-) and
deproteinised ( ) activity during and after
14






Maternal (•) and fetal (0) plasma total (-)
and deproteinised ( ) activities during and





Haematocrits in both fetal and maternal blood of experiment CI
remained reasonably constant throughout the experimental period.
Maternal range was from 25-27.5% and fetal from 32-36.5%.
In experiment C2 maternal haematocrits remained very stable
(28-29%) during the first 24 hours and in days 2-7 ranged between
24.5 and 29%. Fetal haematocrits also remained constant (35-37%) up
to day 3, but had increased to 44% on day 7. Individual haematocrit
values may be found in Appendix U.
b. Total Plasma Radioactivity Measurements
Maternal total radioactivity increase was linear in both
experiments (fig 5i and 6i). The only exception was the decrease
in total activity between hours 2 and 3 of the phenylalanine infusion,
mirrored in deproteinised plasma 30 minutes later which could be
due to changing fluid volumes, haematocrit values, placental transfer
or variations in the infusion rate (viz. p222).
The increase in total fetal plasma radioactivity was also linear,
3 3
but the rate of increase (1.94 x 10 d/min/ml/hr and 1.51 x 10 d/min/ml/hr
for experiments CI and C2 respectively) was slower than that of maternal
total plasma in both experiments.
103
Deproteinised Radioactivity Measurement
In both experiments (Fig 5i and 6i) the increase and decrease
in maternal deproteinised (i.e. plasma water) radioactivity on
starting and stopping infusion respectively was rapid. There was
only a small increase in the activity of deproteinised plasma in
maternal samples taken between 30 minutes and 4 hours (final) after
the start of infusion. In both experiments there was a rapid
decrease from the plateau activity in the hour after completing
the infusion, with maternal deproteinised plasma radioactivity being
below that of the fetus in samples taken after ending the infusion.
Fetal deproteinised plasma activities differed from those of maternal
samples in that the increase was slower on infusirj the amino acid
and there was no decrease on ending it.
The two infusions differed in that deproteinised radioactivity
reached a plateau, similar to that of maternal samples in the
phenylalanine CI infusion, but continued to increase in the leucine
C2 infusion. The final radioactivity was however also similar to




Maternal (®) and fetal (0) activity in whole blood
during and after 250 u Ci l'^C phenylalanine (-) and
14
250 ju Ci L C leucine ( ) infusions into the
maternal jugular vein.
Radioactivity in Whole Blood
During the first 24 hours radioactivity in whole blood (fig 6ii)
was similar to that of total plasma activity, although in experiment
Cl (phenylalanine infusion) the slight fall found in maternal plasma
at 2| hours did not appear to be present. This might indicate a
sudden increase in the proportion of activity present in or attached
to the blood cells as an increase in haematocrit was not observed.
An increase with time was observed in the cellular proportion of
radioactivity, and at all times a higher percentage of activity was
associated with fetal RBC than was found in maternal RBC's.
The proportion in maternal samples increased from approximately
12% to 45-60% between the end of infusion and the samples taken
approximately one week later (5-9 days). Similarly in fetal samples
there was an increase from 35-55% to 75-80%.
Tissue Digestion Allantoic and Amniotic Fluids Radioactivity
Details of radioactivity found in tissues are given on page 1^0.
3
In the phenylalanine experiment total activities were 0.44 x 10 d/min
3
in the allantoic and 0.19 x 10 d/min/ml in the amniotic fluid sampled
at delivery, and in the leucine experiment the radioactivities were
3 3
0.61 x 10 d/min/ml and 0.23 x 10 d/min/ml in allantoic and amniotic
fluids respectively.
10b
































Maternal (•) and fetal (0) phenylalanine (-) and
tyrosine ( ) activity in plasma water (below)
and free amino acid SA (above) during and after








































f. Experiment CI -(Maternal Phenylalanine Infusion)
Specific Activity Measurement
Plasma water specific activity was determined in maternal
samples taken at 30 min, 2, 3, 3%, A and 22 hours and 3 and 7
days and in fetal samples taken at 2, 3, A, 5 and 11 hours and
day 3. Both plasma water and hydrolysate specific activities were
determined for phenylalanine and tyrosine on the 2, A and 22 hour,
3.and 7 days maternal samples. Hydrolysate results have been combined
with those of the dual infusion and may be found on page \2-b.
The specific activity of free plasma phenylalanine and tyrosine
is shown in fig 5ii . Changes in free phenylalanine and tyrosine
plasma concentration may be seen from Table V.
Maternal Values
Analysis of the first maternal sample at 30 minutes showed
that the bolus injection of 50 p Ci phenylalanine had produced a
1A
rapid rise in SA reaching 68.20 d/min/nmol and that C labelled
tyrosine was already present (0.52 d/min/nmol) thus indicating
that rapid hydroxylation of the phenylalanine must have occurred.
The tyrosine:phenylalanine SA ratio rose
until the 22 hours sample although individual activities ranged
from 0.98 to 78.90 d/min/nmol . phenylalanine during this time.
At the end of infusion a rapid fall in phenylalanine but not
tyrosine specific activity was observed. However, activity
was detectable in the phenylalanine fraction up to day 7 but not
beyond 22 hours in the tyrosine fraction.
. From'the plateau SA maternal flux was calculated to be 4036 jamol/hr.
10^
Fetal
Fetal plasma water phenylalanine and tyrosine specific
activities were below maternal values, this being largely a result
of the greater concentration of amino acids in fetal plasma, the
acEivity per millili;Lre of plasma at equilibrium being similar
ia both maternal and fetal samples. Fetal phenylalanine SA
iEereased from 7.03 d/min/nmol at 2 hours to 9.20 at 3 hours
then only slowly to 10.20 d/min/nmol at A hours, the plasma
water phenylalanine concentration thereafter falling from 75.A
to 6A.A • ^imol/1. This decrease in fetal plasma water phenyl¬
alanine concentration was less marked than that found in maternal
plasma and significant quantities of labelled phenylalanine
and tyrosine were found in plasma 7 hours after the infusion had
stopped. Tyrosine SA equilibrated at the same time as
phenylalanine SA i.e. from 3 hours onwards although during this
time plasma amino acid concentration also fell from 97 to 81.2
^inol/1. The ratio of tyrosine to phenylalanine SA reached a
maximum of 0.15 at 3 hours, and unlike maternal plasma little
change was noted thereafter.
no
Distribution of Free and Bound Radioactivity
14
The maximum percentage of the C phenylalanine infused
recorded in the maternal plasma as phenylalanine and tyrosine is
6.89 per cent at 22 hours, the major fraction of this being
present in the hydrolysate - 6.85 per cent of the infused
radioactivity. The maximum percentage recorded as total
radioactivity was 8.0 per cent at 6 hours, followed by a plateau
of 7 per cent at sacrifice. The only sample with a greater
percentage in the plasma water was at 30 minutep - plasma .
water 2.85 per cent with none detectable in the protein
hydrolysate. This sample also had the highest percentage of
the infused activity observed in maternal plasma. Fetal plasma
water has very little of the infused activity present, from
5 hours to 3 days having between 0.024 or 0.028 per cent present
as phenylalanine and tyrosine. Total radioactivity increases
slowly to between 0.4 and 0.45 per cent.
Maximum activity in maternal plasma (8 hours) of the leucine
infused animal represented 6.15 per cent of the total infused activity.
Fetal plasma of this experiment accounted for 0.47 per cent of the infused
activity at its highest concentration (day 7). The maximum percentage
of infused activity in maternal plasma water was 0.28 per cent and in






Maternal (♦) and fetal (0) activity in total plasma
(-) and deproteinised plasma ( ) during and after
14
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Fetal Infusion LU C Phenylalanine
14 . . .
LU - C Phenylalanine 250 p Ci in 25 ml isotonic saline
was infused by syringe pump at 5 mis (50 p Ci/hour) into the
umbilical venous catheter for four hours after a bolus
injection of 5 ml had been given at 11.30 hours. Maternal
samples were taken from the jugular vein and fetal blood
•samples from the umbilical arterial catheter. The intervals
of time between samples were as in experiment CI, but the
experiment was terminated one day earlier. Fetal urine was
obtained.
Results
a. Haematocrit values were within the range 26 - 30.5 per cent in
maternal samples and 24 - 28 per cent in fetal blood samples.
b. Total and Deproteinised Plasma Ratio Activity Measurements
Transfer of labelled material from fetal to maternal circul¬
ation did occur (Fig 7i) but at a very slow and gradual rate,
3
(0.16 x 10 d/min/ml/hour). Deproteinised plasma radioactivity
of maternal samples was very low, being only just above background
after the infusion ended.
Fetal total plasma activity increased in a linear manner at
3
33.79 x 10 d/min/ml/hour during the 4 hours of the infusion, but









Maternal (®) and fetal (0) whole blood activity
during and after 250 p Ci L phenylalanine




Fetal plasma water phenylalanine (-) and tyrosine
14
( ) sA during and after 250 >1 Ci L C phenyl¬
alanine infusion into the umbilical vein.
llfT
Radioactivity in Whole Blood
The increase in whole blood radioactivity during the experiment
is shown in Fig 7ii. Like maternal infusions the proportion of
whole blood radioactivity associated with fetal RBC was low
during the first 2 days (5 - 27 per cent) increasing to 71 per cent
at experiment termination.
The proportion of activity associated with maternal RBC
increased from approximately 25 per cent during infusion to
45 - 60 per cent in days 3 to 8.
Tissue Digestion, Allantoic Amniotic and Fetal Urine Radioactivity
Radioactivity associated with various fetal and maternal
tissues is given on page )C\D.
3
Allantoic fluid recorded 6.06 x 10 d/min/ml and amniotic fluid
1.23 x 10^d/min/ml.
Specific Activity
The specific activity of free phenylalanine and tyrosine in fetal
plasma water during the infusion and at one hour post infusion is
shown in fig 7iii. The increase and decrease on starting and
stopping the infusion were similar to the changes in maternal plasma
SA during maternal infusions.
From the plateau SA fetal flux was calculated to be 100 ^jamol/Kg/hr.
11 £3
f. Distribution pf Radioactivity
Of the radioactivity infused into the fetus, samples taken
between 2 and 6 hours showed 7.90 - 7.99 per cent of this
activity to be in fetal plasma. A rapid rise to this value
was observed (5.38 - 6.56 per cent at 30 minutes and 1 hour
respectively) after which a slow decline from the plateau value
followed (6.74, 4.98 and 3.97 per cent at 11 hours, 22 hours
and 3 days respectively). Plasma water still accounted for
1.02 per cent of the infused activity at 11 hours and thereafter
declined to 0.73 and 0.57 per cent at 22 hours and 3 days.
Maternal plasma total activity exhibited a plateau activity
of 0.25 - 0.32 per cent of the infused activity from hours 1
to 4 during infusion and thereafter increased very gradually
to 0.66 per cent at 7 days. Maternal deproteinised plasma
contributed less and less of the percentage activities with
time, from 0.086 per cent at 30 minutes to 0.042 per cent




iii Dual H and C Infusion
Experiment C4
14





LU — C Phenylalanine 175 ju Ci in 25 ml of mineral cocktail *
*
(without dextrose) and 25 ml cocktail (without dextrose) con-
.3
taining 250 }i Ci L H phenylalanine, each in separate 50 ml
syringes placed in the same syringe pump, were infused into
the maternal jugular vein and the umbilical vein respectively.
A bolus of 5 ml of each solution was given simultaneously
by manually pushing the syringe pump and infusion of both
continued at 5 ml/hour for four hours (11.17 - 15.22 hours)-
therafter. Blood samples were taken/after the same time
intervals as in experiment C3. and the experiment continued for
8 days. Fetal urine was obtained.








Maternal («) and fetal (0) plasma total (-) and
deproteinised ( ) '^C activities during and after
simultaneous infusion of 175/1 Ci l'^C phenylalanine
3
into the maternal jugular vein and 250 /i Ci L H


















Maternal (•) and fetal (0) plasma total (-) and a*\c\ to)
3
deproteinised ( ) H activities during and after
3
simultaneous infusion of 250 jJ Ci L H 2 - 3
phenylalanine into the umbilical vein and 175 Ci





Maternal (C) afid fetal (0) phenylalanine (-) and
14
tyrosine ( ) C activity in plasma water
(below) and free amino acid SA (above) during and
14
after 175 p Ci L C phenylalanine and 250 ;u Ci
3
L H 2 - 3 phenylalanine infusion into maternal
jugular vein and umbilical vein respectively.
V2.1
TABLE VI
Amino Acids Concentrations with Time
Time (hr) Tyrosine Phenylalanine
jumol/1 yimol/1










3 days 32.2 30.4
7 days 30.0 39.2













Both maternal and fetal haematocrits were stable throughout the
infusion, maternal values being between 27 and 30% and fetal values
between 35 and 37% on the day of the infusion. On day 1 a fetal
haematocrit of 73% was recorded, but thereafter fetal haematocrits
were between 28.5 and 34% and maternal between 23 and 29%.
b. Total and Deproteinised Plasma Radioactivity Measurements
Total and deproteinised plasma radioactivity in maternal and fetal
samples after maternal isotope infusion is shown in fig 8i
3 . ....
and after fetal H isotope infusion m 811.
C. Specific Activity Measurements
Plasma Water Values
Deproteinised plasma phenylalanine and tyrosine SA and the
activity of these amino acids in one millilitre of plasma are
1A 3
shown in Figs 8iii ( C) and 8iv ( H) . In Table VI the concentration




Phenylalanine SA increased rapidly to a peak value of
53.79 d/min/nmol at 30 minutes. Between 2 and 7>\ hours after
the bolus injection phenylalanine SA was at a plateau (24.29 -
27.90 d/min/nmol). However, although labelled tyrosine was
detected at 15 minutes the tyrosine SA increased for a longer
period of time than that of phenylalanine, and only two samples
^23
at 3 and 3h hours were of similar activities, 5.39 and 5.32 d/
min/nmol respectively. Both phenylalanine and tyrosine decreased
rapidly in the interval between the 3% and A hour samples,
suggesting that the infusion was effectively finished before
the A hour sample was taken. Activity was undetectable in the
tyrosine fraction from 5 hours post bolus injection, but labelled
I
phenylalanine decreased more gradually, activity being just
detectable at 22 hours and 3 days. The tyrosine:phenylalanine
SA ratio increased from 0.07 in the 2 hour sample to 0.20 in
the 3 hour sample, and like SA, decreased rapidly (from 0.19
to 0.05) in the time interval between the 2>k and A hour samples.
Fetal Samples
After A hours infusion the final phenylalanine SA(11.A 1 d/
min/nmol) was greater than that of the maternal A hour sample
(10.89 d/min/nmol) although the maternal SA had fallen rapidly
from 27.90 d/min/nmol at 3\ hours. Unlike maternal phenylalanine
SA, fetal SA increased appreciably between the 2 and A hour
samples (7.62 to 1 1 .A 1 d/min/nmol) after which there was only
a slow decline to A.60 d/min/nmol at 5 hours, 2.28 d/min/nmol
at 10 hours and 0.35 d/min/nmol at 7 days. Tyrosine SA was also
highest at A hours but both the increase to and decrease from
the level (1.20 d/min/nmol) was slower, this being reflected
in the tyrosinerphenylalanine SA ratio which reached a maximum





Fetal phenylalanine (-) and tyrosine ( ) H activity
in plasma water (below) and free amino acid SA (above)
during and after simultaneous infusion of 250 p Ci L
3
H 2 - 3 phenylalanine into umbilical vein and 175 C
14 .
L C phenylalanine into the maternal jugular vein.
J2.S
b . H Isotope
Maternal Samples
3
Slow back diffusion of H labelled phenylalanine was observed.
The highest SA was 1.04 d/min/nmol in the sample taken \\ hours
3




Unlike the C isotope, H phenylalanine SA was at a plateau
(123.9 - 128.8 d/min/nmol) between 2 and 4 hours and although, like
14
C SA, decreased between 4 and 5 hours, the decrease was faster.
3
In the 5 hour sample H SA was 29.4 per cent of the 4 hour value
14
compared with 40.3 per cent for the C isotope. The decrease
in SA continued beyond 5 hours but activity was still detectable
in the seventh day sample. No plateau SA was found in the
tyrosine fractions, the SA increasing from 10.23 to 90.54 d/min/nmol
14 3
between 2 and 4 hours. Unlike both the C and H phenylalanine SA,
3
H tyrosine SA was unchanged at 5 hours and m the 10 hour sample
3
was still 63.9 per cent of the 4 hour sample and H tyrosine was
still detectable after 7 days. The highest tyrosine:phenylalanine
14
SA ratio was present at 10 hours. Unlike the C isotope appreciable
activity was eluted from the ion exchange columns coincident with
the elution of DOPA. Activity was 1.65, 1.94, 0.25 and 0.73 X
3
10 d/min/ml plasma in the 5 and 10 hours, 2 and 7 day samples
respectively. These fractions were not collected from the 2 and
4 hour samples.
12-U
iv Hvdrolvsates of Plasma Protein from Maternal L C t'henylalanine (CI)
14 3
and Simultaneous Maternal L C and Fetal L H Phenylalanine. (C4)
Maternal |, 2, 4, 22 hour and 3 and 7 days samples and fetal
5, 10 (C4) or 11 (CI) hour and 2 (C4) or 3 (CI) day samples were
hydrolysed. In Experiment C4 maternal 15 minute and fetal 7 day
samples were also hydrolysed.
Results
The ~^C radioactivity in the hydrolysed samples are shown in
3
figs 9i and 9ii and the H radioactivity in samples from the dual
infusion in fig 9iii.
In both experiments maternal samples had detectable radioactivity
in both the phenylalanine and tyrosine fractions after 2 hours, but
only the experiment C4 sample had detectable radioactivity present
at 30 minutes and this only in the phenylalanine fraction. Maximum
radioactivity in the phenylalanine fraction was recorded at 22 hours
but although this was also true of tyrosine in experiment CI, no
increase at this time was found in experiment C4 (dual infusion).
14
In both experiments maximum fetal C activity was found in the
samples taken 6-7 hours after completing the infusion. In experiment
CI (maternal infusion) phenylalanine activity in protein increased
* 1 3between hours 4 and 11 from 150 x 10 d/min/g
3 ...
to 227 X 10 d/min/g protein although tyrosine activity appeared
constant. Incorporation of unlabelled phenylalanine and tyrosine
into protein would be expected to be increased or decreased to
an equal extent. The divergence in SA could therefore be
partially due to greater error at the lower activity level of
tyrosine in samples but could also reflect decreased hydroxylation




























Maternal (•) and fetal (0) phenylalanine and
tyrosine( ) activity in plasma protein from
one millilitre of plasma (below) and per gram
of protein (above) during and after 250 p Ci







Maternal (6) and fetal (0) phenylalanine (-) and
.-14
tyrosine ( J C activity in plasma protein from
one millilitre of plasma (below) and per gram of
protein (above) during and after simultaneous
14
infusion of 175 y Ci L C phenylalanine into
. 3
maternal jugular vein and 250 y. Ci L H 2 - 3









































Fetal phenylalanine (-) and tyrosine ( )
3
H activities m plasma protein from one
millilitre of plasma (below) and per gram
of protein (above) after the simultaneous
3
infusion of 250 p Ci L H 2 - 3 phenylalanine
14
into the umbilical vein and 175 ju Ci L C
phenylalanine into the maternal jugular vein.
ISO
SA. Unlike maternal plasma in which the ratio of tyrosine SA:
phenylalanine SA increased from hours 4 to 22, the small change
observed in th£ fetal plasma was in the opposite direction -
14
suggesting decreased hydroxylation of the C phenylalanine.
This was not true of Experiment C4, however, in which both maternal
and fetal tyrosinerphenylalanine SA rations increased.
Tritium activity in the maternal phenylalanine and tyrosine fracti
eluted from the ion exchange column was only a few counts above back¬
ground and therefore too low for calculation of specific activities.
Although the level of radioactivity per gram of protein was unchanged
at 10 hours in the fetus there was a significant decrease by day 2.
This contrasts with the C hydrolysate measurements in which activity
decreased only slowly. However, the rairio of tyrosine:phenylalanine
■ • ... 14
activity per gram protein was similar to that of C isotope, being 0.37
and 0.42 at 2 and 7 days respectively compared with 0.31 and 0.38
14
for the C isotope.
Tissue Digestion
Activity of tissues (C4) are given in ici."-- V : ;■ (Page 1*30).
Flux
Maternal flux (^C isotope) was calculated at 1374 jumol/hr
3
Fetal flux ( H isotope) was calculated at 231 ^mol/kg/hr
Flux is discussed in Chapter 4.
13!
Discussion
L^C Phenylalanine and L^C Leucine Activity
a. Maternal Infusions
In maternal infusion experiments including both L
phenylalanine experiments CI and C4 (Fig 5 and 9) and L leucine -
Experiment C3 (Fig 8) fetal plasma water activity was greater than
that of maternal plasma water reflecting the higher plasma free
amino acid concentration in the fetus. Unlike the previous
tritium experiments, inL^C phenylalanine and L C leucine infusion,
total activity increased both maternal and fetal plasmas for
approximately 2 hours beyond the end of infusion. The con¬
tinued increase in total activity with a simultaneous rapid
decline in f^ree plasma water activity suggests either a slow
equilibration between plasma, tissue free amino acids and
incorporated amino acids, or continued release of the pre-
labelled proteins/peptides into the plasma over a prolonged period.
However, immediate release of some proteins/peptides must occur
as total plasma activity is greater than that accounted for by
activity in plasma water and^tota\nactivity and shows a linear
increase from the first maternal and fetal samples obtained
J "5$after commencing infusion. This is in agreement with Peters"
experiments in which labelled albumin was released from liver
cells 15 minutes after incubation in labelled medium. In fetal
lambs approximately one third of the placentally enriched blood
has been reported to enter the fetal circulation directly via
the ductus venosus and two thirds via the left lobe of the liver
' '
. Rapid hepatic uptake of the labelled amino acids could
\3"2_
therefore both reduce this concentration of labelled amino acids
reaching peripheral tissues and facilitate the labelling of
hepatic proteihs e.gl albumin which may be subsequently released.
14
The extended incorporation of C isotope into the protein
precipitated fraction could also suggest a continued "secretion"
of labelled amino acid from the placenta. Complex formation
of these labelled amino acid at a cell membrane site prior to
protein synthesis (Hendler Adamson) or uptake of labelled amino
acids by tissue cells, thereby maintaining the intracellular
pool "reserve" of precursor amino acids could prolong the
synthesis of labelled protein. Alternatively catabolism of
prelabelled protein could similarly maintain the precursor
pool radioactivity level. The predominant anabolic state of the
fetus and the "drain" this causes on maternal reserves may favour
the former mechanism in the fetus and the latter in the mother.
Further evidence for the role of the placenta as a S-A reservoir
was found in fetal infusions
b. Fetal Infusions
Infusing 250 }\ Ci L phenylalanine directly into the
fetus - experiment C2 - obviously resulted in a greater level of
radioactivity in fetal plasma but the distribution of activity with
time was similar to that observed in maternal experiments.
The abrupt end to the linear increase in total plasma
activity contrasts with the continued increase in activity
observed during maternal infusions. It supports the concept
2k , 'q|. , <U., 23 ,34,55,1 /£. „' that the placenta may accummulate
labelled amino acids during infusion which are then secreted
II -
into the fetal circulation after the infusion had ceased
Clow back diffusion, also observed in the tritium experiments,
probably reflects slow exchange and passive diffusion down a
concentration gradient from the fetus and placenta to the
maternal circulation.
with S A measurements (page255) the difference probably being
explained by the presence of small peptides in the plasma water
fraction. A continued release of these prelabelled unprecipitated
peptides, which might also have a longer half life than amino
acids could explain an increase in the plasma water activity
from hours 4 to 5.
^.Specific Activity
14
The C isotope of L phenylalanine was infused into the
maternal jugular vein in experiment CI and C4 both experiments
rapid increase in maternal total plasma phenylalanine S A. occurre
but unlike activity measurements of tritium, plasma water equili¬
brium was not rapidly established - a suggestion of a plateau
only being detected after 2 hours. This failure to rapidly
establish a plateau level of S A is significant when planning
radioactive infusion experiments as the plateau value of S A is
an important measurement in calculating flux rates. Slow mixing
of both the injected bolus and infused radioactivity with the
plasma water free amino acid pool, or an unequilibrated system due
to a steadily increasing rate of entry of amino acids into cells
or fetal drain on maternal amino acids, could account for the
slow attainment of plateau activity.
In both experiments, after stopping the infusion the S.A
of the free amino acid in plasma water decreased at a faster rate
in maternal than fetal samples.
The continuous increase in deproteinised plasmaAcontrasts
\~hU-
As the fetus is in an anabolic state it might have been
thought that accelerated protein synthesis would deplete the
free labelled amino acid pool faster than in the mother, but
replenishment from the placental reservoir could maintain the
fetal labelled free amino acid pool. Conversely in the mother
uptake by the placenta could deplete the pool and subsequent
proteolysis may further dilute the pool with unlabelled amino
acids. Similarly incorporation of labelled amino acids into
newly synthesized protein would (be expected to) diminish
earlier in the fetus. However, this was not the case. The S A
of hydrolysates, i.e. the ratio of labelled:cold phenylalanine,
continued to increase in the plasma protein beyond the end of
infusion, albeit at a slower rate. The abrupt halt
in incorporation of fetal infused H labelled amino acid into
fetal protein in experiment C4 and in experiment C2 inferred
from plasma total activity measurements would support the
concept of continued replenishment of the protein precursor
pool, as a slow increase in labelled protein would otherwise also
have been expected in this experiment. The
slight increase in maternal plasma protein S A would be unlikely
to be due entirely to replenishment of labelled amino acids by
back diffusion from the placenta. Although this could occur
becaose fetal S.A. is greater than that of maternal plasma, the
exchange equilibrium is towards the fetus. Utilisation of
qraino acids for "export" proteins and increased catabolism to
meet fetal demands could contribute towards the maintenance of
maternal plasma protein radioactivity levels(
ivr
Appearance of labelled tyrosine in the fetus could be a
result of placental transfer of maternally prelabelled tyrosine
•
alone or by direct hydroxylation of phenylalanine by the fetus
or placenta. During maternal infusion the maternal plasma
\ I4 1A
water S-A ratio of C tyrosine: C phenylalanine in
experiment C4 varied between 0.046 and 0.063 and that of fetal
plasma between 0.181 and 0.184. These are similar values to those
found in experiment CI - 0.008 - 0.040 and 0.10 - 0.149
respectively. This suggests that the fetus or placenta is
capable of hydroxylating phenylalanine and contributes to
fetal tyrosine. The tyrosine:phenylalanine ratios in experiment
C4 are 0." 12 - 0.23 for maternal protein (per g protein) and
0.31 - 0.38 for fetal protein, and in experiment C! 0.15 - 0.23
and 0.18 - 0.31 respectively, the higher ratios again being
in the fetus. Efficient hydroxylation of phenylalanine to
tyrosine within the placenta or fetal liver could explain the
3
distribution of the tritium label when H phenylalanine was
directly infused into the fetus. In both maternal plasma water
and plasma protein fractions of experiment C4 specific activitj
is too low to permit calculation of ratios but in the fetus
3
plasma water tyrosine H specific activity is surprisingly
3 ....
higher than H phenylalanine specific activity from 4 hours
to between 10 and 22 hours, the S A. tyrosine:phenylalanine ratios
in plasma water being 2.35 - 3.79. However, in plasma proteins
14
the ratio 0.30 - 0.40 is very similar to the C ratio (0.31 -
0.38). Continued hydroxylation of labelled phenylalanine (which
was decreasing) to tyrosine, and or delayed release of labelled
tyrosine from cells into plasma could explain the relatively
slow decline of tyrosine compared with phenylalanine S A
\~i>L
Although 1AC tyrosine was present in fetal
plasma water from the first fetal sample (15 minutes) of
14
both the fetuses infused with L C phenylalanine (experiment C2
and fexperiment Ins CI and therefore hepatic hydroxylation is likely,
14
the ratio of C SA tyrosine:phenylalanine (0.065 - 0.087 and 0.061 -
0.063 respectively) was closer to the maternal SA of the maternal
infusions. This suggests that in the fetuses of the maternal infusions
the increased ratio (greater than the sum of the maternal SA and the fetal
SA in fetal infusions) resulted from both maternal and fetal hydroxylation
and probably also hydroxylation in the placenta.
3
The high H tyrosine SA m experiment C4 is therefore probably
due to lability of the label rather than extensive fetal hepatic or
placental hydroxylation, additional label being added to the phenylalanine
molecule during its hydroxylation to tyrosine.
In man, infants born to phenylketonuria mothers have high
phenylalanine but normal tyrosine plasma water concentrations
suggesting that the enzyme phenylalanine hydroxylase is either
inactive or unable to hydroxylate phenylalanine at a rate
sufficient to maintain normal phenylalanine concentrations
within the fetus. However back diffusion of tyrosine from fetus
to mother (who would have low tyrosine concentrations) and
continuous transfer of large quantities of phenylalanine to the
fetus as a result of the high maternal phenylalanine concentrations
could obscure any evidence of fetal hydroxylation determined




1. At equilibrium fetal plasma activity was greater
than maternal plasma activity.
14
2. C total plasma activity increases linearly' in both
maternal and fetal plasma.
14 14
3. Maternal infusion of L C phenylalanine and L C
/
leucine resulted in both maternal and fetal total
plasma activity increasing for 2 hours beyond the
end of the infusion period.
4. There was an abrupt halt in the incorporation of
activity into the acid precipitated plasma fraction
14
after stopping L C infusions directly into the fetus.
5. The different patterns of total activity found after
%
maternal and fetal infusions suggest that the
y
placenta might act as a "reservoir".
6. Deproteinized fetal plasma activity increased
throughout the fetal infusion of phenylalanine and
continued for 1 hour beyond the end of infusion.
Phenylalanine S A decreased rapidly between hours 4
and 5.
7. Maternal and fetal plasma water free amino acid S A
reached a plateau level of activity approximately
2 hours after the bolus injection at the start of
infusion.
8. Maternal plasma water S A decreased more rapidly
than fetal plasma water S A at the end of infusion
9. "Back" diffusion of activity to the maternal
circulation was slow.
10. The tyrosine:phenylalanine S A ratio is higher
in fetal than maternal total plasma and plasma
water.
3 1AComparison of Infusions using H and C Isotopes
ihe lability of the
3 14
•radioactive isotopes - H and C used to label amino acids has
1 SB 301 '
been found to differ ' The greater lability of tritiated
14
amino acids compared with C isotopes in these experiments may be
confirmed by comparing the two series of results. In experiments
Tlfand CI 250 ji Ci L phenylalanine were infused into the maternal
jugular vein. Total activity in maternal plasma reached 18.00 X
3 14 3
10 d/min/ml using the C isotope but only reached 13.60 X 10 d/min/
ml when tritiated phenylalanine was used. Maximum maternal total
3 . 14
H radioactivity was attained much faster (4 hours) than the C
peak total activity (6 hours). In addition, the distribution of
14
label between bound and free forms was different - the C
3
peak plasma water activity being 1.40 X 10 d/min/ml whilst
3
tritium was almost double this at 2.40 X 10 d/min/ml - i-e..
14 3
7 per cent of C but 18 per cent of the H label was present in
the plasma water fraction. Plateau activity of plasma water
from the tritiated infusion was also higher that that from the
]/. 3 3
C infusion - 2.20 X 10 d/min/ml compared with 0.90 X 10 d/min/
ml - and the decrease from the plateau level was less -
3 3
at 7 hours H activity being 1.18 X 10 d/min/ml (53 per cent of the
3 3
K plateau level) compared with 0.22 X 10 d/min/ml (24 per cent
of the ^C plateau). This suggests that in the tritium
experiment a greater proportion of the activity is present in
water soluble freely labile compounds, possibly even in water
'39
3
itself. The higher H background count of the column effluent
from S A measurements of samples taken during the first 5
hours of experiment C4 - 24 d/min compared with that from samples
taken at 10 hours (12 d/min) and 3 days (8 d/min) also suggests
1 ^0
a high degree of label lability. As observed by Hider 1969
the tritium label appears to be lost during amino acid incorpor¬
ation into protein. Assuming protein incorporation rates to be
14 ....
similar in the C and tritium infusion, if the higher tritium
plateau of plasma water reflected a higher S.A rather than
label diffusion,an increased proportion of the precursor pool
should be labelled and therefore higher total activities would
be expected - the opposite to that which was found.
3 14 ...
Comparison of H and C fetal infusions point to a similar
.3
interpretation. Although 500 ju Ci H phenylalanine were infused
14
compared with 250 ju Ci C phenylalanine, by day 2 (the first day
3
of H fetal sampling) the fetal total plasma activity was
3 3
116.00 X 10 d/min/ml compared with 80.00 X 10 d/min/ml of the
14 . .
C sample. In contrast, maternal total activity levels m the
3
ewe infused with the tritium isotope reached 4.93 X 10 d/mi-n/ml at
3 14
11 hours compared with 0.90 X 10 d/inin/ml in the comparable C
3
samples. At 48 hours the respective values were 5.53 X 10 d/min/
3
ml and 1.00 X 10 d/min/ml.
One could speculate that a higher plasma water plateau
activity in fetal plasma during and continuing beyond the end
of infusion of tritiated phenylalanine increased the diffusion of
label across the placenta to the maternal circulation and thereby




Comparison of Hand C Phenylalanine Infusion
3 ...
1. L 2 - 3 H phenylalanine infusion resulted in higher
Pi asma water and lower total plasma activities than
14 ...
L C phenylalanine infusion.
3
2. Maximum maternal total plasma H activity was obtained
14 . .
faster than-i C activity.
3. Distribution of activity between plasma total
(representing the amino acid incr> porated into protein)
and plasma free amino acid ac tivity differed with
3 14 14
H and C infusions - 7 per cent of the C but
3
18 per cent of the H activity being present in plasma
water.
4. In the 7 days after the infusion, plasma water
activity remained at a higher level of activity in the
3 . 14
H infusion than m the C infusion.
3
5. Infusion of L 2 - 3 H phenylalanine into the fetus
resulted in higher maternal total radioactivity than
14 ....
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Part IV
L^C Amino Acid Infusions with Insulin
14
In these experiments each fetus acted as its own control, L C
amino acids being infused for a four hour period into the fetus (3
experiments) or mother (1 experiment) prior to infusing insulin into
the fetus. Because of the delay in establishing plateau S A in the
primed experiments of the previous year, the bolus quantity and
infusion rate were reduced, from 50 p Ci and 50 p Ci /h r to 30 juLi and
30 /Jti/hr. Infusion of the labelled material directly into the
fetus increased the S A of the free amino acid in plasma and reduced
the effect of placental metabolism as opposed to transfer of the
amino acid. Three fetal and one maternal infusion were carried
out. Additionally one infusion into the amniotic fluid is reported.
14 14
LU C phenylalanine and LU C leucine were identical
*
14
with those used in year 2. LU C lysine monohydrochloride
had a specific activity of 330 m Ci/mmol and a radioactive
concentration of 50ju Ci/ml. It was obtained from the
Radiochemical Centre, Amersham. Crystaline insulin 20 iu/ml
(Burroughs Wellcome and Co., London) was diluted to give
a final concentration of (2 iu/12.6 ml) in isotonic saline
containing 1 per cent low salt human albumin (Scottish Blood
Transfusion Service). The pump was calibrated to deliver 4.2
ml/hour from a 50 ml syringe, the pump holding 2 syringes.
During the first four hours amino acid plus saline solutions
were infused. At four hours the saline syringe was replaced
•
with the one containing insulin, excess solution being
expelled as the syringe was fitted into the pump. After
\Wb
k
a further three hours infusion with amino acid and insulin
solutions, (0.66 lu insulin/hour) the insulin syringe
was replaced by a syringe containing saline and infusion
continued until the syringes were emptied approximately
3-4 hours later. Animals were then immediately sacrificed.
Amniotic and allantoic fluids were aspirated into syringes.
Tissues from the first four experiments were taken for auto¬
radiography and from the fifth for tissue counting and auto¬
radiography. Tissues taken for autoradiography were:- adrenal,
kidney, liver, spleen, muscle, heart, thyroid and for tissue
counting fetal and maternal liver,spleen and kidney. Placental
cotyledons were taken for both tissue counting and auto¬
radiography from all experiments. Two cotyledons from each
experiment were separated into maternal and fetal components
•before storing at -70°C. Fetal urine was obtained from
experiments Ins CI,If Table l±'I gives details of the animals,
amino acids and routes of infusion used in these experiments.
IL+ Lf
i Maternal Amino Acid and Fetal Insulin Infusion
Experimental Detail
Experiment Ins CI
Maternal Infusion LU C Lysine and Fetal Infusion of Insulin
14
LU - C Lysine 550 p. Ci in 46.2 ml was infused into the
maternal jugular vein and saline, with or without insulin
was infused into the umbilical vein. As before, infusion
"and bolus injections were at 4.2 ml/hour and 4.2 ml
^respectively. Infusion was started at 00.10 hours and the
•saline/insulin at 04.17 hours. Insulin was stopped at 07.27
hours and the infusion finished at 09.41 hours. Maternal
and fetal blood samples were taken at 5, 1, 2, 3, 4 (preinsulin)
5, 6, 7 (insulin) and 1\, 1\, 8 and 9 hours (post insulin).
Maternal blood samples were also taken at 1|, 2\, 3| hours and




Between hours 1 and 2 the maternal haematocrit fell from
AO.5 (at zero time A2.5) to 35.5 per cent. Values from samples
taken after the second hour were between 30.0 and 33.5 per cent.
Fetal values declined slowly from A I.5 per cent at zero hours











































Fetal plasma glucose concentrations were lower during the
period of insulin infusion, but the decrease was not as great as
that of maternal pXis.na glucose which decreased markedly between
hours 6 and 7. This may be explained by increased fetal demand
for glucose during the period of insulin infusion, increasing
placental transfer and thereby decreasing the maternal con¬
centration. However, because of the relative size of fetal demand
(small) to that of the maternal plasma glucose pool (large) this
explanation would seem unlikely.
\i*L
I Bolus of ,
w30 Ci L C Lysine
14





Maternal (•) and fetal (0) total (-) and de-
proteinised ( ) activities during maternal
continuous infusion of l'^C lysine (30 p. Ci/hr)
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Maternal (•) and fetal (0) whole blood activities
during continuous maternal infusion of l'^C
lysine (30 p Ci/hr) and fetal infusion of
insulin between hours 4 and 7.
M
Insulin Values
The greatest change in plasma insulin concentrations occurred
within the first 30 minutes of infusion. Thereafter the concen¬
tration doubled. An immediate decrease on terminating insulin
infusion was noted, but pre infusion concentrations were not
regained even at the end of the experiment (9 hours).
Total and Deproteinised Plasma Radioactivity Measurements Fig lOi
There was an increase in the rate of accummulation of radioactivity
in maternal plasma for 2 hours after the start of the insulin infusion,
but after terminating the insulin infusion the rate of accummulation
returned to that of the pre-insulin basal period. Deproteinised plasma
radioactivity in maternal samples also increased slowly on infusing
insulin.
Fetal total plasma activity, although at a lower level, changed
in a manner similar to that of maternal samples for the first 7 hours,
but did not return to the pre-insulin rate of accummulation. Radioactivi
in deproteinised plasma increased between Hours 5 and 6 to a new
plateau at which it remained until the experiment was terminated.
Radioactivity in Whole Blood Fig lOii
No change was found in the rate of accummulation of radioactivity
in maternal whole blood until insulin infusion stopped, when the rate
increased for 2 hours. The rate of increase in radioactivity in fetal
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Maternal plasma water lysine SA (below) and
concentration (above) during maternal continuous
14
infusion of L C lysine (30 p Ci/hr) and fetal
infusion of insulin between hours 4 and 7.
I*-"
f. Specific Activity Measurement
Maternal lysine SA and concentration is shown in Fig 12ii.
Between hours 2 and 4 plasma lysine SA fluctuated between 22.2 and
33.6 d/min/nmo1!, but from 15 minutes post insulin until -the end of
the insulin infusion, fluctuation was between 30.8 and 54.7 d/min/
nmol, the highest SA and lowest plasma amino acid concentration
being recorded 1 hour post insulin. Conversely lowest SA and the
highest lysine concentration was recorded 15 minutes after stopping
insulin.
cj. Tissue Digestion
Radioactivity measurements of placental tissue are given
in JlxAh V .
Vv Flux
During the first 4 hours of lysine infusion maternal flux
was calculated at 2220 ^mol/hr (See Chapter 4 ).
Fetal Amino Acid and Insulin Infusion
Experimental details
Experiment Ins CCL
14 . . -
Fetal Infusion LU C Phenylalanine and Insulin
LU - Phenylalanine 330 p Ci in 46.2 ml of isotonic
saline was infused into the umbilical venous catheter at 4.2
ml/hour. In addition saline with or without insulin was
infused from the same pump - giving a total infusion volume
of 8.4 ml/hour. A bolus of 4.2 ml from each syringe was
given by depressing the pump. Infusion commenced at 10.03
hours, insulin being given from 13.45 hours until 16.58
hours and the infusion stopped at 18.59 hours. Dextrostix*
measurement of blood glucose were made and maternal samples
for biochemical analysis of blood glucose taken at 5,6,7,7%
and 9 hours and fetal samples at 5,6,7,7^, 8,9 and 10 hours.
Maternal and fetal blood samples were taken at ^,1,2,3,4
(preinsulin) 4^,5,6,7,7-^,8,9 and 10 hours (postinsulin).
Maternal blood samples were also taken at \t 1% ,2%,3%,3%




Fetal Infusion LU C Leucine and Insulin
14 ....
LU C Leucine 330 jj Ci and insulin were infused into the
umbilical venous catheter under conditions identical with those
in texperiment Ins CI. The leucine infusion commenced at 08.30
hours and insulin at 12.40 hours. Insulin stopped at 15.42
hours and the leucine infusion finished at 18.23 hours.
•Maternal blood samples were taken at the same time intervals
^as in experiment Ins CI but additional fetal samples were
.taken at k,^k and lk hours. Fetal samples for blood glucose
were taken at 4 and 7 hours.
Experiment Ins Cl+
14
Fetal Infusion LU C Lysine and Insulin
14
LU - C Lysine 330 yx Ci was infused into the umbilical
venous catheter during 9k hours, with insulin being given for
3 hours, 4 hours after commencing. Infusion was started at
08.16 hours after the initial bolus of 4.2 ml given at
08.12 - 08.16 hours. Saline and insulin replaced the saline
from 12.29 until 15.31 hours and the infusion was terminated
at 17.50 hours. Maternal and fetal blood samples were-taken
as in experiment Ins C2, 3, and 4V and blood fluoride tubes




In Exp Ins c2 Maternal haematocrit fell from 31.0 per cent at the
~i
commencement of the experiment to 27.0 per cent in the final
sample, fluctuations between these values occurring during the
procedure. Fetal haematocrit exhibited a much greater fall
from A8.5 to 32.5 per cent. However, as the l\ hour sample
had a haematocrit of A5.5 per cent and values of samples
previous to this, with the exception of one (6 hours - 38.5
per cent) were above AO.O per cent it is probably only within
the last 3 hours that adaptation to blood loss might significantly
affect results.
/of Exp Ins C3
Maternal haematocrit values remained steady between 30 and
31 per cent apart from the 8 hour haematocrit (28 per cent) and
9 hour (29 per cent) samples. Fetal haematocrits also remained
within a narrow range only three values falling outwith the
range 38.5 - AO per cent. These three were the 2 hour, 3 hour
and 7^'hour samples, which gave values of 42.5, 41 and 37.5
per cent respectively.
Haematocrits of Ins CA samples remained reasonably constant.
The maternal haematocrit fell from 37 to 30 per cent between
hours 1 and 2 and thereafter remained between 30 and 33 per cent.
The fetal haematocrit remained very constant - between 3A and 36
per cent - after the initial and greatest fall from 37 to 35
per cent in the first 15 minutes.
TA61-E»X
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b. Plasma Glucose and Insulin Values
The concentrations of blood glucose and plasma insulin are given
in Table !X . Fluctuations in maternal glucose concentrations were
unconnected with the infusion of insulin into the fetus. The fetal
'plasma glucose concentrations decreased significantly during the
insulin infusion in experiments Ins C2 and Ins C4, but was only
slightly lower in the leucine infused fetus. Although the glucose
concentrations recovered to the pre-insulin value in the lysine
(Ins C4) infused fetus, in the fetus infused with phenylalanine
glucose was still low at the end of the experiment.
Fetal insulin concentrations increased rapidly during the insulin
infusion, but the percentage increase above baseline concentrations
varied. Likewise although insulin concentrations decreased rapidly
on withdrawing insulin, the degree and rate of disappearance of
insulin from the plasma varied, with baseline concentration only
being regained in experiment Ins C4 (lysine infusion).
I St.
I
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Maternal plasma activity during continuous fetal infusion
of l'^C phenylalanine (30 p Ci/hr) and insulin infusion
between hours 4 and 7
| Bolus of .
t 30 p Ci L C Leu
14
1 Infusion of L C Leucine at 30 p Ci/hour " f
Hours
Fig }2ia
Maternal plasma activity during continuous fetal infusion
of l'^C leucine (30 p Ci/hr) and insulin infusion between
hours 4 and 7.
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Fig |3 ia
Maternal plasma total activity during continuous
14
fetal infusion of L C lysine (30 jj Ci/hr) and









Fetal plasma total (0) and deproteinised (#)
activity during continuous fetal infusion of
L14C phenylalanine (30 Ci/hr) and insulin
infusion between hours 4 and 7.
!(*0
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Fig 12-ib
Fetal plasma total (0) and deproteinised (®)
activity during continuous fetal L^C leucine
infusion (30 p Ci/hr) and insulin infusion
between hours 4 and 7
1 1c\
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Fetal plasma total (0) and deproteinised (•)
activities during continuous fetal infusion of
L^C lysine (30 p Ci/hr) and infusion of
insulin between hours 4 and 7.
1 („2l.
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Maternal (•) ahd fetal (0) whole blood
activities during continuous fetal infusion
14
of L C phenylalanine (30 ju Ci/hr) and
insulin infusion between hours 4 and 7.
113
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Maternal (I) and fetal (0) whole blood activities
during continuous fetal infusion of l'^C leucine
(30 p Ci/hr) and insulin infusion between hours
4 and 7.
1 (off






















H o n r 9
Maternal (•) and fetal (0) whole blood activities
j * 14
during continuous fetal infusion of L C lysine
(30 yu Ci/hr) and insulin between hours 4 and7.
IL>
Total and Deproteinised Plasma Radioactivity Measurements
Figs Hi a and b, 12i a and b, 13i a and b.
Maternal total plasma activities were low, and the radioactivity
of the deproteinised plasma was too low for accurate measurement. The
total activity increased slowly in a linear manner with only small
deviations occurring when insulin stopped in experiments Ins C2 and
Ins C4.
Although the radioactivity was greater in fetal samples, like
maternal samples there was no significant change in the rate of
incorporation (i.e. in total plasma) when insulin was either intro¬
duced or withdrawn. Similarly although the deproteinised plasma
radioactivity showed greater variability in its rate of increase,
insulin was not associated with any significant changes.
Radioactivity in Whole Blood
Figs llii, 12ii, 13ii.
Radioactivity in maternal whole blood was low. Only in experiment
Ins C2 (phenylalanine) was insulin associated with a rapid change in
the rate of increase of activity, a peak at 4| hours and a rapid fall
from a peak at 7 hours occurring. The fall in radioactivity between
7 and 7| hours was also observed in total plasma. These maternal
'peaks' in activity coincide with peaks in the fetal haematocrit -
54% at 4| hours and 52% at 7 hours. Radioactivity in fetal whole
blood however failed to show any response to infusion of insulin or
the changed haematocrit at 4| hours, and only a moderate increase in
radioactivity was observed on stopping insulin. No increase was
observed at the 7 hour haematocrit peak. Fetal whole blood radioactivity
of the other 2 fetuses was unaffected by the infusion of insulin.
[ (plo
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Fetal plasma water phenylalanine (0) and tyrosine (i) SA
(below) and concentration (above) during continuous fetal
infusion of L14C phenylalanine (30 p Ci/hr) and insulin
infusion between hours 4 and 7.
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Fetal plasma water leucine SA (below) and
concentration (above) during continuous fetal
L^C leucine infusion (30 ;u Ci/hr) and insulin
infusion between hours 4 and 7.
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Fetal plasma water lysine SA (below) and
concentration (above) during continuous fetal
14
infusion of L C lysine (30 jj Ci/hr) and
infusion of insulin between hours 4 and 7.
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Fetal whole blood free lysine SA (below) and
concentration (above) during continuous fetal
14
infusion of L C lysine (30 p Ci/hr) and
infusion of insulin between hours 4 and 7.
I^O
Specific Activity Measurements
Figs lliii, 12iii, 13iii and iv
The SA of phenylalanine and lysine in plasma water of the fetuses
infused with the respective amino acid was changed significantly
when insulin was infused. However insulin had no effect on the
leucine SA of the fetus infused with that amino acid.
Both free phenylalanine and lysine plasma concentrations decreased
on infusing insulin but the concentration of leucine remained
constant, its only decrease being earlier during the 4 hour basal period
at a time when fetal haematocrits fell from 48.5 to 42%. The decrease
in plasma phenylalanine and lysine concentrations was associated with
an increase in SA. However, in the phenylalanine infused fetus SA
had fallen (duplicate analyses) prior to the time at which insulin
infusion was thought to have begun (See page Hb). Tyrosine did not
decrease, but did increase from 4 to 5 hours. From 5 hours onwards
the phenylalanine and lysine SA returned towards pre insulin values,
withdrawing insulin having little affect on the phenylalanine infused
fetus and producing only a small temporary increase in lysine SA.
The SA of free lysine in whole blood, although increasing rapidly
on infusing insulin had already returned to pre-insulin values by hour
7 when insulin was withdrawn. SA was unaltered at this time but the
free plasma lysine concentration increased markedly reaching 1150 )imol/l
at 10 hours.
Flux
Fetal phenylalanine flux was calculated at 13 7/111101/Kg/hr, leucine
flux at 217.3 /imol/Kg/hr and lysine flux at 318 yiraol/Kg/hr.
Experiment Ins CS
14
Fetal Infusion LU C Lysine and Insulin
Although there was some doubt, it was thought that the
umbilical catheters were correctly sited. However, it had
not been possible to obtain fetal blood samples from the
umbilical arterial catheter for some days although it was
still possible to flush the catheter. For this reason
infusion was into the "umbilical arterial" catheter and
samples were withdrawn from the fetal venous catheter. It1
was later discovered that infusion had been into the amniotic
sac and the gxperiment was repeated (experiment Ins C t).
14
Infusion of 330 ^ Ci LU C lysine, under conditions identical
to experiments Ins Cjl and Ins CJ, was commenced at 22.01 hours
and infusion of insulin at 02.00 hours. Insulin was stopped
at 05.00 hours and the infusion at 08.06 hours. Maternal
and fetal blood samples were taken as in experiment Ins C2.
Blood samples for glucose estimations were taken into




Maternal values were all within the range 28-31 per cent




































* All samples precipitated with 3 per cent perchloric acid.
From the table it can be seen that fetal plasina glucose decreased
during insulin infusion but fluctuation with low concentrations
were also recorded in periods off insulin. Maternal glucose was
unaffected by fetal insulin infusion, fluctuations being present
throughout the experiment. No correlation between maternal and
fetal glucose was found.
\
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Fetal whole blood (above) and plasma total (0)
and deproteinised (•) activities (below) during
14 ....
L C lysine infusion into amniotic fluid, with
insulin infusion between hours 4 and 7.
nif
Insulin
Measurement of insulin concentration confirmed that no
insulin had been infused into the fetal blood compartment, little
change being noted throughout the experiment,
Maternal Total Plasma and Maternal Deproteinised Plasma
14
Levels of C activity were too low to measure.
Eetal Total Plasma F*4#-1
14
Fetal plasma C activity gradually increased but the rate
of increase was not consistent for any extended period of time
The same pattern of increasing activity was found in the
plasma water as in total plasma. The decrease between 7 and 7^
hours observed in total activity was more exaggerated in plasma
water and from this time the percentage of total activity present
in the plasma water fraction was less.
14
Whole Blood C Activity llfi
Maternal levels were too low to be detected above background.
No consistent rate of increase was observed in fetal samples.
Tissue Digestion





Ins CI 0.290 12.09
Ins C2_ 0.305 12.73
Ins C3 0.181 7.53
Ins Clf 0.226 9.45






EXPERIMENTS ON THE EFFECTS OF INSULIN INFUSION
Insulin Concentration
The rate of insulin infusion for these experiments was
calculated at 1.44 nmol (Q ,2iu/or 8.33 ug/kg/hr) based on a
fetal weight of 3 kg - the expected weight of the fetuses (which
were thought to be smaller than those of the previous year -
4 kg). At sacrifice, the fetuses were weighed and actual
infusion rates were 2.1 , 2..X, 1.3, i.b, and 1.6 nmol/kg/hr
for experiments Ins CI, Ins C2, Ins C3, Ins C4 and Ins C5
respectively. £ See opposite for infusion rate iu and ^ig/kg/hr.)
With the exception of the Ins C3, in which insulin was infused into
the amniotic fluid, plasma insulin concentrations were increased
between 7 and 55 fold above the initial concentration. The rate
of increase was variable, and although the concentration of plasma
insulin decreased immediately on stopping the insulin infusion in all
experiments, the rate of decline also varied.
It should be noted that fetal plasma of experiment Ins C?_
also appeared to have a considerable increase in insulin
concentration from 0.57 to 6.12 ng/ml before the infusion of
insulin was thought to have commenced with only a small
initial increase in insulin concentration occurring following the
introduction of insulin. It is not possible to determine
retrospectively whether this increase was due to endogenous
insulin secretion or to accidental premature introduction of
insulin into the fetus.
Ml
Activity Measurement
Infusion of insulin had almost no effect on the rate of
accummulation of radioactivity in the plasma and whole blood of both
the fetus and mother, any changes being only minor and temporary.
SA measurements would be necessary to assess the effect on the rate
of protein synthesis:- a decreased SA with an increased rate of
synthesis would obscure any effect in total radioactivity measurements.
Influence of Insulin.on Specific Activity
In the experiment Ins C.I (phenylalanine infusion into the
fetus) there was a twelve fold increase of insulin in the 4
hour fetal blood sample compared with the initial insulin
concentration. Whether this is of endogenous or exogenous
origin should not influence the fetal response, if any, to
this increased concentration and therefore changes resulting
from the affect of insulin on metabolism should be apparent at
4 hours. If the magnitude of response is related to either the
absolute concentration of insulin or degree of change the
greatest change should be observed in this experiment in which
both the highest concentration was reached and the greatest
fluctuations induced.
In the Ins C2. experiment, as the concentration of insulin
increased the phenylalanine S.A. in plasma fell from 250 d/min/
nmol to 160 d/min/nmol. As both input of labelled amino acid
and plasma free amino acid concentrations were constant
during this initial period of insulin infusion this reduction
in S.A. must be the result of dilution with unlabelled amino
acids. From the decreased S A and constant amino acid con-
na
centrations it may also be inferred that the entry and exit
rate of free amino acids into and from the plasma pool are
balanced, but that the two rates (i.e. turnover) are increased
by equal amounts. However, between 0.25 hr and 1 hour after
commencing the insulin infusion the free amino acid plasma
concentration of phenylalanine decreased from 100 to 60/imol/1
and tyrosine from 100 to 55 /imol/1. Small changes in
concentration could be a result of fluctuations in the plasma •
and blood pool volume's or haematocrit. However, it is unlikely
that the changes of 40 to 50 per cent observed in this
experiment would be accounted for solely by such fluctuations
over a period of 45 minutes, particularly as the haematocrit
remained constant during this time (Appendix (t> ) . One hour
post insulin infusi\>n, the concentration of amino acids de¬
creased and the S-A of phenylalanine and tyrosine increased
to levels slightly higher than those pre insulin. This would
indicate that the rate of removal of free amino acids from the
plasma pool had increased, and that this increase was not even
partially compensated for by increased entry of unlabelled amino
acid.
As insulin has been shown to increase cellular uptake
of amino acids (chapter !, 6) it is unlikely that the unlabelled
amino acids entering the plasma pool were from fetal tissue
pools, but more likely they were of maternal origin, increased
placental transfer of the unlabelled amino acids producing the
initial pool dilution.
nq
Changes in placental transfer rates with changing fetal
insulin concentration are probably mediated through altered
amino acid concentration gradients between fetal blood, the
syncytiotrophoblast and maternal blood. Placental parenchyma
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has a high concentration of ammo acids . It is thought that
amino acids are actively taken up from the maternal circulation
into the placental syncytiotrophoblast, from which they are
released through cyto.traph'cfclastr.. into fetal blood by passive
diffusion down a concentration gradient. If fetal tissues
respond to insulin in a manner similar to that of adult
tissues (see page ) cellular uptake of amino acids would
increase, thereby reducing the plasma free amino acid con¬
centration. Lower fetal plasma amino acid concentrations would
thus stimulate transfer by increasing the blood: placenta amino
acid concentration gradient and in fetal infusions this would be
detected by decreased S A- - as seen 15 minutes after the
start of insulin infusion in experiments Ins C.A and Ins Clf.
Insulin might also increase amino acid uptake into fetal
placental cells. Thus, unless placental protein synthesis is
sufficiently active to utilize the incoming amino acids, the
difference between fetal blood and placental intracellular
amino acid concentrations might be increased even more.
However, the increased SA and decreased plasma amino acid
concentrations in fetal infusions (Ins C2. and Ins Clp from 15
minutes to one hour after insulin had commenced, suggests that
the promotional effect of insulin on cellular uptake is more
powerful than the passive diffusion mechanism by which amino
acids are released into fetal blood, the inverse relationship
between fetal plasma amino acid concentration and placental
\<30
transfer disappearing. If the effect of insulin on uptake of
amino acids only related to the fetal margin of placental cells -
only insulin receptors on this side of the cell being exposed
to the infused insulin - uptake from adjacent maternal blood cell
and plasma might also be compromised. Decreased transport
between fetal cells of the trophoblast and maternal blood might
therefore occur - a raised fetal cellular amino acid concentrations
increasing the gradient up which amino acids must be trans¬
ferred. At on! hour post insulin the plasma S.A values'returned
to pre insulin levels. Similarly, from one hour onwards free
plasma amino acid concentrations slowly increased toward the pre
insulin concentrations. An increase in the rate of placental
transfer of cold amino acids would decrease the S A and increase
the plasma concentration. However if this were true the S-A
would be lower than the pre insulin value if amino acids were
continuing to enter cells at an accelerated rate under the
influence of insulin. Thus these changes suggest that although
the concentration of insulin was still increasing the effect of
insulin was diminishing and cellular uptake from free amino acid
pool was decreasing towards pre insulin rates. The end organ
response to insulin may therefore be limited - and may be
more sensitive to rapid change in insulin concentration rather
than actual concentration. Additionally the decreased blood
glucose concentrations from 8.9 to l.y^n^fns CI and from 7.1mmol/l
*. # ...
to ND. in Ins C4 may limit the uptake of amino acids into
cells. This may not only lead to an increase in the plasma
concentration but also allow increased diffusion of amino acids
from the placenta to fetal blood. Increased placental protein
* ND no detected glucose
n\
synthesis because of either the effect of insulin or high amino
acid concentrations could also lower the gradient between
intracellular concentration of fetal placental■cells d
r:,\ •- •,»»■■ •
maternal blood . Withdrawing insulin did not alter the rate of
decrease in phenylalanine S A suggesting that the influence of
insulin on fetal amino acid metabolism and placental transfer
was already diminishing.
During insulin infusion the ratio of tyrosinerphenylalanine
concentration changed from 0.90 to 0.64 returning to 0.88
at 8 hours - 1 hour after insulin infusion stopped. If
phenylalanine had been hydroxylated in the placenta or fetal
liver (see page ;";l->) this could reflect increased uptake of
phenylalanine and tyrosine but reduced release of the metabolised
phenylalanine i.e. tyrosine etc. There was little initial
change in tyrosine S A on infusing insulin at the time when
increased quantities of cold phenylalanine entered the plasma.
This would suggest placental hydroxylation with release of
prelabelled tyrosine - the S-A only increasing when the
tyrosine concentration fell. The fall in S A occurred later
(6-7 hours) than that in phenylalanine S A (5-6 hours) and
again corresponded to the start of amino acid concentration
recovery. On stopping insulin, unlike phenylalanine SA the
tyrosine S-A. increased - possibly reflecting release of pre¬
labelled intracellular tyrosine as the influence of insulin
diminishes.
Although the timing of events was a little different,
plasma changes induced by insulin in experiment Ins -
lysine infusion into the fetus-resembled those of Ins CX
1 *-2-
After 1 hour of insulin infusion, both whole blood and plasma
lysine SA decreased. At this time although the plasma free lysine
concentration was increasing, in whole blood the concentration was
unchanged. This would imply that the effect of insulin was similar to
that in the phenylalanine infusion, and diminished with time.
Withdrawing insulin resulted in a small temporary increase in
plasma lysine SA. This would be compatible with insulin stimulation
of the formation of a membrane amino acid complex, which would disocciate
to some extent as insulin concentration decreased, releasing previously
bound labelled amino acids into plasma and probably cell cytoplasm.
In whole blood although free lysine concentration increased rapidly
after discontinuing insulin there was little change in lysine SA.
Amino acids must therefore be entering from a prelabelled source.
Release of amino acid from a small pool with rapid turnover could
increase concentration whilst maintaining SA. Alternatively, binding
of released tissue amino acids to the RBC could increase the concentration
of whole blood free amino acids on precipitating with acid.
Thus, insulin concentration appeared to have some
influence on size and flux between amino acid pools, in¬
creasing the fetal cellular and thereby decreasing the plasma
afid blood pool. The concentration of insulin in
this experiment was less and the percentage increase smaller
than in experiment Ins C2_ and could explain some of the
differences found. However, as the S A increased in both
fetuses while concentration decreased, in neither instance was
the transfer rate of amino acids across the placenta able to keep
pace with the entry rate of amino acids into tissues, although
initial dilution with unlabelled amino acid occurred in the
plasma of Ins C2..
This contrasts with the findings in the fetus infused with leucine,
in which there was little response to insulin, both plasma free amino
acids and SA being relatively unchanged. This could be a result of
the smaller increment in insulin concentration, as in both the
phenylalanine and lysine infused fetuses the effect of insulin
diminished as the rate of increment decreased. Even if the rate of
insulin infusion were diminishing because of absorption of insulin to
either the syringe or infusion line, as the plasma concentration of
insulin continued to increase throughout the experiments, the effect
of insulin should be unaffected if it is concentration alone which
determines the response of the fetus to insulin. The lower insulin
concentration would probably have reduced the additional requirement
for glucose so that in the leucine infused fetus, fetal blood glucose
concentrations remained relatively constant. In contrast in both
Ins C2 and Ins C/f fetal blood glucose concentrations were
decreased during the infusion of insulin and in Ins C1+-
maternal glucose was significantly reduced between hours
6 and 7. Thus in Ins C3 either placental glucose transfer
and/or fetal gluconeogenesis was accelerated sufficiently
to meet the increased glucose requirement on infusing insulin,
or the end organ response was depressed and fetal metabolism
was relatively more resistant to insulin induced changes.
Of these factors the observed decrease in maternal glucose
eould suggest an increased placental transfer. The greater
weight of this fetus (3.650 kg) of the same gestational age
as" the other fetuses infused with insulin - 2.160, 2.940,
2.274 and 2.910 kg could suggest a higher mean placental
transfer of glucose during pregnancy. As blood glucose did
not decrease it is unlikely BCAA oxidation increased in muscle,
although a glucose sparing action of increased oxidation cannot
be excluded.
The differences in blood glucose concentrations are unlikely to
account for the differences in SA changes between the leucine and pheny¬
lalanine or lysine infused fetuses. Infusion of glucose together with
insulin failed to alter the effect of insulin on protein synthesis in
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fetal lambs. Additionally, in these experiments the greatest changes
in plasma amino acid concentration and SA were at a time before glucose
concentrations decreased. The diminishing effect of insulin could however
be related to lack of energy for protein synthesis or intracellular
transport, although the requirement for glucose has been shown to be
only for transport and synthesis, stimulation of these by insulin
being independent of glucose concentration.
Alternatively, utilization of phenylalanin eand lysine in gluconeo-
genesis in the latter part of the insulin infusion could have occurred.
If, as in adults glucose homeostasis is controlled by hepatic tissue
(the placenta is also important in the fetus) preferential uptake of
leucine by muscle may be less affected than the extraction of amino acids
1130,231
by liver on infusing insulin.
However, in the adult sheep insulin was found to regulate gluconeo-
genesis by its influence on muscle metabolism and had little effect on
the hepatic extraction of amino acids. Fetal metabolism or increased
glucagon secretion could lead to increased amino acid extraction by the
liver when glucose concentrations are low. Also differences between the
behaviour of leucine and other amino acids could occur if hepatic tissue
were more sensitive than muscle to changes in plasma insulin concentration.
Any difference between hepatic and muscle cellular uptake could also be
exaggerated by the infusion of both insulin and labelled amino acids into
3C7,"308
the umbilical venous blood of which 58 - 67% passes directly through the
liver before entering the general circulation.
m
The shorter half life of hepatic1
proteins - 0.75 days compared with 1.08 days of mixed proteins
in muscle of fetal lambs'" "would also exaggerate any difference
in absolute terms (though not necessarily percentage values),
in the incorporation of amino acids into tissue proteins, and
therefore in amino acid utilization.
Hepatic tissue did bcca.greatest uptake of
activity (represented by the remaining activity in the tissues
at sacrifice - (see page JriQ ), incorporation into protein
being approximately 2-3 times that of muscle in experiments
CI - C4 and 4.5 times that of muscle in Ins C4- (lysine
infusion with insulin). Soltesz , in newborn lambs also
found liver to have the greatest bound leucine activity, the
liverrmuscle S A ratio being 2.34, but free leucine S A
was greater in muscle. Leucine oxidation occurs in muscle but not
brain and liver and this could also partially explain the different
response to insulin.
Differences between phenylalanine and lysine infusion and that
of leucine could therefore be a result of individual variation, insulin
concentration or tissue sensitivity, or the different metabolism of
the amino acids.
If infusion of insulin into the fetus increases placental
transfer of amino acids, the removal rate from maternal blood
would also be expected to increase. Thus maternal plasma amino
acid concentrations should decrease and the S A of maternal'
14
amino acids would be expected to increase m the L C lysine
maternal infusion during the period of insulin infusion into
the fetus ^lthough the larger pool of amino acids in maternal
plasma would reduce the magnitude of change. The concentration
of maternal plasma free lysine did decrease from 118.6 ^pmol/1
15 minutes post insulin to 69.6 jumol/1 one hour post insulin, the
S A increasing from 30.8 d/min/nmol to 54.7 d/min/nmol during
this time. However further fluctuations of both concentration
and S A were observed during the remaining two hours of insulin
infusion. Fluctuations could be those normally occurring but
could reflect the diminishing effect of insulin on fetal
metabolism, with consequent alterations in fetal demand.
Changing fetal demand would alter placental transfer rates and
thereby the demands on the maternal supply,catabolism of
maternal protein subsequently altering to meet the changed
conditions. Greatest fluctuations were observed during
insulin infusion with the exception of the rapid increase in
lysine concentration and decrease in S A in the first 15
minutes after stopping the fetal infusion of insulin - a time
at which fetal concentrations and S A of Ins C2. and Ins Ciq-
indicated placental transfer to be temporarily diminished.
The proportion of plasma water activity associated with lysine
also decreased post insulin, suggesting there was an increased
degradation in place of immediate transfer of amino acids to
the fetus. A sudden decreased placental transfer rate could
also be expected to increase maternal concentration and
decrease lysine S A if unlabelled amino acids, resulting from
maternal catabolism, continue to enter the plasma at the same
14
rate. Thus, even though the proportion of infused C lysine
transferred to the fetus was less there could be an increased
dilution of the labelled lysine and lower S ,A
1ST
Conclusions on the Effect of Insulin on Placental Transfer
1. Insulin decreased fetal blood glucose in three of
four fetuses., Maternal glucose decreased slightly in
two and markedly in one ewe.
2. In the two fetal infusions in which blood glucose
decreased the plasma concentrations of phenylalanine
14
and lysine - the L C amino acids infuse.d - decreased
and the SA increased during the first hour of
insulin infusion. This suggested fetal cellular
uptake was increased.
3. In the same two fetuses the increased S A was not
maintained, and the plasma amino acid concentrations
returned towards preinsulin values, suggesting that the
effect of insulin was only temporary.
4. In the fetus infused with leucine, maternal glucose
decreased but there was no change in either plasma
glucose or leucine S A Therefore either utilization
of lysine and phenylalanine for energy production
was increased, the effect of insulin on placental
transfer and cellular uptake of leucine was different
or the individual response varies.
5. Fetal infusion of insulin with maternal infusion of
lysine indicated placental transfer increased during
the first hour but thereafterwards fluctuated.
Highest plasma lysine concentration and lowest S A
were recorded 15 minutes after terminating the
insulin infusion.
6. Whole blood S A of Ins Cl+ suggested the cellular
components of blood - probably the erythrocyte -
were important in transfer of amino acids and that
this was influenced by insulin. The rapid increase in
S A without any increase in concentration on
starting and the rapid increase in concentration
with no affect on S.A on stopping insulin suggests
binding and release of amino acids to the RBC may
occur rapidly, and on stopping insulin release of
amino acids or breakdown of peptides, preaccumulated
under the influence of insulin,could occur.
Future Experiments
Further research should include the following:-
1. Investigation of the role of the RBC in transport, and
the effect of insulin on this.
2. The effect of insulin on transport with maintainance
of blood glucose concentrations.
3. Investigation of the uptake and transfer of leucine
14
by simultaneous infusion of L C leucine and either
14 14
L C lysine, L C phenylalanine or other essential
amino acid.
14 . .
4. Infusion of L C alanine and the influence of insulin




Structure of Sheep Placental Cotyledon
Autoradiographic Tissue section stained
i?. •«- . y ?. J'v.";
with haematoxylin and eosin. ' " ; -V 1
HP
Autoradiography
Although autoradiography was employed to study the distribution
of activity within tissues, no additional information to that
obtained from tissue digestion and radioactivity counting was
obtained. Activity, represented by dark granules on the tissue slides,
w§s generally distributed throughout the tissues including that
of the placenta, and no zones of activity concentration were
found. This may have been expected in experiments CI to C4
in which tissue was only obtained 7 days after the labelled
infusion, but there was no significant difference between the
distribution of activity in these experiments and that of Ins
C1+ from which tissues were obtained immediately.
A section of a placental cotyledon is shown in Fig lb
Although little activity can be recognised in this, it illustrates
the vascular fetal core of the cotyledon, with the denser
maternal tissue around the outer zone.
Also no difference in the distribution of activity with,in
the placenta was noted between maternal (Ins Ci) and fetal
(Ins C4-) infusions from which tissue was taken at the end of
infusion.
The relatively low activity of these tissues to that normally
present in tissues prepared for autoradiography may have prevented
observation of small differences in distribution.
Tissue Activity and Autoradiography
Tissue Counting
14










































































































































































































































(maternal and fetal phenylalanine infusions) Ci (maternal leucine
infusions) and C4 (dual phenylalanine infusion) is presented
in Table ,.t| , the data being the mean value of duplicate
analyses.
From the table it can be seen that in all infusions hepatic
and splenic tissue were amongs the tissues of highest recorded
activity. However phenylalanine and/or labelled metabolites
accumulated to the greatest extent in thyroid tissue. Thyroxine,
.of which phenylalanine is a precursor, increases in ovine
fetal plasma from days 50 - 110 and thereafter remains at
constant concentration until day 140. The large accumulation
of phenylalanine within the thyroid in these fetuses at 126
and 130 days gestation would imply a continued active synthesis
of thyroxine within the gland. Also the fact that the activity
14
accumulated m the thyroid when L C leucine was infused was
no greater than that found in thymus, adrenal, heart and
kidney cortex suggests the high activity in the phenylalanine
experiments was not due solely to protein synthesis. Specific
activity measurements of thyroxine itself would be necessary
to confirm this.
As in leucine infusions, labelled phenylalanine, whether
%
infused into maternal or fetal blood circulations was
associated with high activity in fetal tissues of the thymus,
adrenal, heart and kidney cortex. The adrenal cortex of the
fetus of the maternal infusion was in fact as great as that
observed in the thyroid in CI and greater than that of the
thyroid in C4. Brain, lung, muscle and the kidney medulla
in all infusions were of lower activity than the more
metabolically or physically active tissues. The
3 14 ...
distribution ot H and C activity m the fetal
TABLEX:?i
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tissues of the dual isotope infusion were similar - the only
exception being that of the spleen, the spleenrmaternal placenta
3 14
tissue activity ratio being 7.16 for H and 1.50 for C.
However, part of this discrepancy may be ascribed to technical
difficulties. Because of the high concentration of haemoglobin
in this tissue there were problems both with colour quenching
3
and, for H chemiluminescence (see page 22.\). The distribution of
3 14
H-was similar to that of the C fetal infusion - CjJ -
although, like maximum plasma activities, the level of activity
was lower.
The sheep placenta consists of discrete cotyledons (see Fig 1 )
with maternal tissue surrounding an inner core of fetal tissue.
r|/VV-~
By removal of inner and outer tissue from a cotyledon analysis of
the fetal and maternal components may be made. Results of these
analyses are given in Table . Maternal components of the
placenta were consistently of low activity but the activity
of the fetal placenta differed with the type of infusion - maternal
or fetal. During fetal infusion of phenylalanine, activity
of the fetal cotyledons was low. However maternal infusion •
of either leucine or phenylalanine, although resulting in only
low activity of maternal placental elements, produced relatively
high activity on the fetal side of the placenta if compared with
other fetal tissues. This may be seen from the tissue:maternal
placenta ratios given in Table XI
Examination of activity in the fetal and maternal tissue of the
placentae from experiments Ins Ci and Ins CI<- produced the results
shown in Table XI,j. From this table it may be seen that the pattern
m
of activity after !0 hours infusion (which included a period of
insulin infusion) was similar to that of previous experiments
terminated after several days. Fetal activity was consistently
greater than that of maternal components, although some back
diffusion did occur. As may be expected, in fetal infusions
fetal activity was greater and maternal activity less than in
the maternal infusion of lysine Ins C*. That ratio of fetal:
maternal placenta tissue activity was therefore higher for fetal
infusions - 5.51, 8.53 and 16.6:1 than in maternal infusion -
1.5:1 - reflecting the greater transfer of activity from the
maternal to the fetal circulations than vice versa. This
ratio (1.5:1) is similar (although the level of activity is higher)
to that found in experiment Ins C'S - in which lysine was infused
into the amniotic fluid. This might imply that there is a relatively
extensive exchange between amniotic fluid and maternal blood and
tissues - the ratio being closer to that of maternal than fetal
infusions. Thus if the amniotic fluid were to be utilized as
a route for in utero nutritional supplementation of fetuses at
risk because of maternal vascular or placental problems there could
be a large loss of the infused material via this route. The
lower ratio of^the fetal infusion CL (2.1:1) and higher ratios
of CI ijiaternal infusion (2.5:1) than the corresponding insulin
infusions could be a result of the extended time interval
between infusion and sacrifice allowing equilibration between
the placental components. However the ratio 1.41:1 of experiment
C2. - maternal leucine infusion - is in agreement with Ins C4
ratio 1.5:1 although activity is lower. This suggests that
subsequent metabolism of individual amino acids such as
phenylalanine might be significant. The relative activity of
hepatic, renal and placental tissue from the fetus infused with
AMNIOTICA D
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lysine was similar to that found in the respective tissues of the
prolonged experiment (Table V ). The higher activity in this
lysine infused fetus results from both the larger quantity of
material infused (330 p. Ci compared with 250 p. CI in experiment
C2) and the difference in time of sacrifice - immediate as opposed
to 8 days. Maternal activity of liver and kidney medulla were
of equal magnitude and unlike fetal tissues hepatic activity
was less than that of the kidney cortex suggesting labelled
material which has diffused across the placenta is as likely to
be metabolised or excreted as incorporated into new maternal
protein.
Amniotic and Allantoic Fluids and Fetal Urine
In the sheep allantoic fluid is present throughout
pregnancy. As pregnancy progresses an increasing proportion
of fetal urine is voided into the amniotic sac rather than via
iqh.
the urachus into the allantoic fluid . This variability
might be inferred from the activity in the amniotic and
allantoic fluid and fetal urine (Table XlV , allantoic fluid
having a higher activity than amniotic fluid in experiments
CI, C2, C3, Ins CIl and Ins C3. but activity being similar in
Ins Ci. However a direct comparison between experiments is
not possible without SA measurements, information on fluid
volumes and the frequency of micturition. The lower activity
in amniotic fluid may have resulted from a faster turnover of
amino acids with between 300 and 600 ml water of a total
volume of 1500 ml being exchanged within an hour in human
pregnancy . The majority of this is removed by fetal
• 2-1,32. ...
swallowing' , and the low activity of amniotic fluid and
increasing activity in fetal plasma in Ins 05, in which
XO i
infusion was directly into the amniotic sac, would support
this. This rapid turnover would be beneficial if intra-
amniotic nutritional supplementation of a fetus were to be
practised.
As would be expected, little activity was found in the
fetal urine obtained from experiments C2 and C3 in which
the collection was made one week after the infusion. At
this time free plasma amino acid activity was very low therefore
even if concentrated by the kidney tubules little activity
3 . .
would appear in the urine. In the fetus of Exp C4 H activity
was surprisingly high. This may be related to the lability
3 .
of the H label (see p 220) an^ to higher plasma water
3 14 14
H activity than C activity m equivalent C infusions.
It may also result from the products of phenylalanine
3
metabolism, with increased renal excretion of H but
retention of the carbon skeleton. The concentration of
activity in Ins C2. and Ins Ci* fetal urines, which were
collected immediately the infusion finished, was 25 per
cent and 34 per cent of plasma total activity and 67 and
100 per cent of the deproteinised plasma activity respectively.
Without information on the frequency of micturition, the
volume of urine produced }its dilution in amniotic and
allantoic fluids and the SA in urine at a time of plateau SA
in plasma, it is not possible to assess renal function and
its influence on the composition of amniotic and allantoic
fluids. In these experiments (Ins C2. and Ins C U) prior to
sampling the SA of free amino acids in plasma had not
returned to a plateau activity after the infusion of insulin.
Therefore not only is the duration and volume of the
2-CZ
collection of fetal urine within the bladder unknown but
also the SA of plasma during that time. However, the balance
between fetal swallowing and urinary excretion would suggest
relatively large volumes of urine are formed, a result of
. 310
lower water reabsorption capacity than in postnatal life
The high activity of these fetal urines does not imply that
there is an extensive loss to the fetus of these amino
acids but rather that they may be recycled via gastro¬
intestinal absorption after swallowing.
CHAPTER IV
Discussion
This section is divided into two sections. In the first
section the influence of animal management on amino acid metaboli
the metabolism of the infused amino acids phenylalanine, leucine
and lysine, and the biochemical techniques for the measurement
of amino acid and radioactivity are discussed. In the second
3 14
section the data from the infusion experiments using H, C
14 .
and C amino acids with insulin is discussed r calculations




Although acute experiments in which the uterus and/or its
contents are manipulated under anaesthesia are now regarded as
unphysiological, it is often accepted that normal physiological
status exists in animals of chronic experiments. This assumption
without reference to any previously determined standard, can lead
to difficulties in interpretation of data"' . Pearson ( 1977)""'
examined chronic animal preparations similar to those used in
the present studies and observed the length of time required
to regain resting or pre-interference states in sheep after a
variety of changes in the animals environment. The most
important factors to be considered in adaptation to experimental
conditions are as follows:-
2.0U
1. Taming
Two forms of adaptation are necessary - the first to experiment
rooms a new diet and management, and the second to being handled,
repeated blood sampling and prolonged experimental procedures.
Five to six weeks may elapse before the animal is "tamed" and
adapted to its new environment. Plasma corticosteroid
concentrations are elevated during the 4-7 days after removal
from the natural field environment. Although the values then
decrease, whether or not the sheep are handled, repeated vene¬
puncture can be associated with an increase in the plasma
cortisteroid level for as long as 36 days. Heart rate, initially
raised, returns to pre-existing values by day7, but for 2-3
weeks can increase when the same attendant enters the pen.
Plasma glucose, sodium and potassium concentrations and osmolality
show no consistent changes.
2. Surgical Stress and Starvation Pre and Post Operatively
Surgery will alter the homeostasis of the animal. A 48
hour pre operative fast increases plasma cortisteroid values, and
a>
reduces glucose concentration. At operation plasma corti/steriods
increase again and may remain elevated for 72 hours. Glucose
%
and sodium concentrations remain relatively constant but
potassium falls, increasing to normal again within 24 hours.
Intravaginal temperature can fall by approximately 3°C during
surgery, returning to normal within 6-6-^ hours. For 2 days
after operation feed intakes decrease by 10 - 50 per cent of the
prefasting values, returning to normal in 3 - 4 days. Plasma
glucose is raised above prefasting values for 7 days post
operatively. The fetus requires a longer time (16 days) to
311 31
recover from catheterisation stresses than the mother (7 days)"'
Even minor stresses imposed on the ewe - for example a change in
ambient temperature or pen cleaning can alter fetal breathing
patterns, and changes in the level of nutrition, feeding pattern
or water balance can cause a change in fetal fluid composition.
3 !2., & I3ij 'J . 4,
Influence on Amino Acid Metabolism (Catabolism)
j. During Catheterisation and Recovery
Amino acid concentrations are influenced by nutritional
status and operative procedures - fluctuations after catheter-
31?isation being present for 6-12 days' . Young et al • 1975
studying effects of cannulating the fetal jugular vein found many
changes in fetal plasma. The total free amino acid concentrations
increased by 13 per cent during operation, with an increase to
40 per cent above the normal taurine concentration and 44 per
cent above the usual amino isobutyric (AAB) acid concentration.
Basic amino acid values, however, decreased by 10 - 30 per cent
24 hours post surgery the AAB value was still increasing,
as were also 1- and 3- methyl histidine (IMH and 3MH) values.
The concentration of glutamic acid was reduced by 30 per cent
lysine by 18 per cent9 alanine by 32 per cent and the branched
chain amino acids by between 9 and 32 per cent. In the period
from the 3rd day until the end of the second week glycine values
returned to normal and then declined. The BCAA, after their initial
reduction, increased - isoleucine to 23 per cent, leucine to 36
per cent and valine to 42 per cent above normal values and
thereafter remained high. Taurine AAB, IMH and 3MH remained
approximately twice normal, but basic amino acids were at control
2?b
levels. Infusion of aminosol glucose into the fetus had no effect
on the blood amino acid patterns.
Clearly, any attempt to assess normal fetal total or
individual free amino acid concentrations during this period could
lead to very misleading results. The decrease in glucogenic and
increase in branched chain amino acids similar to the pattern
observed in starvation suggests placental transport may be impaired.
However, apart from maintaining blood urea concentrations (in
controls urea decreased), aminosol glucose had no effect on the
pattern of amino acids. The increases in the taurine and
methyl histidine values suggest possible liver and muscle catabolism
and possible inhibition of the citrulline-arginine cycle is
suggested by the observed high citrulline and low arginine con¬
centrations. Any assessment of the rate of turnover of
metabolic functions until homeostasis is regained could therefore
lead to erroneous conclusions.
',i. In Fed and Fasted State
Changes of free amino acid values in the fed and fasted state
were studied by Cross _e£ al 1975' ' . An overall reduction of
es'sential amino acids, and an increase in glycine were found in
the fasted state, which also caused an increase in total amino
acid half life, 6.2 - 0.98 minutes compared with 5.7 - 0.51
minutes in the fed group. Short term changes in the peripheral
blood during feeding, although present, are not normally large
because of the protective action of the liver. Feeding can however
produce other effects - such as increased oxygen consumption
0'f)7
heart rate and blood pCC^ and a fall in blood pH and plasma
volume. To minimise these changes pelleted food was offered
hourly. Plasma insulin and growth hormone secretion fluctuations
were also stabilised by this practice. Fetal fluids, including
plasma and urine, show a marked alteration in glucose and
fructose concentrations with changes in feed intakes. Feed
was offered to maintain blood glucose concentrations between
3.00 and 3.50 mmol/1 - that being the concentration normally found
under field conditions.
3. Circulatory Changes and Blood Distribution
Circulation in the fetus near term is fast - one "circuit"
being complete in 12.6 seconds (- 1.0 S.E.M.) 'with " 33 to
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42.5 per cent of the flow being directed through the ductus
venosus. This rapid transfer can result in any changes in the
placenta or peripheral tissues quickly affecting one another.
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Previously Power et al (1967) had found that a large proportion
of the placenta of dogs and sheep do not normally receive
blood in optimum quantities to provide efficient oxygen exchange.
Labelled aggregates of albumin were unevenly distributed among
and within cotyledons but if hypoxia occurred a more uniform
distributions increased flow and improved the efficiency of
31?
exchange. Cohn et al (1974)' 'studying hypoxemia and acidaemia
in 122 - 142 day fetal lambs showed that although blood flow to
the total body decreased with increased proportions being
directed to the heart, brain and adrenals, umbilical vessel blood
flow was maintained with an increase of 41 - 57 per cent of the
flow being directed to the placenta. Transfer "facilities"
on the fetal placenta side therefore appear to be well
2>
protected. However, Duncan and Lewis (1969)" 'found a decrease
from 60 per cent to 32 per cent of the uterine blood flow was
directed through the maternal placenta during maternal hypoxia
in rabbits. In the human, hypoxia raised maternal blood glucose
levels but fetal blood glucose levels either remained constant
or decreased. If the dissociation was associated with an
oxygen dependant carrier mechanism the discrepancy would be
31.0
explained . Hypoxia and acidaemia are therefore both
important considerations in animal preparations because of their
possible direct influence on transport mechanism and more in¬
direct effect on blood flow and distribution.
It is worth noting heart rate increased for 2-3 weeks
when the pen of "untamed" sheep was entered and this could
affect observations on the placental transfer of metabolites.
A placental structure to allow maximum exchange is
important. To interpret affects of haemorrhage or ligation
knowledge of placental structure is required. In human placenta
the typical pattern of one single villous stem and one maternal
* ■
ostium supplying each lobule has been shown to be incorrect
Dissection and graphic reconstruction indicate that one villous
stem supplied several lobules, which were formed from several
stems and arterial ostia. These formed a network at the base
of the placenta and determine the distribution of lobules
Blood Volume and Haemodilution
Fetal haemorrhage in sheep was found to be associated
with a rise in fetal plasma ACTH and arginine vasopressin but no
2.o°l
32.2
consistent trend in hormone growth . Some of these findings
could however be associated with exteriorising the fetus.
Changes occurred after a 20 per cent loss of blood volume and
younger fetuses were more sensitive to this with a greater fall
in blood pressure and heart rate than older fetuses. These
findings are similar to those changes occurring under hypoxic
conditions and surgical stress and may well affect fetal blood
flow in a similar manner. Removal of blood for sampling
would be equivalent to haemorrhage loss. The volume of blood
taken (10 mis per sample) from the ewe would have little
effect on the total blood volume of the ewe - approximately
3.5 litres. The fetus, however, only has a total blood volume
of approximately 200 - 300 mis. This limits both the size and
frequency of sampling. In most experiments approximately 2.5
ml/hour were taken
4. Circadian Rhythms
Actual clock times are noted in the animal methods section.
Plasma amino acid concentrations have been shown to be maximal
323
between 12.00 and 20.00 hours and minimal at 04.00 m adult
37.1+
man and also the neonate only 48 - 72 hours old . The
%
sheep were penned in a room with constant artificial light to
minimise changes and the majority of experiments were carried
out during the day.
Experimental Conditions of Infusion Studies
In present experiments, the ewes had been kept penned indoors
and handled frequently for several weeks before implanting the
catheters. These could not be inserted before day 80 because of
•iic
fetal tissue fragility, at this time placental growth being
complete and rapid fetal growth being about to commence.
Because of the limitations imposed by time of insertion of
catheters and recovery from this procedure only the latter
part of pregnancy can be studied using this technique. At
least 1i days (with the exception of the first tritium infusion)
vjere allowed for recovery following surgical catheterisation,
when amino acids and metabolism changes would be returning
towards the norm-;. As amino acids may be utilized as a secondary
metabolic fuel it was important that additional stress demands
had been abolished. An increased utilization of the amino
acids would not necessarily have been reflected by a decrease
in plasma levels, but by a decrease in the half lives and this
would not have been readily detected unless compared with controls
of longer recovery periods. This increase in usage could be
met either by increased catabolism or by increased transfer of
amino acids from mother to fetus. Any blood circulatory changes
either on the maternal or the fetal side of the placenta could
also alter the transfer rates of amino acids.
Conclusion
*
The sheep used in the experiment were prepared for
experiment to produce a minimally stressed animal. This was
achieved by application of the following procedures
1. The sheep was "tamed" and used to handling and
prolonged experimental procedures involving repeated
blood sampling.
2. Adaptation to environment, feeding regimes and daily
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3. Hourly feeding minimised changes occurring with
feeding and absorption mechanisms.
4. Recovery time from catheterisation stresses was
allowed.
5. Frequency and volume of fetal blood samples were
. restricted.
b.j Biochemical Analysis
) Phenylalanine, Leucine and Lysine Metabolism
Three L amino acids - phenylalanine, leucine and lysine
were infused into sheep. The subsequent metabolism of the
individual amino acids are as outlined in Figs 15,16 andl7
14
The products of metabolism of the universally labelled C
amino acids will contribute towards the plasma water total
activity, although the contribution would be small in
comparison with the parent compound - tyrosine activity and SA
3
being small m comparison with that of phenylalanine. The H
3
label of phenylalanine appeared to be more labile and H
metabolites of phenylalanine accounted for a larger percentage
14
of plasma water activity, (See page249)than the C isotope of
phenylalanine.
Phenylalanine
Phenylalanine metabolism is complex, in that it is the
precursor of several important metabolic compounds including
noradrenaline, adrenaline, (norepinephrine, epinephrine),
thyroxine and melanin. If not required for protein synthesis
the first step in phenylalanine metabolism is hydroxylation to
tyrosine, catalysed by phenylalanine hydroxylase - the enzyme
aB
deficient in most forms of phenylketonuria. If phenylalanine
hydroxylase is deficient transamination to phenylpyruvic acid,
requiring pyridoxal phosphate as co-factor is increased.
Tyrosine is transaminated to p-hydroxyphenyl pyruvic acid
by the enzyme tyrosine-glutamate aminotransferase. The
synthesis of this enzyme in the liver is increased by increased
tyrosine concentrations, adrenal steroids, insulin and glucagon
but is decreased by hypophyseal somatotropin. The degradative
pathway of tyrosine is via p-hydroxyphenyl pyruvic acid
(P.H.P.P.) which is subsequently converted to homogentisic
ase
acid. The copper containing enzyme P.H.P.P. activity is low
in fetal liver and this accounts for the relatively large urinary
excretion in preterm infants of phenyl lactate metabolites.
Lack of ascorbic acid, a cofactor, can also increase tyrosine
concentration. Further metabolism of homogentisic acid to 4-
acetoacetic acid and 4-fumaryl acetoacetate requires a ferrous
enzyme, molecular oxygen and a high concentration of reduced
sulphydryl compounds, e.g. reduced glutathione.
The C atoms of the phenylalanine molecule appear in the
final metabolite, acetoacetate, as follows:-
C becomes the carboxyl C atom of acetoacetate
C 2 of the ring is the precursor of the carbonyl carbon
C 1 or 3 of the ring is the precursor of the terminal carbon
and
J3 C becomes the C of acetoacetate.
The other C atoms of the ring in position i or 3, 4, 5
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Glutaryl-CoA
transmethylglutaconyl CoA
Two important synthetic pathways with tyrosine as precursor
exist. The first, catalysed by tyrosinase, a copper containing
enzyme is through DOPA and dopamine to adrenaline,AMP, GMP,
UMP, CMP, pyridoxal phosphate and ascorbate being cofactors.
Alternatively, DOPA may be diverted via a leucocompound to
melanin. Secondly, iodination of tyrosine requires a copper
containing enzyme for the production of thyroxine.
Leucine
Leucine degradation shares a common catabolic pathway
with isoleucine and valine - i.e. (with the exception of a leucine
specific aminotransferase present in normal liver) enzymes
for the branched chain amino acids are non specific. Branched
chain amino acids are deaminated to their •>*-- Keto acids before
oxidative decarboxylation to the acyl Co A derivative - which has
one less carbon atom than the parent amino acid. Biotin is
required for conversion of 3-methyl crotonyl Co A to 3-methyl
glutaryle Co A and final degradation is through fatty acid
oxidation.
Leucine is the only amino acid known to stimulate protein
synthesis and inhibit proteolysis (see Chapter 1 section 6).
Additionally, *h large proportion of leucine metabolism occurs in
muscle, the tissue most sensitive to altered energy availability,
and plasma branched chain amino acids show a greater reduction
in concentrations than any other group of amino acids in starvatic
(p 71 ). This suggests that leucine may have an important role
in balancing protein synthesis and catabolism. Reduced energy
availability also increased branched chain amino acid oxidation
in muscle, possibly depleting a critical compartment within the
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cell and thereby turning protein metabolism towards proteolysis
rather than synthesis.
Relatively little leucine is extracted by the liver therefore
the concentration of labelled leucine in peripheral blood may be
less affected by immediate hepatic uptake of infused leucine on
the first passage through the liver than the amino acids
phenylalanine and lysine. Incorporation into hepatic proteins,
including those subsequently released into plasma may thus
appear to be lower, as it is possible that the intracellular
phenylalanine and lysine specific activities in the hepatocytes
are higher than would be suggested by the corresponding plasma
specific activities - intracellular hepatic activity being
325 s32.&»
reported as 40 - 60 per cent of that of the plasma specific
activity.
Lysine
Metabolism of lysine is restricted to protein synthesis
and lysine does not participate in transamination reactions.
This reduces recycling and thus frequently makes lysine the
amino acid of choice for studies of protein synthesis and
catabolism. Cofactors required for the degradation of lysine
are NAD (P), NAD (p)H, FAD and magnesium. Final catabolism, like
leucine, is through fatty acid oxidation of crotonyl CoA.
- - •>. Amino Acid Analysis
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Moore and Stein (1951) "originally developed1, the ion
exchange chromatograph method of amino acid analysis. Methods
■52*8
for microdeterminations were then developed and improved
resolution of the amino acids were achieved with lithium buffers
a5!"!
An adaptation of this method (Cockburn 1971) was employed in the
present experiments. Preliminary preparation of biological fluids
for amino acid analysis involves a deproteinisation step.
Picric acid was first used, but as this interfered with
colour production in the ninhydrin reaction excess had to be
removed by passing through a Dowex column. Comparison of the
free amino acid concentrations of plasma deproteinised with picric
acid and sulphosalicylic acid (SSA), which gave no interference,
gave similar results for both - the coefficient of variation for
individual amino acids of both methods being 0.0 - 6.0 per cent
'
. Phenylalanine recoveries were between 92.7 and 108.8
per cent and leucine and lysine between 82.7 and 116.9 per cent.
Stein calculated that 95 - 100 per cent of the total and
amino nitrogen in plasma could be accounted for by the sum of
the individual amino acid values. Traces of protein in the
sulphosalicyclic acid supernatants from samples precipitated
with 0.5 ml 3 per cent SSA to 0.1 ml plasma were reported by
Dickinson, but these were not eluted from the column during
a blank run. Perry e_t jil 1968 used 30 mg solid SSA: 1 ml
plasma ', Hamilton using 3 per cent SSA, having found no
significant difference between this and picric acids. Aoki
et^ a_l 1973 found no difference between 10 per cent and 20 per
cent SSA or 6, 10 or 30 per cent perchloric acid for whole blood
2 Si
The 0.6 mol/1 SSA used throughout these analyses is equivalent
to 15.25 g/100 ml.
Tissue and plasma samples were stored at a temperature
of -70°C at which temperature amino acid concentrations, with
0-1
the exception of glutamme and glutamic acids are stable
ii. Tracer Infusion Techniques
Three types of isotope dilution methods have been employed
single injection, continuous infusion and primed continuous
infusion. The mathematical treatment and theory of these tracer
techniques and compartmental analysis are discussed by Shipley
3*53
and Clark" . White et al 1969 evaluated and mathematically compared
1A ■
these three methods using C glucose" * . The same "irreversible
loss" i.e. flux or entry rate of glucose was found for all three
methods but the pool size and space appeared higher in the primed
infusion than the single injection. Total entry rate can only
be calculated from the latter. Daily feeding compared with
12 feeds given hourly gave essentially the same results, but
the first regime had a greater variance. Using glucose the
ratio of bolus quantity to infusion rate was important, ratios
P (priming injection in nCi): F (infusion rate in nCi/min)
between 69:1 a<nd 98:1 leading to more consistent results-. For
any of the results to be valid all glucose (or tracer used)
entering into the system must mix in the sample pool under
relatively steady state conditions and there must be no re¬
cycling. An indication of recycling may be a slow equilibrium,
although slow turnover can also produce this effect. Amino
acid tracer infusion techniques have been employed to calculate
protein turnover and synthesis rates, " > >- '> >• ■>
based on that of Waterlow and Stephen "
Equilibrium (plateau) specific activity is reached in a
shorter time in a primed infusion than a continuous infusion alone
and the effect of insulin on this plateau can be observed (single
injection experiments would not allow this). For these reasons
the primed infusion technique, with a P:F ratio of 60.3:1 was used
in these experiments and the sheep were fed every hour.
Radioactivity Measurements
i. Tritium
Although tritiated amino acids have been used both in
in vivo and in vitro studies, the differing stabilities of the
14 3 .....
C and H isotopes are seldom considered m discussions. Hider
J5'P 3
et al (1969) found the H amino acid was not stable and lost
radioactivity on incorporation into protein. Evans et_ al
3
(1963)' incubating DL amino acid with a general tritium label
3
(G H) in the presence of renal D amino acid oxidase found the
specific activity of the L compound to be lower than expected
(i.e. the same as the parent DL compound). The percentage loss
was equivalent to the percentage of the label found in the hydroge
attached to the (2) carbon atom - alanine (G) 57 per cent (* see
foot note ) leucine (G) 44 per cent, leucine (2T) 17 per cent,
phenylalanine (G) - 32 per cent and tyrosine (G) 39 per cent.
3i,x
Konikova et al in 1947 nad previously noted glutamic - alanine
"aminopherase" (transferase) resulted in a labile ot hydrogen
molecule - even after heating the experimental enzyme system.
Waterfield 1968 studying tritium exchange in dmlute
aqueous solution also found some lability - L-Dopa 256T -
* Foot note number indicates position of hydrogen atom
replaced by tritium T - G indicates general labelling.
15 per cent, L-leucine 4 - 5T - 1 per cent, L-phenylalanine 4T-
2 per cent L tyrosine, (side chain 23T) - 1 per cent and L
tyrosine 3 - 5T - 8 per cent.
A similar reaction to that of D-amino acid oxidase is
suggested by Rider' ''for enzyme involved in the activation
3
of amino acids for protein synthesis. Examining L (G H) leucine,
with 50 per cent label and glycine with 100 per cent label on the
hydrogen atom' - the glycine appeared more labile, proportionately
3
less H being bound when incorporated into protein than with
14 3
leucine. Using C and H labelled amino acids and correlating
the specific activity of the 2 labelled forms in the medium and
14
the corresponding C ratio incorporated after 30 minutes,
3
Hider calculated correction factors of 22 per cent for H leucine
3
and 37 per cent for H glycine.
The use of tritium labelled compounds can thus give misleading
results, particularly if employed in protein synthesis studies
or dual isotope experiments. For this reason the experiment of
Year 1 using tritiated phenylalanine were repeated in Year II
14
with C labelled amino acid.
In addition to the problem of tritium lability, chemiluminesce
is encountered*. This is particularly marked in whole blood samples
Chemiluminescence is produced by spurious events generating a
single paoton, still detected by coincidence liquid scintillation
system because of the number of random events. This gives rise
to a high background countrate and because this varies from sample
to sample, its effect cannot be eliminated. The problem of
chemiluminescence is very significant when counting samples of
low activity. It can be diminished by neutralising the sample
(alkaline proteinaceous material is usually associated with
chemiluminescence) or awaiting the decay which is temperature
dependent, of the spurious activity,
ii. Total and Specific Activity
The most frequently determined and useful measurement of
radioactivity is specific activity SA i.e. the quantity of
radioactivity (disintegrations per minute, d/min), per given
quantity of the compound - amino acids in these experiments.
However, the methods used to obtain specific activity measure¬
ments are technically difficult and require a level of activity
sufficient to enable accurate measurement of activity in the
relevant fraction from ion exchange chromatography. For these
reasons, in addition to SA, blood plasma and plasma water total
activities have been examined, allowing comparison between experiments
and showing simply label movement. Whole blood and plasma radio¬
activity measurements include both free and bound labelled amino
acids and its metabolites, but plasma water (i.e. deproteinised
plasma) measurements reflect only the free amino acid, soluble
peptides or amino acid metabolites. A rapid and continuing
incorporation qf the amino acid into protein, as opposed to a
steady, relatively low concentration of activity in plasma water
has the effect that only whole blood and plasma samples obtained
soon after the commencement of label infusion would be of appreciably
mixed origins, the activity of later samples being principally
that of protein bound or protein incorporated amino acids. Fetal
deproteinised samples may contain small peptides, the centrifugation
procedure employed leaving a slightly opalescent supernatant, but
these peptides would not be expected to elute with the free amino
27
acids on column chromatography.
In the results and discussion sections reference to activity
or radioactivity refers to the measurement of this total activity
and includes all species of labelled molecule and not only that of
the infused species. Specific activity refers to measurement
of the radioactivity present in a particular compound (amino
acid). A plateau measurement of radioactivity in a system can
only be achieved when the amount of radioactivity entering that
system is equal to that leaving the system. This implies that
the system must first be saturated so that continued accumulation
of activity does not occur.
Specific radioactivity measurements eliminate changes in
these measurements due to dilution or concentration of the pool
of the compound (in these experiments individual amino acids)
and at equilibrium will remain constant for a given pool size.
Also metabolism of the amino acid to other labelled compounds
will not interfere with SA measurements or calculations of
e.g. flux from these SA measurements. Any change in SA
occurring once equilibrium has been achieved represents a change
in flux into or out of the pool, and such change may be detected
even although the concentration of the compound may remain constant.
Development of a plateau of SA or radioactivity during
constant infusion of a labelled material will occur when the
infusion rate of labelled material is equal to the rate at
which labelled material leaves the given pool. Injection of
a bolus of radioactivity will speed the development of this
plateau during infusion experiments by decreasing the time
MOTHER
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until saturation point is reached. Provided that the concentration
of infused material is very small in comparison with the total pool
size it enters the infused material will mix with the unlabelled
material in increasing amounts until a maximum is reached. This
maximum plateau is reached when a constant proportion of material
is labelled. The infused labelled material then leaves the pool
with unlabelled material in the same proportions and at the same
rate as it is entering. At this point the flux may be calculated
from the plateau SA measurements. The length of time to reach
equilibrium and the proportion of labelled to unlabelled material
will depend on the size of the pool, (i.e. the amount to-be
saturated) the quantity and rate at which the labelled material
is infused and the flux into and out of the pool. At equilibrium
the pool size and the flux will be constant so the proportion
of labelled material i.e. SA will depend on the infusion rate.
At high flux and slow infusion rates there would be a long lag
phase before a plateau of activity could be reached - and it might
never be achieved. A fast infusion and slow flux would conversely
decrease the period of time until the plateau is reached, but
too- fast a rate might result in mixing and concentration changes
which would obscure slow changes in flux. In these experiments
labelled radioactive amino acids were infused into the blood
circulation. The situation is represented in Fig 13 .
There is a net positive flux of amino acids from mother to
fetus with the result that labelled amino acid concentrations in
the fetus would be expected to increase faster and to a greater
extent during maternal infusions than the maternal specific
activity would increase during fetal infusions.
2 lb
For plateau specific activities to be reached all
transport functions within the system must be constant. During
the experiments maternal and fetal blood were the only readily
measurable compartments of the system and tissue cells remain
as a "hidden" compartment. At termination, the radioactivity
in tissue cells can be determined but it is unlikely that
equilibrium with the possible exception of free intracellular
amino acid pool would have been reached in such short term
experiments. Tissue activities could only be confirmed by serial
biopsy or timed termination experiments. In longer term
experiments equilibrium between tissues should have been achieved,
but this cannot be known with certainty. Additionally, it should
be noted that rapid exchange between plasma and extracellular
fluid compartments has been demonstrated (Chapter ] section 4).
Discrete compartments, although utilized for some mathematical
calculations, may not therefore exist.
c Calculations
Incorporation of Amino Acids into Protein
The rate of incorporation of amino acids into protein
is calculated from the ratio ) of the S.A. of bound amino
acid (S3) to the S.A. of the precursor amino acid (Si) at
equilibrium. Protein half lives and turn-over may be
calculated from the incorporation rates (See Appendix 12)
In these experiments incorporation rates of amino
acid into tissue protein have not been measured. Tissue
was taken from experiments CI to C4 but in these experiments
sacrifice was at 7 - 9 days past infusion. Extensive
recycling could therefore have occurred and very little
of the total activity would be expected to be present in
the plasma water. Total activity measurements were made in
these tissues (Chapter 3 section 2) a major proportion of
this activity being accounted for by the bound labelled
14
amino acid in protein - the C phenylalanine bound
activity which was found to be present in the hydrolysates
from CI and C4 accounting for over 90 per cent of the total
activity in plasma protein. In the series of experiments
Ins CI and Ins C5 the three hour period of insulin infusion
2-3 hours priot to sacrifice could have caused a con¬
siderable alteration in the ^ ratios. Infusion of insulin
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at 0.26 - 1.66 iu insulin/kg/hr in fetal lambs of 135 days
gestation reduced plasma glucose and the intracellular free
amino acid content of heart (70 per cent) liver (40 per cent)
and muscle (90 per cent) but not of brain" The S.A. of
the intracellular leucine of heart, liver and muscle also
increased. Although insulin infusion rates in these
experiments were slightly lower (0.18 - 0.31 iu/kg/hr) to
those of Chrystie ejt al (0.4 iu/kg/hr)" "* plasma insulin
concentrations were similar in the fetal lambs of these
experiments Ins CI - Ins C5, including the fetus of
Ins C-S in which there was no change in plasma glucose.
As in the experiments of Chrystie et_ al in which there was
no change in S^, total label uptake rate showed no alteration
on starting and stopping insulin, although the SA of plasma
and therefore probably S' increased. Equilibrium may not
therefore have been re-established after the 3 hour insulin
infusion. In rats equilibrium i.e. plateau SA only occurred
in serum and liver after three hours of continuous lysine
32.E?infusion and in muscle after 6 hours""', tissue SA's
were not therefore measured, the acceleration of plateau
SA by use of a primed injection probably having little
effect after altering the metabolic equilibrium by infusing
insulin.
In all calculations of protein turnover and synthesis
rates the SA of the precursor amino acid has to be determined.
Most calculations assume intracellular free amino acids'to
be the precursors but several studies have indicated that
extracellular or' combined extracellular and intracellular
amino acids could be the precursor - possibly an amino-acid-
membrane complex being the actual precursor for protein
synthesis (Chapter 1 Section 4). Changes in the source of
precursor or differences between SA of intracellular and
extracellular amino acids could significantly alter the
apparent synthesis rates. This could be particularly
important if insulin were to alter the equilibrium
2 -1
between intracellular and extracellular amino acids. The
maximum SA would not however be greater than that of plasma.
An estimate of amino acid incorporation into mixed
proteins released into fetal plasma was made from the
data. The assumptions made in the calculations, with the
drawbacks of these are as follows:
1. The SA of plasma amino acids at the end of the
measured period of time (usually an hour) was assumed to be
the precursor SA. As most plasma proteins are synthesised
in the liver the SA of the precursor for these should be
used. This is normally assumed to be that of the intra¬
cellular amino acid - approximately 60 per cent that of
plasma (Waterlow)'""'" "although there is evidence that extra¬
cellular amino acids may be utilized. Rapid changes caused
by insulin infusions would have resulted in a changing
SA during the time intervals. A higher assumed Si than
actually present would reduce the apparent synthesis rate.
2. The SA of the bound activity was based on the acid
precipitated fraction of plasma (i.e. total activity -
the free amino acid activity). This would increase the
apparent activity as activity from products of metabolism
and transamination reactions would be included. However
activity from these sources would not be expected to be
large. The activity of plasma water was not used as the
presence of small peptides or degradation products in the
deproteinized plasma was not excluded. Thus apparent
bound SA i.e. jumol/g protein would also be high - but this
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Incorporation rate of amino acid into plasma protein
MaternalIncorporationRateint PlasmaProteinju olesysing
plasma protein was measured (■-'.- - and ~ .; J;. ] ~ ).
However, only newly synthesised protein released into the
plasma would be detected, thus synthesis rates would
depend not only on synthesis but on rates of release into and
removal from the plasma.
• In both Ins and Ins C/j (and Ins C2„ at 4 hours) the
lowest rate of amino acid incorporation was recorded during
insulin infusion. However, in Ins C- and Ins C U, infusions
the rate was falling prior to insulin infusion. In Ins C.li -
and Ins C*h a rapid increase in synthesis (or release)
occurred within 15 minutes of stopping insulin, but in
Ins Clothe increase to pre-insulin values only occurred after
2 hours, decreased "incorporation" being observed at 15
minutes post insulin. Plasma free lysine SA increased at
this time, possibly indicating a brief reduction in net
synthesis rate when insulin was withdrawn. Unlike SA
measurements, leucine incorporation showed the greatest
change on stopping insulin, incorporation increasing from
3.83 to 11.44 ;umols leucine per gram of protein per hour
in 15 minutes.
From Sephadex separation of plasma protein (part (2,)
page 23S")';he major portion of activity was associated with
the albumin fraction. Additionally a larger proportion
of the phenylalanine is present in a small peptide precursor
(Chapter 1 Section 4). A more rapid response in SA of the
albumin precursor may also occur than in albumin itself.
Maternal lysine incorporation rates were lower
(mean 2.05 - 1. 18 jumol/g/hr) than the equivalent fetal rates
(4.62 - 2.21 jumol/g/hr) and showed little change until after
3 hours of fetal insulin infusion, when only 0.09 jumoles
lysine were incorporated into protein in an hour. This could
reflect preferential catabolism of albumin (suggested to be
1
a storage form of amino acids ') to meet the increased
fetal demands of this period. As these reduced on stopping
insulin and maternal amino acids were again available for
synthesis, a surge of albumin - (total protein increased from
56.8 g/1 to 61.9 g/1) may be released into the plasma to
replace that utilized for fetal supply - resulting in the
incorporation rate increase from 0.09 to 4.38 jamol lysine
per gram tissue per hour.
Overall incorporation rates for both maternal and fetal
infusions are probably low - as the Si value of precursor
activity based on plasma is liable to be more accurate than
that of SB, the pfotein bound SA. Iri vitro determination
of the rate of leucine incorporation into tissue albumin
19 Z
(of adult man) ' ""showed that leucine was incorporated at
1.0 - 0.1 ^imol/g/hr if incubated in medium with amino acids
at plasma concentrations (1.2 - 0.1 jamol/g/hr if insulin
were present) but to be 3.1 - 0.4 jamol/g/hr if incubated in
medium wifh amino acid concentrations 4 times that of the
plasma. Fetal turnover rates have been shown to be greater
than those of adult tissues " ' the higher intra¬
cellular plasma free amino acid concentrations of the
fetal cell being a likely contributing factor. However,
incorporation rate of leucine into hepatic albumin
(incubation at 4 times plasma 4 hr) was 5.1 - 0.6 ,umol/g/hr
but only 0.87 - 0.17 jamol/g/hr in the albumin released into
the medium.
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. .. Sephadex separation of Plasma Protein
Sephadex G200 was used to separate plasma proteins into fractions
of similar molecular weight. The presence of a protein fraction
in the eluate was detected by monitoring absorption at 280nm.
Plasma from maternal samples taken at 3j hours and 8 days
(Experiment CI) and fetal samples taken at 4 hours (Experiment CI)
and 2 days (Experiment CI and CS) were applied to the Sephadex
column. The 280nm absorption trace of the elu.ate from Sephadex
columns after applying either maternal or fetal plasma is shown
in Figure SI. Six fractions were discernable from maternal
plasma but only two from fetal plasma. The probable composition
of these fractions is indicated on the figure.
From figure S2 and table XV., which gives the radioactivity
associated with each plasma protein fraction, it can be seen that
over 78 per cent of the activity was present in the albumin fraction
in the fetus and over 89 per cent in that of the mother, the
remaining activity being associated with a mixed <*. andyS globulin
fraction. No activity was detected in the maternal plasma K
globulin fraction. Baseline activity of the column eluate during
the period of <*.and& globulin elution and activity associated with
fraction 2 increased with time. However, in maternal plasma the
"fraction 2: fraction 4 activity ratio remained constant, whereas in
fetal plasma the ratio decreased, a result of an increased contribution
of fraction 2 to total activity. No difference in the proportion of
activity associated with fractions 2 and 4 was found between the fetus
directly infused with labelled phenylalanine and the fetus of an
infused mother.
The 3| hour maternal and 4 hour fetal samples had activity
associated with the amino acid fraction but no activity was found in
Inter samples. However, the diffuse nature of the amino acid fraction
(4 hours elution time) resulted in luw activities in the 9 separate
Hours
Fig. S\ Absorption at 280 nm of eluate from
Sephadex G200 column
o
Fig. 52 - Activity in plasma protein fractions separated
on G200 Sephadex
2:7
samples collected. No estimate of total free activity was
therefore made.
Discussion
The albumin : and globulin ratio was lower in
maternal plasma than in the plasma of the fetus and non¬
pregnant adult, the concentration of albumin being reduced
3 ifS
and that of*-and globulins increased during pregnancy" ".
No X'globulin was found in the ovine fetal plasma, V globulin
only appearing postnatally with the onset of suckling"" .
Fractions 3 and 5 were not detected in fetal plasma. These
fractions might have been present below the detection limit
of 280 nm monitoring of the eluate, plasmaproteins being
at lower concentrations in the fetus than mother and only
small volumes of fetal plasma (0.5 ml) compared with
maternal plasma (3 ml) being available for Sephadex
chromatography.
The relatively high activity in the albumin fraction
(fraction 4) is consistent with its pool size and rate of
turnover. Albumin (M.W. 69,000) is the largest single pool
of plasma protein (53.6 per cent of total plasma protein
in the adult sheep) and has a rapid turnover. It is
%
synthesized exclusively in the liver. In the fetus and
new born lamb the half life of mixed hepatic proteins is
—— "J . , 2 ,4- -y
0.7 days compared with 6.9 days in the adult sheep
However, these half lives are short when compared with
those calculated from rn vitro studies of human liver in
ISi
which the half life was estimated at 57 days' In the
same study the half life of hepatic albumin was 20 days
whereas that of albumin released into the medium was only
2.39
3.2 days. This is similar to that of serum albumin
in the rat (3.7 days) where turnover has been calculated
33q
to be 0.027 mg/hr/g . In the in vitro studies of
l<2?>
Lundholm et_ al a higher activity was found to be
associated with a hepatic protein component which, although
it reacted with albumin antisera, migrated more slowly than
albumin orv gel elecl/.-pbb'is'is. unless it was first subjected to
mild proteolysis.
This component was therefore thought to be albumin precursor
i.e. albumin with' . the attached proalbumin (Page 7:j
In these experiments activity in the plasma albumin
would be equivalent to that released into the medium.
The labelling of the albumin may explain the increase in
activity between hours 4 and 6 in the maternal samples
of experiment CI, the higher activity still being maintained
on day 8 (Table XV)
Activity in fraction 2 is probably associated with A
globulins e.g. transferrin (M.W. 85,000) haptoglobulin
(M.W. 85,000) and plasminogen (90,000). These have a
small pool size (16.3 per cent of the total plasma protein)
but a faster turnover (0.036 mg/hr/g half life of 0.5
days in rats) than that of serum albumin and would
therefore be preferentially labelled in constant infusion
experiments of short duration. r
oe and £ globulins have variable half lives. Together
they account for 21.1 per cent of the total protein pool.
Some activity in fraction 4 - the majority of which is
23°l
albumin may be that of low molecular weightw.2 globulins
such as prothrombin (M.W. 62,700) but no activity was
associated with either theyorixl globulins such as
ceruloplasmin (M.W. 150,000) the elution time of which
would be similar to that of globulin. 2 globulins of
intermediate M.W. may be a component of fraction 2. No
activity was found in either the fraction containing
a" globulin (M.W. 170,000) which has both a small pool
size (9.4 per cent of total protein in adults) and a
relatively slow turnover (0.011 mg/hr/g in rats) or in
fraction 5, that associated with<*hglobulins in which
position fetuin, (M.W. 45,000) an ex., globulin reported to
be relatively large quantities in the plasma of ungulate
f tj'U , . 31(t,34-1fetuses would be expected to elute
Maintenance of activity for 8 days in plasma albumin
in spite of its short half life would indicate either
extensive recycling of amino acids within the liver or
late release of prelabelled stored hepatic albumin.
Labelled albumin has been reported to be incorporated
into globulins but this could have resulted from recycling.
With a faster turnover of/S globulins than albumin re¬
cycling or incorporation of albumin into globulins
would result in a relative increase with time of activity
in the globulin fraction, as was found in these experiments.
The faster fetal turnover rates would enhance this effect
- the-ratio of fraction!?-: fraction 4 being decreased by




The flux (i.e. metabolic clearance rate) of an amino
acid into and out of the total amino acid pool may be
calculated from the plateau S.A. of the amino acid i.e.
the point at which the quantity of labelled amino acid
entering the pool is equalled by the quantity leaving.
Essential amino acids in the plasma of the fetus
must have been trasported across the placenta from the
maternal blood. Amino acids from proteolysis are probably
rapidly utilized for protein synthesis within the cell
(it has been suggested amino acids released in protein
catabolism are preferentially utilized in protein
synthesis' ) and would therefore re-enter the plasma
compartment. Additionally, the rapid growth and rate of
protein turnover in the fetus would "bind" amino acids
into protein, resulting in net amino acid flux into
cells. Fetal plasma amino acids would therefore be
expected to be derived directly from maternal blood
via the placenta rather than from the fetal catabolism
and release of amino acids into plasma. Thus the
removal rate, i.e. metabolic clearance of amino acids
from the placenta would represent the rate of placental
transfer and fetal utilization, although not the protein
synthetic rate because amino acids could also be trans-
aminated, degraded or excreted via urine, skin or lung
secretions.
The calculated whole body (i.e. plasma) fluxes for

































































































Flux calculated from the formula
Flux = q SjL umol/hr
SA
where q = rate of infusion (timol/hr)
Si = SA of infused amino acid
SA = SA of plasma at plateau
"
3
H Phenylalanine SA = 1000 .uCi/jumol
"14C Phenylalanine SA = 522 ;aCi/jumol
14
C Leucine SA = 324 jaCi/.umol
14
C Lysine SA = 330 juCi/;umol
3
H phenylalanine (50 yUCi/hr) == 49.5 X
_3
10 ;umol/hr
C phenylalanine (50 juCi/hr) = 95.8 X
-3
10 jumol/hr
(35 jiCi/hr) == 67. 1 X
-3
10 jamol/hr
(30 juCi/hr) = 57.5 X
-3
10 jamol/hr
C leucine (30 ^Ci/hr) = 92.6 X
_3
10 jumol/hr


















-40-+50+9-0.271-+0.339+0. 6 -10-+60+220.034- 0.2 3Q 75 -10-+0.40+ 2-0.034-+0.136Q. 1
+0.213 +0.073 +0.060
*transfer;ug/kg/day=v-ua(jig/N^ ml)Xbloodf w(168ml/k / in)1440
**IS^transfer=̂lgN^flux/kg/hrX24 X-Mean.
2.1+3.
C4. are given in Table Flux is normally calculated from
plateau SA, but in experiments which included a period of
insulin infusion the flux has also been calculated from
the SA of the samples taken during and after stopping
the insulin infusion, i.e. at a time when the metabolic
equilibrium of the fetus was disturbed. Although total
maternal flux was obviously greater than that of the fetus,
expressed on a body weight basis, the fetal flux is greater.
The faster flux is consistent with the greater metabolic
activity of fetal tissues, both anabolic and catabolic
proceeding at a faster rate in the fetus than the mother.
The leucine flux in experiment Ins C3 of 217.3 jumol/
kg/hr was less than that reported for newborn Clun lambs
(689 - 950 jumol/kg/hr) " . Anaesthesia, differences in
maturity and environment (extra uterine as opposed to
intrauterine), species and individual variations could
account for the discrepancy. This is supported by the
fact that there is close agreement between transfer rates
based on the flux measurements from these experiments and
the net placental transfer of amino acids to the fetus
calculated from the data of Lemons et al'2"^. In Lemons®
experiments fetal blood flow and amino acid concentrations
in umbilical venous and arterial blood were measured in
unstressed fetal lambs of 118 - 146 days gestation, enabling
transfer rates to be calculated using the uv:ua difference
(in the calculation of table JtVItthe range of uv:ua difference
was derived from^figures ). A comparison of the
calculated transfer rates is shown in Table ,
Calculated values for lysine transfer were 0.060 and
0.213 >Jg/kg/day for leucine transfer 0.075 and 0.073
>ig/kg/day and for phenylalanine 0.041 and 0.060 jag/kg/
day based on the data of Lemons et al and these
experiments respectively. Placental transfer of some
amino acids, including leucine and phenylalanine is
considerably in excess of the estimated growth re¬
quirements based on carcass analysis. This would suggest
transamination and oxidative degradation of essential
amino acids does occur in the fetus, this possibly
varying with gestation as changes in uvtua concentration
differences have been found towards term' ". With the
exception of aspartic acid (which is closely associated
with amidation to asparagine) lysine is the only
amino acid in which the estimated requirements from
carcass analysis are in close agreement with the
calculated transfer rate. As lysine is not trans-
aminated, this could imply that most of the difference
between the two types of estimation is due to de-
- gradation rather than transamination.
b
t
The reduced flux and decreased amino acid con¬
centration associated wTith insulin infusion might reflect
increased net protein synthesis. The decrease in flux
could suggest that placental transfer had decreased, and
that any net increase in protein synthesis might be the
result of reduced catabolism rather than increased
synthesis. It also supports"the concept that .insulin
.stimulation of amino acid uptake from the fetal plasma
into the placenta is more powerful than the passive

























































































aten ryintos udy: SVD=spontaneousvert xdeliv ry KFD=eillandsforcepd ivery CS=aesareansectio IRDS=ideopathicrespiratoryistresssyndrome
CHAPTER V
Neonatal Studies
Both maternal and fetal insulin secretion appear to influence
fetal growth (see chapter 1 section 5 p 64 ). In the newborn infant
adaptation of insulin release to altered and fluctuating plasma
concentrations of glucose and amino acids as a result of both a
changed and intermittent dietary intake is necessary for continuing
post natal weight gain. The initial response of insulin secretion
to a change in plasma glucose and amino acid concentration is delayed,
but becomes brisker after a few days. As insulin facilitates movement
of amino acids into cells and increases net protein synthesis,
administration of exogenous insulin may enchance utilization of
parenterally infused amino acids and thereby encourage protein synthesis
2,4
in the preterm infant.
Plasma amino acid concentrations were measured in parenterally
fed preterm infants before, during and after the infusion of insulin.
No assessment of the role of intravenous feeding or the suitability
of the aminoacid solution used was made, only the changes in concen¬
tration on and off insulin being studied.
Materials and Methods
Eight infants were entered into the study and these were
randomly allocated to one of two insulin infusion schedules (see
following page). Clinical details of the infants and the schedule
to which the infant was allocated are given (on the opposite page).
*
/
All infants were parenterally fed Vamm 7% , 10% dextrose/
electolyte/vitamin solution* and Intralipid 20^ were infused at
60, 40 and 10 ml/kg/day respectively for Tw, Gt, Ad, An and Ga and
at 30, 90 and 10 ml/kg/day for infants Bl, Fo and Gr, providing Kcal/
kg/day.
Insulin to give 0.2 iu/kg/hour was added to the dextrose solution
together with low salt albumin.
* see appendix'?for composition
2.U1
albumin (200 mg/ 1 OQnl dextrose/electrolyte/vitamin solution),
according to one of the two schedules given below:-
1) C/I/C
Control 24 hour period (Vamin, cocktail plus albumin,
intralipid only)
24 hour insulin infusion (plus Vamin,cocktail plus albumin,
Intralipid)
Control 24 hour period
2) I/C/I
24 hour insulin infusion
Control 24 hour period
24 hour insulin infusion
Blood samples were taken (via an indwelling catheter) at 0,3,24,
27, 48, and 72 hours from all infants who completed the trial period
or at these time intervals until withdrawal from the study because of
their clinical condition. Additional samples were taken at 12., 36 and
60 hours from infants Ga Gt and Tw and a further 24 hour period was
completed in infants An and Tw.
In addition to samples for biochemical analysis, blood glucose
was monitored using dextrostix strips and heel prick blood samples
every 3 hours during insulin infusion.
Blood glucose, plasma amino acids, total lipid and non-esterfield
fatty acid (NEFA) concentrations, osmolality, pH and blood gas status
were measured.
24 hour urine samples were collected (unless the perineal skin
condition precluded this) to correspond with the 24 hour infusion
periods. Volume, osmolality and amino acid concentrations were

















































































































































































































































































































































































Osmolality mosm/kg 163 191 189 461 483 137 352 (436+366+218)278) 224 288 346 326 329 326

















233 245 223 437 280 268





Blood, pH and gas partial pressures and plasma
osmolality results are given in Table Nl.
Urine volume, osmolality and labstix results are
summarised in Table N2.
Blood glucose, total lipid, NEFA and selected
amino acid results are presented in histogram form. The
amino acids illustrated in the histogram represent
different functional and transport groups p2L/+)
Measurements made at zero hours (•) and at 3 hours (represented
by open circles or solid white circles within the black histograms)
and 24 hours (histograms) after a change from or onto insulin
infusion are displayed in the following figures. Periods of
insulin infusion are represented by solid black histograms and periods









































Infant Fo: Plasma (above) and urine (below) amino acid
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PHE TYR PRO GLN ALA
Infant Gt: Plasma (above) and urine (below) amino acid
concentrations during ■ and off a insulin infusion.
(0-3 hours after changeover)
(n - 2-1* ^
2SS'
I
PHE TYR PRO GLN ALA
x ] x2 x30 x20 x20
Infant Tw: Plasma (above) and urine (below) amino acid
concentrations during ■ and off □ insulin infusion.
(0-3 hours after changeover)
.> » " )
(n - X "
y _ Multiplication Factor
Infant An: Plasma . amino ac
concentrations during ■ and off □ insulin infusion.
(0-3 hours after changeover)
(r\ ~ 21+ "
X - Multiplication ractor




1 °0-| x 1 x 1 x 10
PHE TYR PRO GLN ALA
x ] x2 x30 x20 x20
Infant Ad: Plasma (above) and urine (below) amino acid
concentrations during ■ and off a insulin infusion.
(0-3 hours after changeover)
(n - 2.1+ " " " }
X - Multiplication Yoctor
2-5 8
taoon
Infant Bl: Plasma (above) and urine (below) amino acid
concentrations during ■ and off a insulin infusion.
(0-3 hours after changeover)
























Infant Ga: Plasma (above) and urine (below) amino acid
concentrations during ■ and off o insulin infusion.
(0-3 hours after changeover)
(n - ^ " " )
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PHE TYR PRO GLN ALA
Infant Gr: Plasma (above) and urine (below) amino acid
concentrations during ■ and off □ insulin infusions.
(0-3 hours after changeover)
( n ~ " " " )
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Blood glucose, total lipid and NEFA concentrations
during ( >1 ) without ( D ) insulin infusion.
2.4,3
Glucose Total Lipid NEFA
Blood glucose,
during ( « )
total lipid and




Gluconeogenic amino acids - alanine and glutamine
Branched chain ketogenic acids - valine* and leucine*
Liver metabolised amino acids - phenylalanine*, tyrosine*
cystine* methionine*.
Muscle "metabolised" amino acids - proline - leucine*, valine*.
"Inert" - limited metabolism - lysine*.
An indication of the effect on these amino acid
concentrations when insulin infusion is either started or
stopped in shown in Tables N3 and N4.
Discussion
Fetal plasma amino acid concentrations are greater
than those of neonatal plasma (See Chapter I , Section 1 )
and therefore it could be argued that for the preterm
infant high plasma amino acid concentrations are more
"normal" than those of full-term infants . During the
early period of this study Vamin was infused at a high rate
but subsequent clinical practice has reduced the rate to
give a ratio of 9:3:2 (Cocktail:Vamin:Intralipid) - that
used for the last three infants included in the study.
Theoretically the infusion of exogenous insulin would be
expected to increase cellular uptake of amino acids and
thereby reduce plasma free amino acid concentrations
(see page However, the simultaneous infusion of
large quantities of crystalline L amino acids may cause an
increase in plasma free amino acid concentrations and this
in turn may stimulate endogenous insulin release - thus
obscuring responses to the infused insulin. Also if
insulin precipitously decreased plasma glucose concentrations,
* essential amino acids in newborn preterm human infant.

































































































decreased 64 45 73 33 64 45 54 36 36 45 64 54 54 54
*changegreatertha10%




















































































































glucagon secretion might be stimulated and amino acids -
particularly alanine and glutamine - may be mobilised and
utilised as energy sources resulting in a changed amino
acid profile.
In these studies a significant decrease (p <0.001) in
blood glucose concentration, as judged by 24 hour values,
did occur during insulin infusion, and all babies recorded
dextrostix readings of 25 mg/100 ml or less on at least
one occasion when on insulin. Three hours after changing
regimes there was little correlation between blood glucose
and total lipid but at 24 hours the decrease in glucose
on infusing insulin was always accompanied by a decrease
in the total lipid concentration. Similarly the increase
in blood glucose at 24 hours after withdrawing insulin
resulted in increased total lipid concentrations. The
correlation coefficient r = 0.566 of blood glucose and
total lipid was not significant for the group as a whole nor
was there correlation with either the group on or the group
off insulin infusion. However, although the relative
concentrations of plasma glucose and lipid vary with
individual infants, the close relationship between falling
blood glucose and falling total lipid concentrations suggest
that the infants begin to utilise or accelerate the metabolism
of fat to meet their metabolic energy requirements.
Transition from carbohydrate to fat metabolism is faster
3 '-4$in children than in adults* ' . In term infants with
relatively large adipose stores but small carbohydrate
reserves this is very important. In the preterm infant
with smaller fat stores, infusion of intralipid may permit
2^3
the same adjustment to take place when glucose concentrations
fall as a result of raised insulin concentrations. No
correlation between non-esterified fatty acids and either
blood glucose or total lipid was found - possibly because
the proportion of Intralipid being utilised for energy
or deposition was changed rapidly. If energy requirements
are compromised, it is unlikely that optimum protein
synthesis is possible and although amino acids may be
encouraged to enter the cell on infusing insulin it may well
be they then enter the catabolic pathways - and the second
protein synthetic stimulatory action of insulin or its
inhibitory effect on catabolism is abolished. Improved
control of Intralipid and dextrose could therefore increase
protein synthesis on the same amino acid regime, Chen
et al 'having previously demonstrated caloric supply
influences the plasma amino acid profile. During these
studies alanine and glutamine, the two amino acids most
sensitive to caloric deficits behave in a manner similar to
other amino acids, so that although catabolic pathways may
be operating in the cells, it suggests that mobilisation of
amino acids is limited. From the histograms it can be
seen that there was a general decrease in plasma glucose
and amino acids after infusion of insulin, although this
was not true for all amino acids in all infants. Few
significant changes in plasma free amino acid concentrations
were found during periods on and off insulin. Those found
to change significantly were:-
Glycine (P<0.5) - Tw
Glutamine (P < 0.5) - Tw and Fo
Valine (P <0.01) - Fo
TABLEN5 Effectofinfusings linnpla maaminoc dconcentrati nsthwofusisch dules. No.ofPlasmaAminocidsDe reased* Aminocid1stInsulinfusio of Schedule3HoursP st 2ndInsulinfusion of Schedule
24HoursP st
1stInsulinfu io of Schedule







































































































































TABLEN6 EffectofTerminatingInsulinusionPla maAmi oc dConcentrat o s. No.ofPlasmaAminocidsIncrease * 3Hoursposttermination
24Hoursposttermination
Aminocid





































































































Phenylalanine (P<0.5) - Tw
Tyrosine (P<0.01) - Tw
(P < 0.05) - Ga
The large variability in plasma amino acid con¬
centrations in any one infant when infused with amino acids
during the 24 hour periods on or off insulin may obscure
insulin induced changes. Adaptation to the higher levels
of insulin and the half-life of insulin after its withdrawal
could well contribute to the large standard deviations
of plasma amino acid concentrations found even in individual
infants. It is possible that in utero conditions of Gr,
an infant of a diabetic mother, might have affected the
postnatal response to insulin (page ), therefore baby
Gr has been excluded from the combined data in Tables
N3 - 6.
From Table N3, in which the direction of change in
concentration between the last sample taken before starting
insulin and the samples taken 3 or 24 hours later is
examined, it can be seen that there is no trend for insulin
to decrease plasma amino acid concentrations although it
should be noted that in more than half of the samples
plasma amino acids were decreased and in very few cases was
there an actual increase. However, if the two regimes -
C/I/C and I/C/I are examined separately (Table N5) it can
be seen that when insulin is infused after an initial 24
hour period of Vamin alone the decrease is significant at
2
the 0.1 per cent level (X test). Immediate infusion of
Vamin with insulin obscures any response of amino acids to
insulin in the first 3 hours of the second schedule I/C/I.
2T72-
At 24 hours after the start of the first insulin infusion,
the number of occasions on which amino acids are decreased
is no longer significant in either group - both groups
having fewer decreased concentrations at this time than
at 3 hours. If a second period of insulin infusion was
given, in the I/C/I regimen although a smaller proportion
were decreased during the first 3 hours, an increased
proportion - significant at the 5 per cent level - were
decreased by 24 hours. Only one infant on the C/I/C
regimen had a second period of insulin - during which time
amino acid concentrations were little changed from the
previous 24 hour values.
It therefore appears that if amino acids and insulin
are initially infused together, the increased input of
amino acids is of greater importance in determining plasma
amino acid concentrations than the presence of insulin,
which would decrease the plasma amino acid concentrations.
However, insulin did reduce the initial increase in plasma
amino acid concentrations in the I/C/I regimen and decreased
amino acid concentrations after the infusion of insulin in
the C/I/C regimen and after the second insulin infusion of
the I/C/I regimen. The lower infusion rates of amino
acids for Bl, Fo and Gr did not alter the overall response
of amino acid concentrations to insulin infusion although
the changes were smaller. Previous studies have reported
hyperaminoacidaemia on withdrawing insulin from infants on
prolonged intravenous therapy. In this study, in both
groups of infants, a significant number (P 0.05) of
increased amino acid concentrations were noted (Table N6)
in the blood samples taken 3 hours after discontinuing
insulin compared with the last sample taken during insulin
therapy. The same was true for samples taken at 24 hours in
infants on the I/C/I regime. When data for all periods
in both groups of infants was combined - Table N4), the
slow increase in plasma amino acids occurring after the
second period of withdrawal and the decreased number
of amino acids (in the C/I/C regimen) with increased
concentrations 24 hours after insulin withdrawal obscured
any insulin effects. The longer period of hyperamino-
acidaemia in the I/C/I regime might have been caused by
supressed endogenous secretion during the initial insulin
infusion. In the C/I/C group either insulin secretion
or end organ responses could have been primed during the
first control period of amino acid infusion, greatest
increases being in those infants (An and Ad) not previously
infused with Vamin.
The behaviour of tyrosine should be noted: it was the
amino acid most resistant to any decrease in concentration
after infusion of insulin and the amino acid most often
increased after withdrawal of insulin. This may be caused
by the late maturation of the p-hydroxyphenyl pyruvic acid
oxidase enzyme complex in the liver of preterm infants
being superimposed on the changes in concentration of
amino acids occurring in response to altered insulin
concentrations.
Essential and non essential amino acids appeared to
respond to insulin concentrations in a similar manner.
Changes in the ratio used by Whitehead" - total molar
concentrations of plasma glycine, serine, glutamine and
27
taurine: leucine, isoleucine, valine and methionine - which
may be regarded as an index of nutritional status (high
values being found in cases of protein-calorie malnutrition)
were random and showed no significant difference between
periods on or off insulin infusion in the same infant.
However, after 24 hours of insulin infusion on 10 out of
12 possible occasions the ratio was decreased. The mean
and S.D. ratio value for all infants when off insulin was
2.47 - 0.99 (n = 28) and when on insulin 2.15 - 0.95
(n = 28).
Infusion of insulin with amino acids during the
first 24 hour trial period usually resulted in either a
decreased or unchanged plasma amino acid concentrations
within the first 3 hours, whereas infusion of amino acids
alone, whether previously infused or not, always resulted
in increased plasma amino acid concentrations. Thus although
no significant effect was noted, insulin infusion abolished
the increase in amino acids which normally occurred with
the start of amino acid infusion.
The exception to this was Gr, an infant of a diabetic
mother, in whom amino acid concentrations increased at 3
hours post insulin even although amino acid infusion had
commenced 3 days previously. The effect of maternal
diabetes on fetal plasma glucose and insulin concentrations
in utero might have altered the infant's usual postnatal
response, insulin release normally being depressed during
the first few days of life. Increased endogenous insulin
secretion from B islet cell hyperplasia could result in a
smaller net increment of insulin on infusion. In addition
XJS
end organ response might be more effective and glucagon
release and change to lipid metabolism swifter - blood
glucose concentration remaining relatively constant
(N.B. the study commenced on day 5 and therefore beyond
the normal postnatal period of hypoglycaemia of infants
of diabetic mothers.)
Examining changes in individual infants?twenty four
hours after commencing the insulin and amino acid infusion
in schedule 2 plasma amino acid concentrations increased
above the initial concentrations in two infants (Ad and Bl)
but in another decreased to concentrations below those
of the first sample - although it should be noted the
concentrations in this infant - Ga - were high in the
original sample. In An and Gr the concentrations of amino
acids were similar to the initial concentration, some
amino acids being slightly increased and some slightly
decreased. The opposite trend occurred in the infants
initially infused with amino acids alone, plasma amino
acid concentrations increasing at 3 hours and then falling
during the subsequent 21 hours. As amino acid infusion
was commenced at the same time as insulin for An and Ad
and within 12 hours of intravenous feeding for Gr the
observed reduction of plasma amino acids may not be a total
reflection of insulin's effectiveness in lowering plasma
amino acid concentrations. In infants receiving a second
period of insulin infusion (An, Ad and Bl) the decrease
in amino acid concentrations after 3 hours was observed
only in the plasma of Ad, plasma amino acid concentrations
2.74=
in B1 and An being increased. Although the absolute
decrease was greater in the second period of insulin infusion
in Ad, the percentage decrease was greater during the
initial period. After 24 hours the plasma amino acid
concentrations of Ad was further decreased, and although
in both An and B1 the plasma amino acid concentration
was below that of the 3 hour post insulin sample only in
An were plasma amino acid concentrations consistently
decreased compared with the sample taken before commencing
insulin.
The high concentrations of amino acid found in Ad's
plasma during amino acid infusion might be a reflection of
a catabolic state. The decrease in amino acids during
insulin infusion and the increase during the second 24
hours when off insulin would suggest that exogenous insulin
was capable of stimulating cellular uptake. Unknown
factors are the rate of protein synthesis as opposed to
increased cellular amino acid content, and the effect of
catabolic hormones such as hydrocortizone and nonadrenaline
in conditions of stress.
The continued low plasma amino acid concentrations
in Bl during amino acid infusion both with and without
insulin suggests that amino acids were being utilised for
synthesis and weight gain would confirm this (1.44 to
1.55 kg in 4 days). This could explain the absence of
an increase in amino acids when insulin infusion stopped
at the end of the first 24 hour period. Prolonged infusion
of Vamin prior to this might have altered responses or
conceivabl catabolic hormones release might have been low
2.11
in the anabolic state which had been achieved. Also, it
is possible that a greater release of endogenous insulin
could have resulted in a reduced response to exogenous
insulin during the second 24 hour infusion period.
The three infants on regimen (1) - off/on/off insulin
all showed an increase in plasma free amino acid concentrations
at 3 hours but then subsequently decreased towards pre insulin
values. Stimulation of endogenous insulin secretion with
resultant increased cellular uptake could explain this pattern
of changing concentrations. Increased protein synthesis is
also indicated as even during the second period off insulin
amino acids remained within the normal range. Insulin
during the second 24 hour period in most instances reduced
the concentration of amino acids in the first 3 hours of
insulin infusion and insulin further decreased it during the
next 21 hours. This suggests that cellular amino acid
uptake was not maximally stimulated by the endogenous
insulin secretion during the first 24 hour period. Although
in Fo a "rebound" increase (approximately doubling of the
concentration) was noted on terminating insulin infusion,
twenty four hours later the concentration had returned to
that of the original, 24 and 48 hour samples - i.e. there
appeared to be a rapid adaptation to either increased or
decreased insulin concentrations. Plasma amino acids in
Tw were observed to increase 3 hours after withdrawing
insulin, but unlike Fo, who had previously been infused
with amino acids, they continued to increase to concentrations
greater than those found after the initial infusion without
insulin.
Thus, simultaneous administration of insulin when a
xn
solution of crystalline amino acid is first infused appears
to prevent immediate hyperaminoacidaemia• After a short
period of time adaptation by the infant to this new level
of insulin and the basic metabolic state of the infant
e.g. anabolic or catabolic, may counteract effects of
exogenous insulin and be more important in determininglplasma
amino acid concentrations. This would imply that protein
synthesis is stimulated by an initial increase in the
concentration of the anabolic hormone insulin, but that
prolonged stimulation depends on other factors e.g. energy
supply. There is a complex interaction between energy
supply amino acids and insulin involving inter alia, glucagon,
hydrocortisone, noradrenaline and the acid-base status of
the infant.
Reduced concentrations of plasma amino acids observed
during the experimental period were not a result of renal
overflow. Amino acid analysis of 24 hour urine samples
corresponding to the 24 hour periods on and off insulin
did not reveal any significant or consistent changes with
a change in regimen. Even when very high plasma concentrations
of amino acids were recorded (Ga and Ad) no renal overflow
was observed. Glycine and proline were the only amino acids
consistently excreted in large quantities - whether on or
off insulin - this being in accord with the known immaturity
of the glycine and mino acid transport mechanism within
the kidney tubule during the first weeks of life (see pal ).
The high concentrations of amino acids in the urine Gt
represent urinary concentration - total urine volumes for
the two 24 hour periods being only 40 and 31 mis. with
2.77
osmolality values of 460 and 485 mosm/kg respectively.
Urine output and osmolality are within the ranges 31-270
mis and 135-485 mosm/kg respectively. No correlation
between volume and the osmolality of urine existed, 31.9
- 19.0 mosmoles being the mean daily excretions of the whole
group. However, individual variation, apart from Fo on
day 2 is smaller.
Plasma osmolality was particularly measured because
of the very high osmolality - approx 1400 mosm/kg of Vamin
solution. With the exception of Ad in whom plasma osmolality
of 333 mosm/kg at 48 hours and 326 mosm/kg at 72 hours and An
with plasma osmolality of 330 at 48 hours were recorded,
osmolality values in plasma ranged between 278 and 308
mosm/kg. Zero hour samples ranged between 282 and 295
mosm/kg. During infusion of amino acids osmolalities
increased within 3 hours in all but Ad's plasma, but no
consistent pattern with changing insulin regimens were
subsequently found. Again with the exception of Ad and An
osmolality changes between any 2 samples were less than 15
mosm/kg and usually below 10 mosm/kg, but Ad and An showed
marked "swings" on changing insulin regimens with a low
of 295 mosm/kg and a high of 333 mosm/kg.
Conclusions
Although the number of infants studied was small, an
indication of the effect of altered insulin concentrations
on plasma amino acid concentration can be found in the data.
Apart from the expected lowering of blood glucose
concentration, infusion of insulin lowers the concentration
230
of plasma free L-amino acids without increasing urine excretion.
Therefore by inference insulin encourages entry of amino acids
into cells thereby encouraging protein synthesis - page >. r
However, the effect of insulin may not be sustained, amino
acid concentrations returning towards pre-insulin concentration
indicating adaptation to the higher insulin concentration.
Adaptation could be a result of altered sensitivity of the
end organ response, diminished endogenous secretion or a
shortened insulin half-life, or increased secretion of
glucagon,nor adrenaline or corticosteroids. Hyperamino-
acidaemia often occurs on insulin withdrawal but this also
may be of a transient nature, possibly depending on the
endogenous insulin secretion or end organ response - which
may be increased if previously exposed to high amino acid
infusion rates while receiving exogenous insulin.
Further study should include a larger number of infants
in these schedules and a number of infants in whom the
infusion periods are extended - perhaps to 3 days. Additionally
the effect on plasma amino acids of giving a single bolus
of insulin - given in preterm infants if glucose concentrations
are greater than 130 mg/100 ml - should be examined.
2Si
CONCLUSIONS
Placental transfer of amino acids from mother to fetus
is rapid. Subsequently, the transferred free amino acids are
quickly cleared from fetal plasma, only a small proportion
of the infused amino acid being present in plasma water.
Under the experimental conditions employed, plasma free amino
acid S.A.reached a plateau 2 hours after a bolus injection
given at the start of the continuous infusion of labelled
amino acid. This was in contrast to total plasma activity,
in which there was a linear increase throughout the infusion.
This indicated that rapid attachment to or incorporation
into and release of fetal plasma proteins, particularly
albumin, must occur. It was proved that the labelled amino
acids were incorporated into proteins and that this
incorporation and release was approximately 2.32 (phenylalanine)
to 7.95 (lysine) gimol/hr/g plasma protein. Tissues taken at
termination of the experiments also showed extensive incorporation
of labelled amino acids into tissue protein. Thus a slow
transfer of amino acids e.g. because of placental malfunction
or maternal circulatory problems could rapidly reduce the
protein synthetic rate. This should be considered not only
*
from the clinical viewpoint but also in the design of
experiments, any change in the distribution or rate of maternal
blood circulation from that in the physiological normal
state probably having a marked influence on the estimated rates
of protein synthesis.
Some protection from short term fluctuations in the
supply of amino acids to the fetus may be given by the placenta
Z%Z
It may act as a reservoir whereby amino acids from maternal
blood are accumulated and then released only slowly to
the fetus. This would allow a continued release of amino
acids to the fetus at times when blood circulation through
the placenta or maternal plasma amino acid concentrations
were temporarily reduced. Evidence for this reservoir role
was seen in the different patterns of increase in fetal plasma
total activity after ending maternal and fetal infusions.
Whereas there was an abrupt halt to the increase in fetal
plasma total activity after fetal infusions, fetal activity
continued to increase after the infusion into mother had
ceased. Calculation of placental transfer rates based on the
fetal plasma flux of leucine, lysine and phenylalanine (i.e.
their clearance rates from fetal plasma) gave values of +
0.213 (phenylalanine) + 0.073 (leucine) and + 0.060 (lysine)
pg N^/kg/day, values similar to those obtained by measurement
of uv:ua concentration differences and umbilical blood flow
J-2.U
in unstressed fetal lambs of similar gestation' . The
effect of insulin on these transfer rates was variable. '
Although the plasma concentrations of leucine, lysine and
phenylalanine all decreased, the S.A. of lysine and phenyl¬
alanine increased whereas that of leucine was unchanged
during the first hour of insulin infusion.
These observations suggest that, as previously found
in in vitro and in vivo acute experiments, insulin removes
amino acids from the extracellular to the intracellular
compartment. The increase in S.A. would imply that the
placenta is initially incapable of accelerating transfer
2S3
rates sufficiently to compensate for this removal, or may
itself remove amino acids from fetal plasma. However the
return of amino acid S.A. to pre-insulin values during
continuous insulin infusion would suggest there was only a
temporary effect of insulin on placental transfer rates, and
that the fetus adapts to a higher basal insulin concentration.
The unaltered leucine S.A. would indicate that either insulin
influences individual amino acid transfer rates or that
there is individual variation in the response to insulin.
Variation in the response to insulin by different tissues,
particularly liver and muscle, could alter the change in
S.A. of amino acids such as leucine, which is primarily taken
up by muscle.
The rapid change in phenylalanine and lysine S.A. on
infusing insulin, followed by a slow return towards pre-insulin
values could suggest that fluctuations are of greater
importance than the absolute insulin concentration in
determining the metabolic response to insulin. The unaltered
. . 1A
plasma total activity, and unchanged or decreased rate of C
incorporation per gram of protein released into plasma during
insulin infusion supports the concept that insulin promotes
k
growth i.e. net protein synthesis by decreasing catabolism
rather than increasing the rate of protein synthesis. Thus
if the placental transfer of glucose (or gluconeogenic amino
acids such as alanine and glutamine) were increased sufficiently
to satisfy energy requirements, increased synthesis could
temporarily occur at the same amino acid placental transfer
rate. A sustained increase in net synthesis would, however,
eventually require an increased transfer of amino acids from
xsu
mother to fetus. Fluctuations in supply, allowing short
periods of a higher rate of net synthesis might result in
a faster overall growth rate if these were followed by a
brief period of increased placental transfer to replace the
incorporated amino acids. Thus in diabetic pregnancies the
greater fluctuation of maternal insulin and glucose
concentrations may have a more significant influence on fetal
- metabolism and growth than their actual concentrations.
Prolonged maternal hyperglycaemia and fetal hyperinsulinism
might by increasing placental size and surface area increase
nett amino acid transfer/protein synthesis. /and
In preterm parenterally fed infants increasing plasma
insulin concentration by infusion of insulin at 0.1 or 0.2
iu/kg/hr for a period of 24 hours also produced a variable
metabolic response. Although plasma amino acid concentrations
decreased, both the percentage and absolute decrease varied
and was for and after a variable time. Discontinuation of
insulin infusion increased plasma amino acid concentrations,
but the timing and degree of the response was also variable.
The clinical and metabolic status of the individual infant,
postnatal ^ge and- duration of amino acid infusion prior to
insulin administration were of more significance in determining
the absolute plasma amino acid concentration, although
insulin did affect the plasma amino acid concentrations of
both anabolic and catabolic infants, infants of three weeks
post natal age receiving parenteral nutrition from birth and
neonates previously fed only dextrose. Continuous infusion of
insulin may therefore promote protein synthesis in "healthy"
preterm infants but in a "sick" catabolic infant, insulin may
only cause a dangerous increase in the intracellular amino
23S"
acid concentration, (particularly if amino acids are already
at high concentrations) without promoting the utilisation
of amino acids in protein synthesis. Prolonged insulin
therapy may also result in supressed endogenous insulin
release, adaptation of end organ response to the higher
insulin concentration and alteration in other antagonistic
hormonal responses e.g. glucagon and catecholamines.
Thus there may be little long term benefit from continuous
insulin infusion. Additionally, sudden withdrawal of
insulin, from either an anabolic or catabolic infant could
result in a period of hyperaminoacidaemia, and if insulin
supresses catabolism, in increased catabolism. Insulin
infusion in the newborn human infant therefore needs careful
biochemical monitoring of not only plasma glucose, but also





0.15 g reagent copper sulphate CuS0^.5H20 and 0.60 g reagent
grade sodium-potassium tartrate cOOK.CHOH.CHOH.COONa.-4H20 were
dissolved in 50 ml water and transferred to 100 ml volumetric
flask. 30 ml 10 per cent (2.5 N) carbonate-free sodium
hydroxide NaOH was added with stirring and the reagent made up
to the mark with distilled water.
APPENDIX . ,
Non Esterifield Fatty Acid Reagent
Solution A: Cobalt nitrate-acetic acid — potassium sulphate
was prepared by adding 6 g CoCNO^^l^O and 0.8 ml glacial acetic
acid to a filtered saturated solution of K„S0. - additional
2 A
potassium sulphate solution being added to 100 ml.
Solution B: Sodium sulphate Na2S0^ was added to boiling
water until saturated.
Cobalt Reagent
1.35 ml triethanolamine, 8.65 ml Solution A and 7 ml Solution
B were well mixed together. The reagent is unstable therefore
was freshly prepared for each batch of analyses.
APPENDIX 3
Phosphate Buffer
10 mmol/1 sodium phosphate
150 mmol/1 sodium chloride
gag




Buffer 1 - pH 2.85 46.5 g Lithium citrate
100 ml Lithium hydroxide
40 ml Brij
20 ml Thiodiglycol
Buffer 2 - pH 3.75 28.2 g Lithium citrate
50 ml Lithium hydroxide
20 ml Brij
10 ml Thiodiglycol
Buffer 3 - pH 6.25 - 46.4 Lithium citrate
168.4 g Lithium chloride
100 ml Lithium hydroxide
40 ml Brij
Buffers 1 and 3 were made up to 4 litres and buffer 2 to 2
litres with cooled boiled deionized distilled water, titrated with
6N HC1 to the required pH and filtered through Whatman GF filter




20 g Ninhydrin (Koch-Light) for amino acid analysis
3 g Hydrindantin
3000 ml 2-methoxyethanol (methyl-cellosolve)
400 ml Sodium acetate buffer
600 ml Cooled boiled distilled deionized water
Ninhydrin and hydrindantin were dissolved in methyl
cellosolve before adding the sodium acetate buffer and water.
The deep red solution was filtered through Whatman G.F. papers
before bubbling with oxygen free nitrogen for 30 minutes to
displace the air. The ninhydrin reagent was stored under nitrogen.
Sodium Acetate Buffer
1088 g Sodium acetate trihydrate
200 ml A.R. glacial acetic acid
Made up to 2 litres with distilled water.
Hydrindantin
80 g Ninhydrin
80 g Ascorbic acid
Ascorbic acid in approximately 100 ml distilled water at 40°C
was added to ninhydrin in 2 litres of water at 90°C. Gentle heating
was continued for 15 minutes and then the solution allowed to cool
slowly. The precipitated hydrindantin was filtered off using a
Buchner funnel and the precipitate dried for 3 night;sin a vaccum
dessicator over phosphorus pentoxide.
APPENDIX6
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* .Changegreatert n2p rce t
Rateofincreased/min/ml/hrndcorrelationcoeffic e t( ) ofrateinc easewithtimduringinfusions
.EXP T2 T3 TIt C! ca C3 C414C
Time Hr
2--4 2-4 ^2-4 2-4 4-6 0-4 4-6 0-4 4-6 H-3 %—4
Blood (Total)
MatrFe 3.830 995 1.000.993 2.18 0.85
1.920.999 0.60.933 1.3 1 .00 24.100.978
Mat 3.01 0.56 3.02 5.30
1 .35 3.34 1 .60 0.16 3.62
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InsC415.0462 214.8472 313.5572 4 ,8.9770 4%9.10126 56-20180 615.485 710.7710 l\9.60145 813.19 915.6664
32.5 33.6 30.5 31.1 27.5 22.2 22.0 24.6 28.8 28.9 30.1 32.1 36.3




Correction factors - quenching (see
- Recovery a) concentration
area sample peak
area norleucme peak x norleucme equivalent
Norleucine equivalent = area known quantity amino acid
area known quantity norleucine
b) radioactivity - sample counts x radioactive standard counts
Radioactive standard counts
added
Flux - or Entry or Clearance Rate
Q (flux) = qSi ^mol/hourSA
where q = rate of amino acid infusion (;jmol/hour)
Si = Specific activity infused amino acid
SA = Plateau Specific Activity
Fractional synthesis rate or turnover rate - Garlick 1969
Soltesz et al_ 1973
-55- = ^2*" - k2t - ^2 Where SB = SA protein bound amino acidSl T-eT K~J~
Si = SA free amino acid
K
1 = fract.rate uptake amino acid
into protein
= fractional rate protein
breakdown
%
t = time of infusion
Assuming pool sizes are constant and t is sufficiently
K 0
long K jq = K2Q X 1/K^ = /q = R - where q & Q correspond to
amounts/g of free bound amino acid.
Substituting RK^ for Kj
K„ t K„
SB ' Jn2
A plot of Si v K curve gives the half lives t = K
Protein bound activity, provided adequate washing and
careful hydrolysis are carried out can easily be estimated.
However the full specific activity of the precursor is
controversial, as the true identity - whether total intra¬
cellular, discrete intracellular or even extracellular
amino acids of the precursor is not entirely agreed. If
true intracellular specific activities are calculated the
extracellular fluid volume of tissue has first to be
14
established -usually from the C mulin space. Then
Intracellular space cpm/ml = total cpm in tissue - cpm/ml
medium X Inulin space (or extra-
cellular fluid)
total tissue water - Inulin space
£63
APPENDIX la
Dextrose Mineral Cocktail Per Cent
Dextrose Anhydrous 9.5






Potassium acid phosphate 0.163
Immediately before injection add 4 ml inj Ca gluconate 10 per cent
to produce /100 ml -
Na 5.9 mmol





SO, = 0.33 mmol4
H„P0,- 1.20 mmol2 4
Lact. 1.29 mmol
APPENDIX B
























Young V R, Scrimshaw N S, Bier D M. J. Agric. Food Chem.
(1981) 29 440 - 447.
Pearson A. Ph.D. Thesis (1976) University of Edinburgh.
Mellor D J. in Animal Models in Fetal Medicine (1) (1980)
et Nathanielsz P W. Chapter 2 Elsevier/N Holland Biomedical Press,
Amsterdam, New York, Oxford.
Liggins G C. in Size at Birth CIBA Foundation Symposium 27
(new series) (1974) pp 165 - 183. Associated Scientific Publishers
Elsevier - Excerpta Medica, North Holland, Amsterdam, Oxford,
New York.
Thorburn G D. ibid pp 185 - 214.
Persson B. ibid pp 247 - 273.
Liggins G C. in Fetal Physiology and Medicine (1976) ed
Beard R W, Nathanielsz P W. pp 254 - 270. Saunders W B. and Co.,
London, Philadelphia, Toronto.
Van Assche F A, Hoet J J, Jack P M B. ibid pp 121 - 136.
Beard R W, Oakley N W. ibid pp 137 - 157.
Morse A. Bull John Hopkins Hosp. (1917) 28 199 - 204.
Glendenning M B, Margolis A J, Page E W. Am. J. Obstet.
Gynec. (1961) 8_1_ 59 - 593.
Christensen P J, Date J W, Schonheyder F, Volqvartz K.
Scand. J. Clin. Lab. Invest. (1957) 9 54 - 61.
Ghadimi H, Pecora P. Pediatrics (1964) 33^ 500 - 506.
Lindblad B S, Baldesten A. Acta. Paediatr. Scand.
(1967) 56 37-48.
Young M., Prenton MA., J. Obstet. Gynaec. Br. Commonw.
(1969) ]b_ 333 - 344.
Furaya H, Maehara D. J. Jpn. Obstet. Gynaec. Soc.
(1964) JJ_ 167 - 172.
Soupart P. Clin. Chim. Acta. (1960) 5 235 - 249.
Zinneman H H, Seal U A, Doe R P. J. clin. Endocr.
(1967) 2_7 397 - 405 .
Ryan J. Fed. Proc. (1958) 17 p 138.
Robertson G L, Hagerman D D, Richardson G S, Villee C A.
Science (1961) 134 1986 - 1987.
Zinneman H H, Johnson J J, Seal U S, J. clin. Endocr.
(1963) 22 996 - 1000.
Bjornesjo KB. Clin. Chin;. Acta. ( 1968) 20 11 — 15.
23- Cockburn F, Blagden A, Michie E A, Forfar J 0. J. Obstet.
Gynaec. Br. Commonw. (1971) 78_ 215 - 231.
.24. Cockburn F, Robins S, Forfar J 0. Br. med. J. (1970)
2 747 - 750.
25. Cockburn F, Giles M, Robins S P, Forfar J 0. J. Obstet.
Gynaec. Br. Commonw. (1973) 80 10 - 18.
26.. Young M, McFadyen I R. J. Perinatal Med. (1973) 1
174 - 182. ~
27. Dickinson J C, Rosenblum H, Hamilton P B, Pediatrics
(1965) 36_ 2-13.
28. Lindblad B S. Acta Paediat Scand. (1970) 59. 13 - 20.
29. Clemetson CAB, Churchman J. J. Obstet. Gynaec. Br. Emp.
(1954) 21 364 - 371.
30. Lindblad B S, Zetterstrom R. Acta. Paediat. Scand. (1968)
21 195 - 204.
31. Plentl A A. Clin. Obstet. Gynaec. (1966) 9_ 427.
32. Pritchard J A. Obstet. Gynec. (1965) 25 289 - 297.
33. Cockburn F, Farquhar J W, Forfar J 0, Giles M, Robins S P.
J. Obstet. Gynaec. Br. Commonw. (1972) 79_ 698 - 707.
34. Naeye "fc. L. Paediatrics (1965) 21 980 - 999.
35. Hoet D A. in Size at Birth CIBA Foundation Symposium 27
(new series) (1974) p 213 discussion, Associated Scientific
Publishers, Elsevier - Excerpta Medica, North Holland, Amsterdam,
Oxford, New York.





Raihi NCR. Pediatrics (1974) 21 147 - 156.
Cockburn F. Clin. Endocr. Metb; (1976) 5 191-219.
—
. W » jit f *«•Cockburn F, Current Med. Res. Opin. (1976) 4:9- 99.
40 . Harper A E, Ann. N Y Acad. Sci. (1958) 69_ 1025 - 1041.
41. Harper A E, J. Nutr. (1959) 68_ 405 - 4 18.
42. Harper A E, Kumta U S. Fed. Proc. (1959) _1_8_ 1136 - 1142.
a
'43. Henderson L N, Koeppe 0 T, Zimmerman JH H, J. Biol
Chem. (1953) 20J_ 697 - 706.
44. Kumra U S, Elias L G, Harper A E. J Nutr. (1961) 7j3
229 - 235.
,
45. Munaver S M, Harper A E. J. Nutr. (1959) 69 58 - 64.
46. Grau C R, Kamei M. J. Nutr. (1950) 4J_ 89 - 101.
47. Fisher H, Shapiro R, Griminger P. J. Nutr. (1960) 72
16 - 22. ~
48. Fisher H, Shapiro R. J. Nutr. (1961) 75 395 - 401.
4g. Kumta U S, Harper A E. Proc. Sec. Exp. Biol. Med.
(1962) _M0 512-517.
5 <3 Sauberlich H E, Salmon WD. J. Biol. Chem. (1955) 214
463 - 473.
- 51. Sanahuja J C, Harper A E. Am. J. Physiol (1962) 202
165 - 170.
52. Sanahuja J C, Harper A E. J. Nutr. (1963) 8J_ 363 - 371.
53. Harper A E. In: Mammalian Protein Metabolism ed. Munro H N
and Allison J B., (1964) Vol.11 pp 87 - 134 Academic
Press New York, London.
'54. Smith C, J. Pediat. (1947) 30 229 - 243.
"55. Antonov A N. J. Pediat (1947) 30 250 - 259.
• 56. Rahimtoola R J, Mir S, Baloch S. Acta Paediat. Scand.
( 1968) 57_ 534 - 536.
.57, Lindblad B S, Rahimtoola R J, Said M, Haque Q, Khan N,
Acta. Paediat. Scand. (1969) 58 497 - 505.
58t Arroyave G, Wilson D, De Funes C, Behar M. Am. J.
Clin. Nutr. (1962) U. 517 ~ 324 *
'59. Edozien J C. Clin. Sci. (1966) 3_j^ 153 - 166.
60. Saunders S J, Truswell A S, Barbezat G 0, Wittman W,
Hansen J D L. Lancet (1967) II 795 - 797.
6-1. Holt L E, Snyderman S E, Norton P M, Riotman E, Finch J,
Lancet'(1963) II 1343 - 1348.
62. Mestyan J, Fekete M, Jarai I, Sulyok, Imhof S, Soltesz G Y.
Biol Neonate (1969) 14 153 - 177.
63. Whitehead R G, Dean R F A. Am. J. Clin. Nutr. (1964) _1_4
313 - 319.
64. Young M, Soltesz Gy, Noakes D, Joyce J, McFadyen I R, Lewis B V.
J. Perinatal Med. (1975) _3 180 - 197.
65. Gruenwald P. Biol. Neonate (1963) 5^ 215 - 265.
66. Aherne W, Dunhill M S. Br. Med. Bull. (1966) 22^ 5-8.
67. Pearse W H, Sornson H. Sm. J. Obstet. Gynec. (1969) 105
696 - 701.
68. Wootten R, McFadyen I R, Cooper J E. Biol. Neonate (1977)
333 - 339.
69. Hopkins L, McFadyen I R, Young M. J. Physiol. (1971) 215
9 - 10P.
70. Slater J S, Mellor D J. Res. Vet. Sci. (1979) 26_ 296 - 301.
71. Reilly P E B, Ford E J H. Br. J. Nutr. (1971) 26 249 - 263.
72. Slater J S, Mellor D J. Biochem J. (1972) 129 p 12P
73. Ford E J H, Reilly P E B. Res. vet. Sci (1969) 10 409 -
'418.
7'4. Ford E J H, Reilly P E B. Res vet Sci. (1970) ~l~l 575 -
579.
75. Setchell B P, Bassett J M, Hinks N T, Graham N. McC.
Q Jl. exp Physiol (1972) 57_ 257 - 266.
76. Anand R S, Sperling M A, Ganguli S, Nathanielsz P W
Pediat. Res. (1979) _L3 783 - 787.
77- van Marthens E. Biol. Neonate (1977) 31 324 - 332.
78. Everitt G C. Nature Lond. (1964) 201 1341 - 1342.
v
79. Rosso P. Biol Neonate (1976) 30 163 - 168.
,80. Wigglesworth J S. J. Path. Bact. (1964 ) 88 1 - 13.
81. Hayter C J, Hutchinson E A, Karvonen M J, Young M.
J. Physiol. (1964) L75 11 - 13P.
82. Hopkins L, McFadyen I R, Young M. J. Physiol. (1971) 215
11 - 12P.
83. Hill P M M, Young M. J. Physiol. (1973) 235 409 - 422.
84. Reynolds M L, Young M. J. Physiol. (1971) 214 583 - 597.
85. Cockburn F, Giles M. Proc. Nutr. Soc. (1977) 36 17 - 23.
86. Young M. in Placental Transfer (1979) ed Chemberlain G U R,
Wilkinson A W. pp 142 - 158 Pitman Medical.
87. Young M. Placenta (supplement) (1981) 125 - 138.
88. Wilson T H, Lin E C C. Am. J. Physiol. (1960) 1030 - 1032.
89. Oldendorf W H. Arch. Neurol. (1973) 28^ 45 - 48.
90. Beyer K H, Wright L D, Skeggs H R, Russo H F, Shaner G A.
Am. J. Physiol (1947) 151 202 - 210.
91. Akedo H, Christensen H N, J. Biol Chem (1962) 237 i13 - 117.
92. Reiser S, Christiansen P A. Am. J. Physiol (1965) 208
914 - 921.
93. Milne M D, Br. Med. J. (1964) 1 327 - 336.
94. Oxender D L. Christensen H N. J. Biol. Chem. (1963)
-•I • 238 3686 - 3699.
95. Parsons D S, Pritchard J S. J. Physiol. (1968) 198 405 - 434.
96. Longo L D, Yuen P, Gusseck D J. Nature, London (1973) 243
531 - 533.
97. Stave U, Armstrong M D. Biol. Neonate (1976) 2J3 347 - 352.
98. Holzman I R, Lemons J A, Meschia G, Battaglia F C. J. Devel. Physiol.
(1979) _1 137 - 149.
99. Stegink L D, Pitkin R M, Reynolds W A, Filer L J, Boaz D P,
Brummel N C. Am. J. Obstet. Gynec. (1975) 122 70 - 78.
100. Stegink L D, Pitkin R M, Reynolds W A, Brummel N C, Filer L J.
Metabolism (1979) 28 669 - 676.
101. Pitkin R M, Stegink L D, Filer L J, Reynolds W A.
C^uoheol Vol-vnci KA , Ple».£enfc«^ I) I2,"?—13*3
102- Page E W, Glendenning M B, Margolis A, Harper H. Am. J.
Obstet Gynec (1957) 73_ 589 - 597 .
103. Schneider H, Mohlen K H, Challier J C, Dancis J. Br.
J. Obstet Gynaec. (1979) £16^ 299 - 306.
104. Kelly W T, Hutchinson D L, Friedman E A, Plentl A A.
Am. J. Obstet Gynec (1964) ^9 776 - 786.
105 Scriver C R, Schafer I,A, Efron M L. Nature Lond. (1961)
192 672 - 673.
106. Hagihira H, Wilson T H, Lin E C C. Am. J. Physiol
(1962) 203 637 - 640.
107. Baerlocher K E, Scriver C R, Mohyuddin F. Proc. n'atn
Acad Sci (1970) 65 1009 - 1016.
108. Roth K S, Hwang S M, London J W, Segal S, Am. J.
Physiol (1977) 233 F241 - 246.
109. Scriver C R, Pediatrics (1969) 44_ 348 - 357.
110. Baerlocher K E, Scriver C R, Mohyuddin F. Biochim. Biophys.
Acta. (1971) 249 353 - 372.
111. Schneider H, Dancis J. Am. J. Obstet. Gynec. (1974) 120
1092 - 1098.
112. Dancis J, Money W L, Springer D, Levitz M. Am. J. Obstet. Gynec.
(1968) 101 820 - 829.
113. Ryan W L, Carver M J. Nature, London (1966) 212 292 - 293.
114. Young M. in Fetal Physiology and Medicine (1976) ed Beard R W,
Nathanielsz P W. pp 59 - 79 Saunders W B & Co., London,
Philadelphia, Toronto.
115, VJapnir R A, Dierks-Ventling C. Biol. Neonate (1971)
373 - 380.
116. Sturman J A, Neimann W H, Gaull G E. Biochem J. (1971)
1*25 78 - 79 P
11-7. Larson P R, Ross J E, Tapley D F. Biochem Biophys Acta
(1964) 88 570 - 577.
11®. Matthews D M, Laster L. Am. J. Physiol (1965) 208
601 - 606.
119- Dierks-Ventling C, Cone A L, Wapnir R A. Biol. Neonate
( 197 1 ) _17_ 36 1 - 372.
120_ Joyce J, Lewis B V, 24cFadyen 1 R, Noakes D, Young M.
J. Physiol (1974) 239 5 - 6P.
121. Prenton M A, Young M. J. Obstet. Gyriaec. Br. Commonw. (1969)
7_6 404 - 411.
122. Hayashi S, Sanada K, Sagawa N, Yamada N, Kido K. Biol. Neonate
(1978) 34 11 - 18.
123. Velazquez A, Rosando A, Bernal A, Noriega L, Arevalo N.
Biol. Neonate (1976) 2_9 28 - 40.
124. Lemons J A, Adcock III E W, Douglas Jones Jr. M, Naughton M A,
Mexhia G, Batteglia F C. J. Clin. Invest. (1976) 58 1428 - 1434.
125. Sugawa T, Nakomura K, Ozaki M. J. Jap. Obstet. Gynec. Soc.
(1963) 10 1 - 7.
126. Jakubovic A. Biochem Biophys Acta (1971) 237 469 - 475.
127. Robins S P, Baird D T, Cockburn F, Livingston J R B,
Smith I I. Archs.Dis. Childh. (1971) 46_ 397 - 398.
'128. Berry H K, Cripps R, Nicholls K, McCandless D, Harper C.
Biochim. Biophys. Acta (1972) 261 315 - 320.
129^ McGee M M, Greengard 0, Knox W E. Biochem J. (1972)
127 669 - 674.
130. Brenneman A R, Kaufman S. J. Biol. Chem. (1965) 240
3617 - 3622.
131. Kenney F T, Kretchmer N. J. Clin. Invest (1959) )38_
2189 - 2196.
132. McLean A, Marwick M J, Clayton B E. 3. clin Path
( 1973) 26 678 - 683.
133. McGee M M, Greengard 0, Knox E. Biochem J. (1972) 127
675 - 680.
154. Hommes F A, Beere A. Biochim Biophys. Acta. (1971)
237 296 - 300.
135. Sturman J A,. Gaull G, Raihi NCR. Science ( 1970)
169 ?4 - 75.
V36 Westall R G. Biochem. J. (1960) 7_7 135 - 144.
137* Greengard 0. in Early Diabetes in Life (1975) ed Camerini-
Davalos R A, Cole H S. pp 9 - 14 Academic Press New York.
138. Schimke R T, Doyle D. A Rev. Biochem (1970) J39 929 - 976 .
139. Banos d, Daniel P M, Pratt 0 E. J. Physiol (1974)
236 29-41.
140. Munck B G, In: Transport across the Intestine (1972)
ed. Burland W L, Samuels P D. pp 169 - 185.
Churchill Livingstone, London.
144. Settergen G, Lindblad B S, Persson B. Acta Paediat.
Scand. (1976) £5 343 r 353.
142. Battistip L, Grynbaum A, Lajtha A. Brain Res. (1971)
29 85 - 99
143. Mabry C C, Denniston J C, Nelson T L Son C D, New
Engl. J. Med. (1963) 269 1404 - 1408.
Allan J D, Brown J K, In: Some Recent Advances in Inborn
Errors of Metabolism (1968), Proceedings of 4th
Symposium of S.S.I.E.M., Dublin-, 1966. ed; Holt K S.
V P Caffey pp 14 - 38 E 4 S Livingstone, Edinburgh.
-j45. Wong P W K, Justice ?. In: Advances in Experimental
Medicine and Biology (1572) ed Velk 3 W, Aronson S M.
pp 163 - 17-4. Plenum Press, Nev York.
146. Chase H P, O'Brien D. Pediat. Res. (1970) 96 - 102.
147. Li J B, Fulks R M, Goldberg A L. J. Biol. Chem. (1973)
248 7272 - 7275.
148. Kipnis D M, Reiss E, Helir.reic'n E. Biochim Biophys Acta
( 1961) 5J_ 519 - 524.
149- Rosenberg L E, Berman M, Segal S. Biochim Biophys Acta
( 1963) 7J_ 664 - 675.
150. Hider R C, Fern E B, London D R. Biochem J. (1969)
114 17 1 - 17S.
151. Hider R C, Fern E B, London D R. Biochem J. tly/l^
121 817 - 827.
152. Hendler R W. Nature Lond. (1962) 193 821 - 823
153. Adamson L F, Herington A C, Bornstein J. Biochim
Biophys Acta (1972) 282 352 - 365.
154. Castles J J, Wool I G. Biochem J. (1964) 9J_ 11 - 13C
155 . Scharff R, Wool I G. Biochem. J. (1965) 97. 272 ~ 276*
156. Khairallah E A, Mortimore G E. J. Biol Chem. (1976)
251 1375 - 1384.
157. Lundholm K, Schersten T. Acta Physiol Scand. (1975)
93 433 - 44 1 .
1513. Mortimore G E, Woodside K H, Henry J E. J. Biol. Chem
( 1972) 247_ 2776 - 2784 .
159. Millvard D J. Clin. Sci. (1970) 39 577 - 590.
.160. Waterlow J C, Garrow J S, Millwatd D J. Clin. Sci.
(1969) 36 489 - 504.
161. Millward D J. Clin. Sci. (1970) 39 591 - 603.
162. Jeffay H, Winzler R J. J. Biol Chem. (1958) 23± 101 -
1 16.
163. Rothschild M A, Oratz M, Mongelli J, Fishman L,'
Schreiber S S. J. Nutr. (1969) _98 395 - 403.
164- Waterlow J C, Stephen J M L. Clin. Sci. (1967) 33_
489 - 506.
165. Meier P R, Peterson R G, Bonds D R, Meschia G, Battaglia F C.
Am. J. Physiol. (1981) 240 E320 - 324.
166.. Muller-Eberhard U, Liem H H, Cox K H, Conway T P.
Pediat. Res. (1975) 9_ 519 - 521.
167. HcMenamy R H, Lund C C, Oncley J L. J. Clin. Invest.
(1957) 36 1672 - 1679.
168. McMenamy R H, Lund C C, Neville G J, Wallach D F H.
J. Clin. Invest. (I960) 39_ 1675 - 1687.
■)6g. Peters T. Jr. Adv. Clin. Chem. (1970) _L3 37 - 111.
170. Bourgoin S, Faiure-Bauman A, Hery F, Ternaux J-P,
Hamon M. Biol. Neonate (1977) 3J_ 1A 1 - 154.
171. McMenamy R H, Oncley J L. J. Biol. Chein. (1958) 233
1436 - 1447.
1*72, Koffenberg R, Black E, Brock J F. J. Clin. Invest.
( 1966) 45 143 - 152
^73. Hoffenberg R. Biochem J. (1972) p 3P
174. James W P T, Hay A M, J. Clin. Invest. (1968) 47
1958 - 1972.
175- Kirsch R, Frith L, Black E, Hoffenberg R. Nature
Lond. (1968) 217 578 - 579.
176. Picou D, Waterlov J C. Clin. Sci. (1962) 22 459 -468.
177- Russell J H, Geller D M. Biochem. Biophys. Res. Commun.
( 1973) 55 239 - 245.
178. Peters J. J. Biol. Chem. (1962) 237 1186 - 1189.
Glauman H, Biochim. Biophys. Acta. (1970) 224 206 - 218.
180. Geller D M, Judah J D, Nicholls 15 R. Biochem J.
( 1972) 127 865 - 874.
181. Judah J D, Nicholls K R, Biochem J. (1971) 123 649 -
655.
182* Schreiber G, Rotermund H-M, Maeno H, Weigand K, Lesch R
Eur. J. Biochem (1969) _10 355 - 361
183- Rotermund H M, Schreiber G, Maeno H, Weissen U,
Weigand K. Cancer Res. (1970) _30 2139 - 2146.
184. Judah J D, Gamble M, Steadman J H. Biochem J. (1973)
134 1083 - 1091.
185. Russell J H, Geller D M. J. Biol. Chem. (1975) 250
3409 - 3413.
186. Quinn P S, Gamble M, Judah J D. Biochem J. (1975)
146 389 - 393.
187» Urban J, Inglis A S, Edwards K, Schreiber G. Biochem.
Biophys. Res. Commun. (1974) 6_1_ 494 - 501.
%
188. Lundholm K, Schersten T, Lindstedt G, Lundberg P-A.
Eur. J. Clin. Invest.' (1977) 7 275 - 282.
189. Edwards K, Schreiber G, Dryburgh H, Urban J, Inglis A S.
Eur. J. Biochem. (1976) _63_ 303 - 311.
190. The Physiology of Human Pregnancy (1971) 2nd edition,
ed. Hytten F E, and Leitch I. p 395. Blackwell
Scientific Publications, Oxford, London, Edinburgh.
191. Shearman R P, Shutt D A, Smith I D, In: Size at Birth,
CIBA Foundation Symposium 27, (new series) (1974) pp 27 -
39. Associated Scientific Publishers. Elsevier-
Excerpta Medica, North Holland, Amsterdam, Oxford, Hew York.
1 g2- Physiology and Biophysiology (1973) ed. Ruch T C, and
Patton H D. p 346 Saunders W B & Co. Philadelphia,
London, Toronto.
193. The Borderland of Embryology and Pathology (1962)
2nd edition, ed. Willis R A. p 204 - 206. Butterworths
London.
194. Reproduction in Mammals, Book 2: Embryonic and Fetal
Development (1972) ed. Austin C R, Short R V., p 85,
Cambridge University Press.
195. Lancet (1976) 889 - 890.
196. Foetal and Neonatal Pathology (1970) 3rd Edition ed.
Morison J E. p 156. Butterworth, London.
197. Hill D E. In: Size at Birth, CIBA Foundation Symposium
27 (new series) (1974) p 213 (discussion) Associated
Scientific Publishers, Elsevier-Excerpta Medica,
North Holland, Amsterdam, Oxford, New York.
198. Hoet D A, ibid p 213 (discussion)
199. Malaisse W J. Proc. Nutr. Soc. (1972) 31 213 - 217.
200. Malaisse W J, Sener A, Herchuelz A, Hutton J C.
Metabolism (1979) _28 373 - 386.
201. Watts C, Gain K, Sandin P L. Biol. Neonate (1976)
30 88-94.
202 Mintz D H, Chez R A, Horger E 0. J. Clin. Invest.
(1969) 48 176 - 186.
203. Adam P A J, Teramo K, Raihi N, Gitlin D, Schwarz R.
Diabetes (1969) 18 409 - 416.
204. Jorgensen K R, Deckert T, Pederson L M, Pedersen J.
Acta. Endocrin. , Copenh. (1966) 52^ 154
I %
205. Paterson P, Page D, Taft P, Phillips L, Wood C.
J. Obstet. Gynaec. Br. Commonu. (1968) 7_5 917 - 921.
206. Willes R F, Boda J M, Stokes H. Endocrinology (1969)
84 671 - 675.
207. Milr.er R D G, Hales C N, Br. Med. J. (1965) J_ 284 - 287.
t
208. Alexander D P, Andrews R D, Huggett A St. G, Nixon D A,
Widdas W F. J. Physiol. (1955) 129 352 - 366.
209. Bassett J M, Thorburn G D, J. Endocr. (1971) 50 59 - 74
210- Philipps A F, Carson B S, Mesc'nia G, Battaglia F C.
Air.. J. Physiol (1978) 235 E4 67 - 4 74 .
211. Alexander D P, Assan R, Britton H G, Fenton E,
Redstone D. Biol. Neonate (1976) 30 1 - 10.
212. Simmons M A, Jones M D, Battaglia F C, Meschia G.
Pediat. Res. (1978) 12 90 - 92.
213. Hill D E. In: Size at Birth, CIBA Foundation Symposium
27 (new series) 1974. p 271 (discussion) Associated
Scientific Publishers, Elsevier-Excerpta Medica, North
Holland, Amsterdam, Oxford, New York.
214.. Fisher D A. In: The Physiology of the Newborn Infant
(1976) 4th edition, ed. Smith A C, Nelson N M. p 612.
. Charles C. Thomas, Illinois.
215 • Felig P, Marliss E, Cahill G F. New Engl. J. Med.
(1969) 281 811-816.
216. Milner R D G, Wright A D. Clin. Sci. (1966) 3_1_ 309 - 315.
217. Ponte C, Gaudier B, Deconinck B, Fourlinnie J C.
Biol. Neonate (1972) _20 262 - 269.
218. Heird W C, Driscoll J M, Winters R W. In: Size at Birth,
CIBA Foundation Symposium 27, (new series) (1974)
pp 329 -351. Associated Scientific Publishers, Elsevior-
Excerpta Medica North Holland, Amsterdam, Oxford, New York.
219. Hill D E. ibid p 350 (discussion)
220 . Turkington R W. Biochem Biophys. Res. Commun. (1970)
4_1_ 1362 - 1367.
221 . Cuatrecasas P, Desbuquois B, Krug F. Biochem Biophys.
Res. Commun. (1971) 44_ 333 - 339
222 . Freychet P, Roth J, Neville D M Jr. Proc. Nat. Acad.
Sci. U.S.A., (1971) 68 1833 - 1837.
223. Cuatrecasas P,. 'Proc. Nat. Acad. Sci. U.S.A., (1971)
68 1264 - 1268.
224
. Gavin (III).J R, Roth J, Jen P, Freychet P. Proc.
Nat. Acad. Sci. U.S.A., (1972) 69_ 747 - 751.
225 • Gavin J R, Gorden P, Roth J, Archer J A, Buell D N,
J. Biol. Chem. (1973) 248 2202 - 2207.
226 • Posner B I. Diabetes (1974) 23_ 209 - 217.
227 . Posner B I. Diabetes (1973) 2_2 552 - 563.
228 . Grimaldi R D, Jung W, Mahler R J. Diabetes (1966)
JL5 p 534 .
229 . Cahill G F Jr. Aoki T T, Brennan M F, Miller W A. Proc.
Nutr. Soc. (1972) 3± 733 - 238.
230 . Felig P, Wahren J. J. Clin. Invest. ( 197 1) _50 1702 - 171
231. Felig P. A Rev. Biochem (1975) 44_ 933 - 955.
232. Felig P, Owen 0 E, Wahren J, Cahill G F.Jr. J. Clin.
Invest. (1969) 48 584-594.
233. Adibi SkA. J.- Appl. Physiol (1968) 25 52 - 57.
234. Malette L E, Exton J K, Park C R. J. Biol. Chem.
(1969) 244 5713 - 5723.
235- Felig P, Pozefsky T, Marliss E, Cahi'll G F. Science
(1970) 167 1003 - 1004 .
236. Snell K. Trends Biochem Sci. (1979) 4 124 - 128
237. Felig P, Kim Y J, Lynch V, Hendler R. J. Clin. Invest.
(1972) 52 1195 - 1202.
238 FellS Lynch V. Science (1970) 990 - 992.
239. Kim Y J, Felig P. Metabolism (1972) 22 307 - 512.
24a Felig P, Wahren J, J. Clin Invest (1971) 50 2703 -
2714. —
241- Kaijser L, Eklund B, Riccardi G, Carlson L.
Scand. J. Clin. Lab. Invest (1979) 39^ 321 - 328.
243 Goldberg A L, Odessey R. Am. J. Physiol (1972)
223 1384 - 1391.
243- Meikle A W, Klain G J. Am. J. Physiol. (1972) 222
1246 - 1250.
244- Odessey R, Goldberg A L. Am. J. Physiol. (1972) 223
1376 - 1383.
245- Buse M G, Biggers J F, Friderici K H, Buse J F.
J. Biol. Chem. (1972) 247 8085 - 8096.
246. Fulks R M, Li J B, Goldberg A L. J. Biol. Chem. (1975)
250 290 - 298.
247. Jefferson L S, Korner A. Biochem J. (1969) 111 703 -
712.
248t McGowan E, Richardson A G, Henderson L M, Swan P B,
J. Nutr. ( 1972) 103 109 - 116.
249. Morgan H E, Earl D C N, Broadus A, Wolpert E B,
Giger K E, Jefferson L S. J. Biol. Chem. (1971) 246.
2152 - 2162.
250. Morgan H E, Jefferson L S, Wolpert E B, Rannels D E.
J. Biftl. Chem. (1971) 246 2163 - 2170.
251. Buse M G, Biggers J.F, Drier C, Buse J F. J. Biol.
Chem. (1973) 248 697 - 706.
252. Buse M, Reid S S. J. Clin. Invest. (1975) 56^ 1250 -
1261 .
253.. Lundholm K, Schersten T. Eur. J. Biochem (1975) _6C)
181 - 186.
254. Lundholm K, Schersten T. Eur. J. Clin. Invest.
( 1977) 7_ 531- 536.
255. Rannels D E, Hjalmarson A C, Morgan HE. Am. J.
Physiol (1974) 226 528 - 539.
256. Millward D J, Garlick P J, Nnanyelugo D 0, Waterlow J C,
Eiochem, J. (1976) 156 185 - 188.
257. Woodside K H, Mortimore G E. Fed. Proc. (1970) 29_
p 379.
258. Rannels E. Kao R, Morgan HE. J. Biol. Chem. (1975)
250 1694 - 1701.
259. Neely A N, Cox J R, Fortney J A, Schworer C M,
Mortimore G E. J. Biol. Chem. (1977) 252 6948 - 6954.
260. Munro H N. Proc. Nutr. Soc. (1969) 28^ 214 - 225.
261. Baliga B S, Rronczuk A W, Munro H N. J. molec. Biol.
(1968) 34 199 - 218.
262. Rothschild M A, Oratz M, Schreiber S S. Gastro¬
enterology (1974) 67 1200 - 1213.
263-
264-
Clemens M J, Korner A. Nature Lond. (1971) 232 252 - 253.
Clemens M J. Proc. Nutr. Soc. (1972) 31 273 - 9.
265. Clemens M J. Biochem. J. (1972) 129 3 - 4P
266. Kipnis D M, Noall M W. Biochem. Biophys. Acta. (1958)
28_ 226 - 227.
267# Manchester K L. Biochem.J. (1961) 135 - 147
26a Guidotti G G, Borghetti A F, Gaja G, Loreti L, Ragnotti G.
Foa P P. Biochem J. (1968) 107 565 - 580.
269. Clark C M. Biol. Neonate (197 1) _19^ 379 - 388.
270. Fritz G R, Knobil E. Nature Lond. (1963) 200 p 682
Scharff R, Wool I G. Biochem J. (1965) 9J_ 257 - 276.271
272 Elsas L J, Albrecht I, Rosenberg L E. J. Biol. Chem.
(1968) 2JJ3 1846 - 1853.
275. Manchester K L, Young F G. Biochem, J. (1968) 70
353 - 358.
274. Hernandez T, Coulson R A. Am. J. Physiol (1969) 217
184 6 - 1852.
275. Adamson L F, Langeluttig S G, Anast C S. Biochim.
Biophys. Acta (1966) 115 355 - 360.
276
279-
Hahn T J, Downing S J, Phar.g J M. Am. J. Physiol.
(197 1) 220 1717 - 1723.
277- Phang J M, Valle D L, Fisher L, Granger A. Am. J.
Physiol. (1975) 22J5 23 - 26.
27a Phang J M, Downing S. Am. J. Physiol. (1973) 224
191 - 196.
ManchesterK L. Biochem J. (1966) 98 711 - 719.
280- Penhos J C, Krahl M E. Am. J. Physiol. (1963) 204
140 - 142.
281* Forker L L, Chaikoff I L, Entenman C, Tarver H.
J. Biol. Chem. (1951) J_88 37 - 48.
282- Manchester K L, Diabetes 1972 suppl. 2. 447 - 452.
283- "Krahl M E. J. Biol. Chem. (1953) 200 99 109.
284- Sincx F M, MacMullen J, Hastings A B, J. Biol. Chem.
( 1952) J_98 6 15 - 6 19.
285- Sender P M, Garlick P J, Biochem J. (1973) 132 603 - 608.
286- Chain E B, Sender P M. Biochem J. (1972) 129 13 - 14P
287- Pozefsky T, Felig P, Tobin J D, Soeldner J S, Cahill G F.
J. Clin. Invest. (1969) 48 2273 - 2282.
28Q Pozefsky T, Santis M R, Soeldner J S, Tancredi R G,
- J. Clin. Invest. (1973) 52 1608 - 1615.
289. Susa J B, Cowett R 1-5, Oh W, Schwartz R. Pediat. Res.
(1979) _T3 594 - 598.
290. Brockman R P, Bergman E N, Joo P K, Manns J G. Am. J. Physiol.
(1975) 229 1344 ->550
291. Prior R L, Christenson R K. J. Amin. Sci. (1978) b6_ 211 - 218.
292- Aoki T T, Muller W A, Brennan M F, Cahill G F.
Diabetes (1973) 22 768 - 775.
293. Elwyn D H, Hamendra C P, Shoemaker W C. Am.' J. Physiol.
(1968) 215 1260 - 1275.
2g4« Anderson D M, Mangan J L, Wright P C. Proc. Nutr. Soc.
(1974) a3 79-80 A.
295. Raabo E, Terkildsen T C. Scand. J. Clin. Lab. Invest.
( 1960) VI 402 - 407.
296. Laboratory Manual of Pediatric Micro and Ultramicro
Biochemical Techniques (1964) 3rd edition ed. O'Brien
D, Ibbott F A. p 260 Harper and Row, New York.
297. Cockburn F, Blagden A, Robins S P. Technicon Symposium
(1969) Automation in Analytical Chemistry (1971) p 165.
Technicon Instruments Co. Ltd., Basingstoke.
298 Me11or D J, Slater J S. Br. Vet. J. (1973) 129 260 -
266 .
299- Pearson R A, Mellor D J. Res. vet. Sci. (1976) 21
100 -*>101. . —
500. Slater J S, Mellor D J. Res. Vet. Sci. (1981) 21 224 - 230.
301. Hodgson J C, Mellor D J, Field A C. Biochem. J. (1980) 186
739 - 747o
302. Hodgson J C, Mellor D J, Field A C. Biochem. J. (1981) 196
179 - 186.
303. Mellor D J, Matheson I C, Small J. Res. Vet. Sci. (1977)
23 119 - 121.
304. Mellor D J, Murray L. Res. Vet. Sci. (1981) _30 198 - 204.
305. Comline R S, Silver M. J. Physiol. (1970) 209 567 - (c>0$.
306. Mellor D J, Matheson K. Res. vet. Sci. (1975) 18
22 1 - 223.
307. Power G G, Longo L D. Gynecol. Invest. (1975) 6^ 342 - 3j5.
308. Reynolds S R M. Obstet. Gynec. N.Y. (1978) 5J_ 245 - 249.
309. Evans E A, Green R H, Spanner J A, Waterfield W R.
Nature Lond. (1963) 198 1301 - 1302.
310.. Vernier R L. Pediat. Clin. Am. (1964) JU 759 - 766.
311. Mel lor D J, Slater J S. J. Physiol. (1372) 227^ 503 - 525.
312. Me11or D J, Slater J S. J. Physiol. (1971) 217 573 - 604.
313. Mellor D J, Slater J S. Res. vet. Sci. (1973) _15^ 317 -
32 1.
31'4. Mellor D J, Slater J S, Matheson I C. Res. vet. Sci.
(1975) JJB 2 19-221.
315. Slater J S, Mellor D J. Res. vet. Sci. (1977) _22
95 - 100.
316. Cross D L, Boling J A, Ely D G. J. Anim. Sci. (19^5)
41 1164 - 1 169.
I
317. Power G G, Longo L D, Wagner H N, Kuhl D E, Forster R E.'
J. Clin. Invest. (1967) 46^ 2053 - 2063.
318. Cohn H E, Sacks E J, Heymann M A, Rudolph A M.
Am. J. Obstet. Gynec. (1974) J_5 817 - 824.
319. Duncan S L 3, Lewis B V. J. Physiol (1969) 202
471 - 481.
320. Karvonen M J, Laamanen A, Raiha N. Acta. Physiol.
Scand. (1956) 36. 245 - 249.
321. Papalia A, Gruenwald P. Biol. Neonate (1976) 2_8 125 - 132.
322. Alexander D P, Britton H G, Forsling M L, Nixon D A,
Ratcliffe J G. Biol. Neonate (1974) 24_ 206 - 219.
323. Feigin R D, Klainer A S, Beisel W R. Nature Lond.
(1967) 215 512-514.
324. Feigin R D, Raymond M W. Pediatrics (1970) 45 782 - 791.
325. Gan J C, Jeffay H. Biochim Biophys Acta (1967) 143 448 -459.
326. Waterlow J C, Stephen J M L. Clin. Sci. (1968) 35
287 - 305.
327. Moore S, Stein W H. J. Biol. Chem. (1951) 192 663 - 681.
32& Hamilton P B. Ann. N.Y. Acad. Sci. (1962) 102 55 - 75.
329- Perry T L, Stedman D, Hansen S. J. Chromat. (1968) 38
460 - 466. —
330. Block W D, Markovs M E, Steele B F. Proc. Soc. Exp.
Biol. Med. (1966) 122 1089 - 1091.
331. Stein W H, Moore S. J. Biol. Chem. (1954) 211 915 - 926.
332 . Tracer Methods for In. Vivo Kinetics (1972/ ea. shipley
R A, Clark R E. Academic Press, New York, London.
333. White R G, Steel J V, Leng R A, Luick J R*. Biocnem.
J. ( 1969) _m 203 - 214."
334. Garlick P J. Nature (1969) 61 - 62.
335. Garlick P J, Millward D J, James W P T. Biochem. J.
(1973) 136 935 - 945.
336. Young M, Noakes D, Horn J, Sloan I, Chrystie S.
Ann. Rech. Vet (197.7) 8 p 499.
337. Young M, Horn J, Noakes D L. In: Nutrition and Growth
of the Fetus and Infant (1979) ed. Visse H K A, pp 19 - 27.
Martiniis Nijhoff Publishers B V, The Hague, Boston,
London.
338. Chrys tie S, Horn J, Stern M, Noakes D, Young M.
.personal communication.
339. Soltesz G Y, Joyce J, Young M. Biol. Neonate (1973)
23 139 - 148.
340 Chrystie S, Horn J, Sloan I, Stern M, Noakes D, Young M.
Proc. Nutr. Soc. (1977) 36_ p 118a.
341. Waterlow J C. Clin. Sci. (1967) _L3 507 - 515.
242* Konikova A S, Dobbert N N, Braunstein A E. Nature Lend.
( 1947) J5_9 67 - 68.
343. Waterfield W R. Nature Lond. (1968) 218 472 - 473.
344. Buttery P J, Beckerton A, Mitchell R M, Davies K,
Annison G F. Proc. Nutr. Soc. (1975) 34_ p 91a.
345* Applied Physiology (197 1) 12th edition ed. Wright S. revise-;
by Keele C A, Neil E. p 548 Oxford University Press,
London. New York, Toronto.
346. Principles of Biochemistry (1973) 5th edition ed. White A,
Handler P, Smith E. L. p 814. McGraw-Hill, Book Co.,
New York.
347. Comprehensive Biochemistry (1963) 7 ed. Florkin M,
Stotz E H. pp 50 and 212. Elsevier Publ. Co., Amsterdam,
London, New York,
34Q Kerr D.S, Stevens M C G, Robinson H M. Metabolism (1978)
2_7 4 1 1 - 435.
\
349- Chen W J, Lin J-Y, Hung W-T. J. Formosan Med. Assoc.
(1978) 77 56-67.




£ i * "
Foetal amino acid*
. CoCKBURN and MkRetb Giles, Department of Child Lift end Health,
etsity of Edinburgh end Simpson Memorial Maternity Pavilion, Royal
mary, Edinburgh
Maternal factors
sternal dietary protein is the major source of foetal amino acids when
rnal nutritional intake and absorption are adequate. In states of maternal
in undernutrition or malnutrition foetal amino acid supplies are maintained at
xpense of maternal tissue breakdown. Rates of placental amino acid transfer
ot readily measurable in man, but measurements of foetal to maternal ratios of
idual amino acids have been used to give an indication of the efficiency of
ntal transport systems for amino acids (Kerr & Waisman, 1967). Maternal
utrition is associated with increased plasma glycine/valine quotients in
er and foetus (Lindblad, Rahimtoola, Said, Haquc & Khan, 1969). In pre-
ipsia with retarded foetal growth there is a generalized increase in maternal
ta amino acid concentrations towards non-pregnant values and the foetal to
rnal plasma amino acid ratios, particularly of the branched-chain amino acids,
ower than normal (Cockbum, Hlagden, Michic & Forfar, 1971)- Higher
■mal plasma branched-chain amino acid concentrations may reflect a release of
amino acids from maternal muscle protein.
te normal fall found in maternal plasma amino acid concentrations during
tancy may be mediated through changes in circulating hormones. Oestrogen,
rsteronc, Cortisol and insulin influence plasma amino acid concentrations
leman, Seal & Doc, 1967; Dancis, Money, Springer & Levitz, 1968) ar.d the
1 maternal plasma concentrations may, in part, be due to an increased urinary
•lion (Zinneman, Johnson & Seal, 1963) or to an increased rate of transfer of
o acid into cells of uterus and into placenta and foetus (Iljorcnesjo, 1968).
Placental factors
tender & Christensen (1959) postulated that amino acids are transported
is cells against concentration gradients from an active uptake site on one side
e membrane to produce intracellular accumulation, while on the other side of
membrane simple diffusion down a concentration gradient was thought to
r. Such a system may function in the placental syncytiotrophoblast since
X « t
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Pearse & Sornson (1969) have described high concentrations of amino acid in the
human placental parenchyma. Hill & Young (1973) demonstrated that in the
guinea pig transfer from placental parenchyma to foetal plasma was blocked when
foetal plasma acid concentrations exceeded the free amino acid concentrations of
the placenta] parenchyma.
There is controversy about the role of insulin in the regulation of placental
amino acid transfer (Villee, 1953; Battaglia, Meschia, Blechner & Barron, 1961;
Freinkel, 1965; Grimaldi, Jung & Mahler, 1966; Szabo & Grimaldi, 1970; Demers,
Gabbe, Villee & Creep, 1972). The demonstration of insulin receptors in human
and animal placentas, with characteristics similar to those in established insulin
target tissues such as fat cells and liver, supports the argument that insulin may
play a role in the regulation of placental function (Posner, 1974).
Changes in placental blood flow on maternal and foetal sides will influence
transport rates. Gross variations in human maternal plasma concentrations of
individual amino acids can disturb foetal amino acid metabolism (Cockburn,
Farquhar, Forfar & Robins, 1972), but lesser degrees of imbalance in the ewe do
not seem to influence unduly foetal lamb values, and there appear to be group
transport systems in the trophoblast similar to those of small intestine and renal
tubule (Young & McFadyen, 1973).
Foetalfactors
The degree to which the foetus can control his own supply of nutrient material is
unknown. In a recent Symposium (Elliott & Knight, 1974) on foetal size the
maternal and foetal factors controlling foetal growth were reviewed. From the
increased rates of growth of infants of diabetic mothers (Persson, 1974) and severe
growth retardation in infants lacking pancreatic islets (Liggins, 1974) it appeared
that foetal insulin might be a major foetal growth promoting factor. There is
evidence in preterm human infants that infusions of insulin can increase the rates
of entry of glucose, potassium and amino acids into tissues (Cockburn, 1976).
Conversely in rhesus monkey foetuses starved by interfering with placental blood
flow, foetal muscle and other tissue protein breakdown occurs and this catabolic
state may be associated with catecholamine, glucagon and Cortisol release (Hill,
1974)-
A small quantity of amino acids may reach the foetus from swallowed amniotic
fluid. At term the human infant swallows approximately 450 ml of amniotic fluid
per day (Plentl, 1966). The amino acid composition of amniotic fluid changes
throughout pregnancy (Cockburn, Robins & Forfar, 1970; Cockburn, Giles, Robins
& Forfar, 1973) and this is only in part related to dilution with increasing volumes
of urine. Table 1 shows the fall in total mean amino acid concentrations of
maternal (MV) and foetal (UA) plasma water, foetal urine (FU) and amniotic fluid
(AF) from mid to late pregnancy. In mid pregnancy FU and AF individual free
amino acid concentrations correlate but by term these correlations are lost and the
fluids are dissimilar (Table 2).
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ble 1. Total mean amino acid concentrations (\imol/l) in fluids from eight
mal human pregnancies between 15 and 20 weeks gestation compared with
lues from eight normal human pregnancies terminated electively by Caesarean
tion between 39 and 40 weeks gestation.
lues for matcm*] vein plasma water (MV), umbilical arterial plasma water (UV), foetal urine
J) and amniotic fluid (AF) free amino acid concentrations were obtained by summation of

































ble 2. Correlations of 24 to 29 individual free amino acid concentrations in
ternal vein plasma (MV), umbilical artery plasma (UA), amniotic fluid (AF)
i foetal urine (FU) obtained from eight normal human pregnancies between
and 22 weeks' gestation and eight normal human pregnancies terminated
ctively by Caesarean section between 39 and 40 weeks' gestation
MV:AF MV:AF UA:AF UA:AF FU:AF FU:AF
(15-20) (39-40) (15—20) (3^-40) (15-20) (39-40)
weeks weeks weeks weeka weeks weeks
*4 26 *7 *5 29 28












Ratios of amino acid concentrations between foetal UA plasma and urine
icate that the foetal kidney at 15—20 weeks gestation can effectively conserve
ino acids, possibly reaching an adult level of competence in this respect
jckburn et al. 1970).
Perfusion of a gravid human uterus at 18 weeks gestation through the uterine
eries for 30 min with blood containing L-{3H]phenylalanine confirmed that after
y avid uptake of amino acid in syncytiotrophoblast high foetal plasma
iccntrations were quickly achieved but very small quantities reached foetal
ne. Autoradiographs demonstrated radioactivity in the proximal tubules but this
s absent from the distal and collecting tubules (Robins, Baird, Cockburn,
dngston & Smith, 1971).
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Placental transfer of phenylalanine in chronically catheterised sheep
Placental transfer and foetal uptake of amino acids have been examined in the
catheterised foetal lamb after infusions of unlabelled amino acids (Young &
McFadyen, 1973; Young, Soltesz, Noakes, Joyce, McFadyen & Lewis, 1975).
Clearance rates for different amino acid groups were calculated and the
postoperative changes in amino acid metabolism determined. In virtually all
studies of amino acid transfer in man, monkey, sheep and guinea pig,
concentrations of individual free amino acids measured in plasma water of mother
and foetus have been compared. The same is true of experiments employing
labelled amino acids where activity is measured in the supernatant plasma water
and the precipitated plasma proteins arc discarded. However, when labelled amino
acid is infused into animals a greater portion of radioactivity is found to be




Fig. .. Relative concentrations of radioactivity in maternal plasma (O), maternal plasma water
(•), foetal plasma (A) and foetal plasma water (A) during and after the infusion of
L-{U-,*C}phcnylalanine into a jugular vein of a 126 d pregnant sheep whose single foetus had
foetal UV and UA catheters inserted at 106 d gestation. 200 pCi of uniformly L-[Ul4C]phenyla]anine
was infused in 20 ml saline (9 g NaCl/1) at a constant rate of 50 pCi/h for 4 h after a priming
injection of 50 pCi in 5 ml saline.
1
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radioactivity found in 1 ml of maternal plasma compared with that found in
asma water from 1 ml of deproteinized plasma (plasma—o-6 M-sulphosalicyclic
:id, 1:1 v/v). Samples were obtained during and after the infusion of L-{U-
C]phenylalanine into the jugular vein of a 126 d pregnant sheep whose single
«tus had foetal UV and UA catheters inserted under general anaesthesia at 106 d
^station (see Mellor & Matheson, 1975 for the techniques of catheterisation and
ire). 200 pCi of [U-14C]phcnylalanine was infused in 20 ml saline (9 g NaCl/1) at a
instant rate of 50 pCi/h for 4 h after a priming injection of 50 pCi in 5 ml saline,
[atemal blood samples were obtained from the other jugular vein and foetal
imples from the UA catheter. It is evident that plasma water activity is at a much
wer level than that of whole plasma and that whereas plasma water values reach
w concentrations after 12 h, high activity is retained in association with protein
jring the 9 d of study.
Foetal plasma water activity is higher than maternal and this is in accord with
e high foetal to maternal ratios found in other studies; and foetal plasma protein
rtivity is high in comparison with foetal plasma water, though it does not reach
e values of maternal plasma protein. Maternal and foetal plasma protein
tivities are converging by the 9th day after infusion. When specific activities are
>nsidered for phenylalanine in maternal plasma water there is a fall from 79x10'
im/pmole at 2 h to 1 x 103 dpm/pmole at 22 h. Values remained at about this level
iring the next 7 days. In foetal plasma water phenylalanine specific activity was
<io3 dpm/pmole at 5 h, 5X103 dpm/pmole at 11 h and 0 ixio3 dpm/pmole at
d. Maternal plasma water ratios of tyrosine specific activity to phenylalanine
•ecific activity increased fairly rapidly from o 008 at 30 min to 0 7 by 22 h.
Acid hydrolysis of the plasma protein sulphosalicylic acid precipitates confirms
at 70-110% maternal plasma protein-associated activity in the samples so far
lalysed is accounted for by tyrosine and phenylalanine.
From the end of the infusion until the end of the experiment phenylalanine
tivity averaged 222 dpm/mg plasma protein in maternal plasma and 174
im/mg foetal plasma protein. Mean maternal plasma protein concentration was
r g/1 whereas in the foetus this value was only 25 3 g/1.
Identical patterns of dissociation between plasma water and plasma protein
tivities have been found during [uC]leucine infusions into the ewe.
Infusions of [l4C]phcnyla!anine into the foetus demonstrate (a) the very rapid I
sociation of radioactivity with foetal plasma protein, (b) that foetal plasma water j
ncentrations exceed maternal and (c) that maternal protein-associated activity
ceeds maternal plasma water activity (Fig. 2).
When [,4CJphenylalanine or [,4C]leucine is added to blood in a test tube or in a
nometer maintaining the blood at a 'physiological' temperature, pH, P0j and
the activity remains in the plasma water fraction. Within 10 min in vivo a
rge proportion of radioactive amino acid is protein-associated. Phenylalanine and
Licine arc firmly attached to or arc incorporated into protein or peptides and the
iture of this association is currently under investigation.








Fig. 3. Relative concentration! of radioactivity in foetal plaama (A), foetal plasma water (AX
maternal plasma (O) and maternal plasma water (•) during and after the infusion of
L-{U-,4C]phenylalanine into an umbilical vein of a 130 d single foetus which had UV and UA
catheters inserted at no d gestation. 200 pCi of uniformly labelled L-phenylalanine was infused
in 20 ml saline at a constant rate of 50 pCi/h for 4 h after a priming injection of 50 pCi in 5 ml
saline.
The role of insulin in placental amino acid transfer
After a meal containing protein or amino acid, maternal plasma amino acid
concentrations rise and normally increased insulin secretion will result. This rise in
maternal insulin will increase insulin attachment at receptor sites on the maternal
aspect of syncytiotrophoblast and encourage the transfer of amino acids into
placental parenchyma. From placental parenchyma amino acids could diffuse down
a concentration gradient to foetal plasma water and in turn be removed from foetal
plasma water to the intracellular compartments of the foetus at a rate mediated by
foetal insulin secretion.
Information gathered about foetal amino acid metabolism in different animal
species is beginning to shed light on factors which control foetal amino acid
v
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itribution, protein synthesis and growth. More information is necessary before
empts can be made to improve the well being of a foetus suffering from
rauterine malnutrition.
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